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Conventional bacteriological methods to establish bacterial burden and
distribution in infected tissues in vivo animal models typically require extensive
bacteriological procedures and therefore are time consuming. An alternative approach has
been suggested to use optical markers, such as luciferases, to labeled pathogens and
monitor their progress and distribution in real time. The objective of the work presented
in this document was to validate the use of Biophotonic Imaging (BI) through in vitro
studies as a first step toward the development of in vivo models to study infectious
disease in the bovine.
For example, the feasibility of detecting bioluminescent Escherichia coli (E. colilux) from within the different bovine reproductive tract segments was studied. Up to 17
% transference of photonic emissions (PE) was detected through the reproductive tract,
suggesting that in vivo or in situ models may provide a novel approach for in real time
screening of uterine infections in large farm animal models.
Further in vitro research conducted toward the development of approaches for non
invasive detection of lux-bacteria in bovine mastitis models demonstrated that detection

Template Created By: James Nail 2010

through the bovine mammary gland might be limited due to tissue thickness and density.
However, imaging of Staphylococcus aureus (S. aureus)-lux presence in teat-end skin
wound in vitro models demonstrated promising results. Furthermore, trials demonstrated
that imaging of lux-bacteria in milk samples, as means to estimate bacterial cell numbers
(CFU), represent an efficient model to monitor bacterial progression in vivo mastitis
models.
According to these findings, the efficacy of an intramammary antimicrobial agent
was evaluated in real time using S. aureus-lux in vivo mastitis models conducted in
lactating dairy cows. Photonic emissions from milk samples collected from challenged
quarters with S. aureus-lux resulted to be an excellent predictor of CFU, as demonstrated
by the high and positive correlation (0.99; P < 0.0001) between CFU and PE. In addition,
BI provided in real time information regarding spatial distribution of S. aureus-lux in
infected mammary gland quarters ex vivo. Collectively, this date positions BI as novel
and promising tool to improve current bacteriological methods to better understand
pathogenesis of bovine mastitis infections.
Keywords: Biophotonic Imaging, experimental mastitis, Staphylococcus aureus RF122,
Staphylococcus aureus-Xen8.1, Escherichia coli-Xen14
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CHAPTER I
LITERATURE REVIEW
Origins of the bovine and their contribution to man
Domestic cattle belong to the order Artiodactyla of the Bovidae family, Bovini
tribe which are members of the genus Bos. These include, in addition to the most
common dairy and beef cattle species found in the US, the Yak, Gaur, Banteng, Gayal,
which are beleive to first appeared in the Miocene epoch 20 millions of years ago
(Bradley and Magee, 2006; MacEachern et al., 2009). It is suggested that the Bovidae
diversification coincided with the widespread emergence of rich pastures-based
ecological niches (e.g., kelp forests and grasslands), which originated during the Miocene
epoch (23 to 5 MYA). All domestic cattle are thought to descend from a common
ancestor, the auroch or primordial ox (Bos primigenius or first cow). All of the humpless
cattle in the Western world are of the specie Bos taurus while humped cattle are thought
to descend from another kind of aurochs and those were given the scientific name of Bos
indicus, because the classic humped cattle from the Indian subcontinent (Montgomery,
2004). Bos taurus cattle predominate in the temperate lands of Europe, West Africa, and
northern Asia, whereas Bos indicus cattle generally inhabit the hot-arid or semi-arid
regions of South Asia and Africa (Bradley and Magee, 2006).
According to various authors (MacEachern et al., 2009; Montgomery, 2004;
Zeder et al., 2006) cattle are the most culturally and economically important species ever
domesticated by man. Most of the world’s advanced cultures that eventually had written
1

languages were developed in the company of a multitude of cattle; cows and bulls of
many sizes and many colors (Montgomery, 2004). From the prehistoric, cows benefited
and assisted man in a revolution in agriculture: people saving seed, planting and
harvesting crops, and raising animals for meat instead of chasing them through the wilds.
Ages were passing, cultures were advancing and cows were there to be adapted to man’s
needs. For example, cows were the first traction of humans for plowing. Rudiments of
agriculture preceded the plow, when people first scratched at the soil and planted seeds.
Milk from cattle was our first renewable and reliable source of protein and fat. In addition
to this and as an interesting statement by Montgomery, (2004) “wherever our ancestors
raised cows, they created or adopted a plethora of alphabets and symbolic characters,
mathematics, and literature.” Consequently, cultures without cattle, as in America and
sub-Sahara Africa, relied on conquest and slavery to create wealth.
Due to the fact that cattle represents a significant source of meat for human
consumption (e.g., total U.S. cattle and beef consumption in 2010 was 26.4 billion
pounds; USDA-ERS, 2010), their use for experimental tissues is readily in large
quantities from abattoirs. In addition, the utilitarian aspects of the cattle-human
association minimize ethical and social objections to the use of cattle in research.
According to Gibbs et al. (2002), research in cattle have helped investigators to improve
the lives of millions of people each year by giving them clues to prevent and treat
illnesses. For example, the development of several vaccines (e.g., smallpox, tuberculosis,
among others) has been possible due to the use of cattle in biomedical research. In fact,
the word vaccine comes from the Latin root for cow; vaca. Using cattle as a model for the
development of vaccines, such as those to prevent tuberculosis, is feasible due to the
strong similarity between the disease in cattle and humans. For instance, calves like
2

human infants, are immunocompetent at birth (Buddle et al., 2005); therefore, are well
suited in prioritizing antigens associated to this deadly infectious bacterial disease for
testing in humans. In addition, cattle as a model for the development of vaccines against
human tuberculosis provide particular benefit over other animal species as it is relatively
easy to collect large volumes of blood from calves at the intervals following vaccination
and challenge, as well as that large numbers of immunological reagents are available for
cattle (Buddle et al., 2005).
Discovery of drugs currently used in humans for treating blood pressure problems
were possible also due to the use of cattle as a model for human medicine. An outbreak
reported in 1920 in Canada where 21 out of 22 cows died after dehorning and 12 out of
25 bulls died after castration, raised suspicions of the presence of a specific compound in
the feed source that might interfere with normal blood coagulation; due to the fact that all
these animals bled to death after the mentioned surgical procedures. It was not until a
year later when a Canadian veterinary pathologist determined that the causative agent
was moldy silage made from sweet clover; the mold functioned as a potent anticoagulant.
In (1941), Stahmann and collaborators identified the anti-coagulant warafin (coumarin) in
the blood of cattle with sweet clover disease. Through degradation experiments, the
mentioned investigators established that the anticoagulant was 4-hydroxycoumarin which
they later named dicoumarol. This anticoagulant was first used as rodent poison and first
registered as warafin in the US in 1948. However, after an incidence in 1951 where a US
army inductee using warafin tried to commit suicide and recovered fully, studies began to
study warafin as a therapeutic anticoagulant. Four years later, it was approved for
medical use in humans. In 1978, the exact mechanism was described; warafin inhibits the
enzyme epoxide reductase, interfering with vitamin K metabolism.
3

The parathyroid hormone was also identified by experiments developed with
cattle. Collip (1925), prepared hot hydrochloric acid from extracts of bovine parathyroid
glands and isolated the active substance, parathyroid hormone. This scientist described
that parathyroid gland extracts would completely relieve tetany that followed removal of
this gland, and established the parathyroid as an endocrine gland which secretes the
parathyroid hormone. In addition, the composition of insulin was also possible due to
studies with the bovine, and was first determined from bovine insulin by Sanger et al.
(1955). Studies in cattle have also been used to develop practical sources to provide
protection against infectious diseases to humans. For example, bovine milk
immunoglobulins (Ig) have been used to provide passive immunity to human infantile
with retrovirus gastroenteritis, as an approach to provide viable means of prophylaxis of
rotavirus babies, day care centers, hospitalized infants and household contacts (Brussow
et al., 1987). Development of the immune system, in particular the maturation of the
mucosa-associated lymphoid tissues, is similar in humans, sheep, cattle and pigs, which
again, make the cattle a good model for studying mucosal delivery of vaccines.
Many studies conducted in animals have contributed greatly towards improving
our understanding of human endocrinology and reproductive physiology. Classical
endocrinologists in cattle led to the current understanding of several reproductive
hormones. In (1961), Wiltbank and collaborators demonstrated the luteotropic effects of
luteinizing hormone (LH). They used cycling cows to determine the effect of daily
injections of human chronic gonadotropins on the maintenance of the corpus luteum and
embryonic survival, establishing that regression of the corpus luteum during the estrous
cycle of the cow may result from a deficiency of gonadotropins, presumably LH. In
addition to these findings, bovine models also provided the fundamental research base for
4

developing human reproductive techniques. For instance, many of the current
reproductive techniques used in humans such as super ovulation, in-vitro fertilization,
embryo transfer, maturation and freezing are based on research conducted with bovine
embryos. Brackett et al. (1982) successfully performed, for the first time, a repeatable
procedure for in vitro fertilization, embryo transfer, and successful gestation with
normally developed calves. In vitro fertilization, in animals for instance, provides a
means to maximize the efficient usage of semen from valuable males (e.g., a single bull
might sire 50 millions calves in a single year). In humans, this approach should yield
significant information for assessment of sperm fertilizing abilities and to improve our
understanding regarding to infertility in humans and as an effort to develop procedures
for in vitro fertilization in humans. According to Brackett et al. (1982), the potential of
the bovine model for improving human reproduction is supported by the facts that (1)
cows have a gestation period similar to humans and also bears a single offspring, (2) the
biological standardization for endocrinological events associated with ovulation timing,
provided by the onset of behavioral estrus in the cow, (3) and that experiments in cattle
are associated with less alarming ethical issues than those found when using humans in
research. In addition, using cattle as human models has greatly contributed to the
development of techniques using frozen semen for fertilization of human embryos and
sexing semen (Johnson et al., 1987; Phillips, 1939; Polge et al., 1949).
More recently, biomaterials from cattle have been studied as an alternative animal
model for bioprosthetic materials in humans. Although human bioprosthetic materials
such as cardiac valves are mostly derived from porcine, studies have shown that
histological and histochemical characteristics of the heart valve of buffalo and some
physiological factors and hematological constituents of indigenous cattle are highly
5

compatible with human, relative to pigs (Islam et al., 2002). In addition, human bone
implantations are being recently made from bovine bones. For instance, RTI Biologics
(2011) is a US company that manufactures human bone implants from bovine bone parts.
Some advantages of using animal derived biomaterials over human derived biomaterials
are that, animal bones are more practical and cost-effective to procure, and while
human’s cadavers yield from 20 to 30 grafts, RTI Biologics technicians can manufacture
more than 300 grafts from a single cow. The company’s first xenograft (animal-derived
implants) was implanted into patients in December 2005 and, since then, they have made
about a dozen xenograft implants in spine, sport medicine, orthopedic, dental and other
surgical specialties (RTI Biologics, 2011).
Gibbs and collaborators (2002), in an interesting communication to support the
sequencing of the bovine genome, as a reference for non-primate, nonrodent, eutherian
genomes to identify new genes and novel regulatory elements in humans, mice and rats,
made the remarkable proposition of using the bovine model to improve human
reproduction. Among them, development of bovine stem cells research, which has played
a critical role in our understanding on human stem cell research. In addition, using the
bovine as a model for human stem cells and other developmental biology type research
would diminish ethical concerns relative to the use of humans
Of all the discoveries that were possible thanks to research conducted in bovine,
the recent completion of the bovine genomic sequence (BGS) might be the most
significant. Some of the characteristics that make the BGS imperative to human health
are its many similarities to the human gene sequence. In addition, the similarities that it
conveys with the human genome are greater than those found in rat and mice genomes,
that were completed earlier than the bovine. Since the human genome sequence is already
6

completed, the BGS can be used to improve our knowledge of genetic variation among
diverse phenotypes and diseases by extrapolating genetic information from comparative
veterinary medicine to human medicine. Therefore, the bovine as a model for human or
animal diseases is a valuable production/research animal. Among the reasons to support
this statement are the genetic and physiological similarities this specie sustains with
humans as well as the fact that bovine experimental tissues are readily available in large
quantities from abattoirs. The studies shown in this document were greatly favored due to
the latter fact. Using abattoir derived tissues (i.e., reproductive tracts and mammary
glands) allowed us to develop models with sufficient experimental units to produce data
with statistical relevance (see Chapters One and Two).
As mentioned above, cattle were originated from rich pastures-based ecological
niches and further raised under similar conditions by the first human habitants. However,
due to the increase in human population, farmers have had to modify traditional
management practices in order to meet the increased demand for cattle derived products
(e.g., meat, leather, milk, etc.). Genetic selection toward production traits (meat and
milk), and feeding high energy feedstuff were among the strategies adapted to allow
farmers to increase production per capital. Although these changes have resulted in an
increased production per animal unit, these practices have been associated to negatively
impact cattle welfare; increasing the incidence of diseases and decreasing reproductive
performance. Therefore, understanding the impact that particular management practices
inflict over the welfare of cattle could result in their modification and therefore provide
benefit to both, the farmers (increasing production by decreasing the degree of stress in
the animal) and to the animals (decreasing the degree of stress).

7

Modern management practices and their association with increased incidence of
diseases in cattle.
During the early establishment of agriculture, livestock was primarily raised in
pastoral herding on rangelands, which was an essential provider for sedentary and seminomadic societies. Animals had essentially as much land space as wild animals, breeding
was based mostly by natural selection (survival of the fittest), and mainly native cattle
were used (adapted to the regional environmental conditions). As a consequence of the
increased human pressure toward land use and/or high-quality protein and dairy product
consumption, agriculture based on large-scale production moved from land-based
systems to “landless” systems, where animals are kept in confinement and/or
overcrowded. Selective breeding, as a means to increase production of milk/meat per
animal, has also been used to supply the increased demand on these products, and to
increase profitability; although not always resulting in increased profits (Uribe et al.,
1995). Additionally, overstocking of barns, as a means to compensate for land use
pressure, has been an attractive practice adapted by farmers to spread the cost of housing
(Bewley et al., 2001). Each of these adapted management practices used to supply the
modern lifestyle of today’s civilization represent a significant stressor to cattle. In
addition, dairy cattle located in tropical, sub-tropical and/or semi arid areas such as the
Caribbean and the southern US have to overcome environmental obstacles, such as heat
stress and humidity, predisposing animals to infectious diseases, such as mastitis.
Genetic selection for milk yield and its association with mastitis incidence
Milk yield per cow has increased more than double in the last 40 years with cows
now producing an average of ~6,000 kg of milk more per lactation. This dramatic
increase in milk production was a result of improvements made in management practices
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such as nutrition, quality of roughages and genetics (Oltenacu and Broom, 2010). In
particular, the use of artificial insemination coupled with intense selection of bulls with
high genetic merit for milk production (Oltenacu and Broom, 2010). Cows with high
milk production have a relatively high frequency of health disorders (Uribe et al., 1995),
which could be attributable to genetics as well as biological factors (Radostits et al.,
1999; Simianer et al., 1991). According to Simianer et al. (1991), the incidence of new
diseases increases as a consequence of genetic improvement toward milk yield. This is
mainly due to the antagonistic correlation between milk production and diseases, which
in the case of mastitis ranges from 0.2 to 0.3, where genes that increase milk yield tend to
increase susceptibility to mastitis (Radostits et al., 1999). More recently, Ingvartsen and
collaborators (2003), using several genetic studies, evaluated the relationship between
lactational performance and the incidence rate of production diseases of economic
importance in dairy cattle. These researchers found a negative effect of increasing milk
yield with ketosis (0.26-0.65), ovarian cyst (0.23-0.42), lameness (0.24-0.48), and
mastitis (0.15-0.68), highlighting the negative impact of genetic selection for milk yield
on other biological traits in the dairy cattle. A physiological explanation for the negative
association between genetic selection for milk yield and the mentioned disorders can be
attributable to the fact that animals have a limited amount of resources to allocate to their
biological processes. As a result of this, if output is increased toward productivity (e.g.,
milk), other functions such as fertility, maintenance, movement, immune defense, etc.
will be negatively influenced (Detilleux, 2009; Oltenacu and Broom, 2010).
Alternatively, although the association between milk yield and mastitis does not imply
causation; indirect consequences of larger mammary glands, such as leaking of milk
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between milkings and increased exposure to injuries, are two biologically plausible
explanations (Radostits et al., 1999).
High stock density and mastitis incidence in dairy cattle
Overstocking livestock has been an attractive practice commonly adopted by
dairy farmers. This in part due to the increased human pressure on land use accompanied
by an increased demand for cattle products, forcing dairy farmers to house more cows in
the same pen without investing in housing improvements/expansion (Bewley et al.,
2001). The effects of high stocking rates on cattle have been shown to negatively impact
the cow’s natural feeding pattern, resting and rumination behaviors. Cows allocated to
high stocking rates perform poorly, in part due to a reduction in animal well-being and
subsequent increase in stress (Bach et al., 2008). The effects of high stock density over
the behavioral response of cattle are, for instance, increased competition during feeding,
which can limit the ability of some cows to gain access to food (DeVries et al., 2004),
increased standing time, and reduced lying time, which collectively translates in
physiological and health function impairments (Fregonesi et al., 2007). In addition to
reduced resting time, which is directly linked to production performance, cows in
overcrowded stalls that are waiting for extended periods of time for a free spot to lay
down have been reported to have higher levels of cortisol (Munksgaard and Simonsen,
1996). Glucocorticoids are well known to suppress the immune system, mainly by
inhibiting formation of pro inflammatory substances such as prostaglandins,
thrombaxanes and leukotrienes resulting in impairment of the inflammatory response
(Cunningham and Klein, 2007).
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Although increasing stocking density in dairy herds has been associated mainly
with an increased incidence of lameness (Nordlund et al., 2006), spreading of infectious
diseases and parasites has also been reported to increase (Lean et al., 2008). Housing
cows increases the degree of contact between animals, eventually predisposing them to
mastitis. According to Albenzio et al. (2002), the major source of coliform in intensively
managed ewe flocks is the environment contaminated with feces, and prolonged exposure
to feces was associated with a higher risk of mastitis. Moreover, levels of gaseous
pollutants as well as airborne particles in animal houses increased as stocking density
increases (Curtis, 1983). This can be injurious to the health of both livestock as well as
humans and disrupts the general performance of animals (Sevin et al., 1999). Moreover,
according to Lean et al. (2008), dairy cattle production intensification is furthermore
related to a greater use of fertilizers, high genetic cultivars that provide low fiber and a
higher protein and energy content, selection of animals with higher genetic potential for
milk production, and more use of supplements with high starch and sugar which
eventually influence the production and health of cattle.
As described above, due to the intensive production practices used in modern
agriculture, dairy cattle have been exposed to many stressors. These practices can
increase the incidence of new diseases by either, increasing exposure to pathogens and/or
suppressing the immune system by either, an increase in stress and/or by genetic selection
toward traits other than the immune system. The immune system is equipped with many
components that have evolved to protect the host from invading microbes. Therefore, it is
important to understand these components, their functions and the management practices
that could disturb their balance, subsequently predisposing cattle to infection.
Furthermore, mammalian organs that are continually exposed to environmental
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contaminants have developed anatomical components to provide immediate protection to
their sterile cavities as well as soluble and cellular components to fight any pathogenic
microbe that had overcome the anatomical barrier. The reproductive tract and the
mammary gland are essential organs involved in the perpetuation of the specie and
therefore are highly equipped with immunological components to ensure protection to the
host and proper prenatal nurse, delivery and postnatal nurse to support the growth of the
calf.
Immune components of the bovine against bacterial invasion into the mammary
gland
Mastitis is a multi-factorial disease that involves a complex relationship of three
major aspects: the environment, microbial agents, and the host immunity. According to
Radostits et al. (1994), the environment plays an important role between the interaction
of the agent with the host, influencing the development of the disease characteristics and
habitat of specific microbiologic agents. These factors are important in the occurrence of
mastitis whereas the host defense mechanisms influence the susceptibility of the dairy
cow to udder infections. A total of 137 microbial species, subspecies, and serovars have
been isolated from the bovine mammary gland, however, due to their epidemiology and
pathophysiological characteristics they are further classified as major and minor
pathogens (Radostits et al., 1994). Additionally, major mastitis pathogens can be further
classified as contagious or environmental based predominantly on the natural source and
means of spread of the organisms involved. Common mastitis contagious organisms
comprise Streptococcus agalactiae, Streptococcus dysgalactiae, Staphylococcus aureus
(S. aureus) and Mycoplasma spp. and are mainly spread by milking procedures,
contaminated machinery and the hands of milkers (Divers and Peek, 2008). On the other
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hand, environmental mastitis pathogens are predominately found in bedding materials,
calving areas, cow stalls, and manure. These include Escherichia coli (E. coli), Klebsiella
pneumonia, Enterobacter aerogenes, Serratia sp., Proteus sp., Pseudomonas sp., and
other Gram-negative, coagulase-negative staphylococci, environmental streptococci,
yeast or fungi, Prototheca¸ Arcanobacterium pyogens, and Cornybacterium bovis
(George et al., 2008).
Defense of the mammary gland against microorganisms is mediated by several
anatomical, cellular, and soluble protective factors that work in a coordinated manner to
provide resistance against microorganism invasion (Oviedo-Boyso et al., 2007; Sordillo
et al., 1997). These factors will dictate the degree of resistance of the mammary gland to
new intramammary infections and are governed by the innate and the adaptive immune
system. The innate immunity refers to antigen non-specific defenses that the host utilizes
immediately (natural barriers) or within hours (neutrofils) after exposure with the
microorganism, in order to prevent development of infection. In contrast, the adaptive
immunity or antigen-specific defense system mechanism requires a longer time period
(~2 weeks) to become fully functional and is designed to react with and remove specific
antigens using specific reactants developed during previous exposure to infectious
microorganism. Although both systems have different modes of action, they are
intricately enmeshed with each other and share many effectors mechanisms (Sordillo et
al., 1997). However, during the different production cycles dairy cattle undergo (e.g.,
parity, lactation, dry period), the mammary gland defenses may fail to operate properly
and cows become more susceptible to mastitis (Sordillo et al., 1997).
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The innate immune system
Natural barriers of the mammary gland against invading microorganims
As mentioned above, defense of the mammary gland against microorganisms is
mediated by several means, including anatomical factors. The initial defense mechanism
of the host against invading microorganisms is natural barriers. In mammalian species
these include surfaces such as skin, mucus, ciliated epithelium, moist surfaces of the eye,
nose, airways and lungs, mouth, digestive system, the urinary and reproductive system,
which provide protection and restrict entry of microorganism into sterile cavities (Ganz,
2003; Murray et al., 2005). Since the teat end is the mammary gland structure that is
constantly exposed to microorganisms such as bacteria, fungi, parasites and viruses, it has
evolved into a highly specialized structure to provide protection against colonization of
internal tissues by these microbial agents. Apart from uncommon cases such as
tuberculosis and leptospirosis, bacteria usually gain entrance to the mammary gland via
the teat canal (Blowey and Edmondson, 2010). For this reason, the teat end is considered
to be the first line of defense against invading pathogens and it is equipped with
anatomical defenses or natural barriers such as skin, sphincter muscles, stratified
squamous epithelium and keratin that provide physical means to prevent invasion of
microorganism.
The surface of the teat skin, for instance, possesses a thick covering of stratified
squamous keratinized epithelium of dead cells that, when intact, provide protection
against bacterial colonization (Blowey and Edmondson, 2010). In addition, the teat skin
also contains fatty acids that provide antimicrobial activity. However, these bacteriostatic
compounds can be removed from the teat skin by continual washing with detergents, as
those found in some pre-milking teat sanitizers (Blowey and Edmondson, 2010). The teat
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end is also equipped with sphincter muscles that provide additional protection against
bacterial invasion. Sphincter muscles surround the teat duct tightly between milkings and
provide a physical obstruction for bacterial colonization from the teat opening to the
interior of the gland (van der Tol et al., 2010). Practices that result in repetitive stress to
the teat, such as excessive vacuum and compression of the lines during milking and/or
prolonged milking periods, could affect the integrity of this structure and therefore
predispose the mammary gland to mastitis. In addition, the teat canal is also lined with
folds of keratinized skin epidermis, covered by a thin film of lipid, crucial for the
maintenance of the barrier function of the teat. Because keratin is a waxy material, its
structure facilitates trapping of invading bacteria, thus hindering their migration into the
gland cistern. These properties, according to Blowey and Edmondson (2010), are most
effective when contraction of the sphincter muscle leads to canal closure. This is essential
to allow the folds to interdigitate and form a tight seal, whereas the hydrophobic lipid
lining ensures that no residual continuous column of milk persists, which could
eventually act as a wick for bacterial entry. Once the teat canal is contracted, the
antimicrobial agents within the keratin lining (e.g., myristic acid, palmitoleic acid,
linoleic) prevent bacteria found in the remaining droplets of milk, after milking, to grow
between milking. In addition, cationic proteins found in the teat canal can cause lysis and
death of invading pathogens. These proteins bind electrostatically to bacterial cell wall,
altering their structure and rendering them more susceptible to osmotic pressure (Sordillo
et al., 1997). However, injury of the teat canal from repeated stretching that occurs with
the milking process could result in a persistent residual column of milk, while fissures
and serum oozing from cracked epidermis would predispose the gland to bacterial
proliferation and eventually predisposing the mammary gland to mastitis (Blowey and
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Edmondson, 2010). As a consequence of this, organisms that ordinarily would be
excluded from the gland are able to make their way past the barrier located within the teat
canal, and with repeated microorganism exposure, an infection can be established
(Cunningham and Klein, 2007).
Cellular and soluble factors of the mammary gland against invading microorganims
The soluble defenses of the innate response mechanism associated with mastitis
are very complex biological processes and involve resident, recruited, and inducible
immune factors. Once bacteria gain access into the teat canal by either colonization or
forced through by the milking machine, it must then escape the microenvironment
antibacterial activity of the mammary gland in order to establish an infection (Sordillo et
al., 1997). These mechanisms are categorized as the innate response, which are factors
continually present in the mammary gland independently of the health status of the host,
and the adaptive immune response, that come into operation in response to bacterial
invasion (Murray et al., 2005). According to Swanson et al. (2009), the innate immune
response is the predominant defense mechanism involved during early stages of infection
and is induced rapidly at the site of insult. The innate response is categorized by the
cellular and soluble factors and includes antimicrobial peptides, complements, natural
killer cells, neutrophils, and macrophages that must quickly rally to the site of insult and
prevent expansion of the microbial invasion. The soluble factors of the innate immunity
are associated with defense functions of the mammary gland in conjunction with cellular
defenses in milk and tissues where each system regulates the functions of the other
(Sordillo et al., 1997). Additionally these soluble factors can be further divided into
innate (e.g., antimicrobial peptides) and specific (e.g., immunoglobulins) components.
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Antimicrobial substances (e.g., cationic peptides, lysozyme, lactoferrin, and
secretory IgA) found in secretions at mucosal surfaces such as tears, mucus, saliva,
epithelial surfaces also provide protection against most microorganims. As previously
discussed, the teat end is the initial site of encounter with microbes. Due to this continual
exposure to microorganims, the mammalian host has developed mechanisms rapidly
inducible in order to provide rapid protection against invaders. This rapid protection is of
essential implication due to the fact that the adaptive immune response mechanism
requires specific antigen recognition and clonal proliferation of immunocytes which
require longer time (i.e., weeks) to fully develop and be effective against bacteria (Ganz,
2003). The difference in time reaction between these two systems is due to the limitation
the innate immunity abide in recognizing every possible antigen, as the adaptive
immunity does. Instead, the innate immune system is designed to recognize characteristic
patterns within molecules shared by groups of microorganism that are essential for the
survival of those organisms. These characteristic patterns are termed pathogen-associated
molecular patterns (PAMPs) and are present within the endotoxin component of LPS,
teichoic acid, fungal glycans, cytosine-guanosine units of DNA commonly found in
bacteria, double stranded RNA produced during the replication of some viruses, and other
molecules (Murray et al., 2005).
Antimicrobial peptides are widely distributed in nature with more than 800
identified in the plant and animal kingdom to day. In mammals, these molecules are small
peptides effectors of the innate immune response important for antimicrobial efficacy of
phagocytes (Sørensen et al., 2008). Antimicrobial peptides are an essential component of
the soluble innate immune response and are secreted by epithelial surfaces from both
barrier epithelia and glandular structures to provide a rapid response against bacterial
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invasion. An example of an antimicrobial peptide found in the mammary gland is the
glycoprotein lactoferrin. Since iron is an essential nutrient for bacterial growth, bacteria
have developed mechanisms to obtain this metal, particularly when invading mammalian
tissues where iron is found in limited quantities. Lactoferrin antimicrobial activity
originates from its iron-binding properties, sequestering it from the environment with
high affinity, therefore depriving potential pathogens of this essential nutrient (Farnaud
and Evans, 2003). However, some of the antimicrobial properties of lactoferrin are
independent of iron binding. According to Appelmelk et al. (1994), lactoferrin also
interacts with cell wall components of Gram negative bacteria (i.e.,lipopolysacharides
;LPS), destabilizing the outer membrane. In addition, lactoferrin has been shown to
interact reversibly with porins of E. coli cell membrane to modulate the activity of
antibacterial agents such as lysozyme, and have synergistic effects with antimicrobials
(Farnaud and Evans, 2003). Transferrin is another protein with iron-binding properties
found in blood plasma, the mucosa, and milk. Transferrin binds to and transports iron
around the body through the blood circulation, to the bone marrow to be assembled into
hemoglobin molecules and also transport iron from the liver to the brain and other tissues
where it is required for different cellular enzymatic reactions. This glycoprotein is
transported into the mammary gland from blood serum by transcytosis in the normal
gland and through exudation of plasma during infection (Rainard and Riollet, 2006). It is
also thought that transferrin may initially provide an iron-chelatin bacteriostatic agent
effect in milk even sooner than lactoferrin concentrations increase (Rainard and Riollet,
2006).
Another peptide with antimicrobial properties found in the bovine mammary
gland is lactoperoxidase. This peptide is a peroxidase enzyme found in mammalian
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secretions such as saliva, mucus, and milk. In the presence of thiocynate and hydrogen
peroxide, lactoperoxidase inhibits the growth of various Gram positives and kill some
Gram negative bacteria (Blowey and Edmondson, 2010). In addition, this enzyme is
thought to contribute to the oxidative mechanism of nitric dioxide by reacting with
nitrate, working as a potential mechanism for local infection control and regulation of
local inflammatory response (Silanikove et al., 2005). However, this enzyme may have
little or no antimicrobial action against pathogens that produce hydrogen peroxidase such
as Streptococcus uberis (Blowey and Edmondson, 2010).
The non specific innate immune response is also equipped with bactericidal
proteins, such as lysozyme. This protein confers its bactericidal properties by hydrolyzing
components of the bacterial membrane, therefore disturbing its osmolarity causing lysis
(Leitch and Willcox, 1999). Although only a limited number of bacterial species are
killed and lysed by lysozyme, this enzyme can synergize with other components of the
soluble innate immunity such as antibodies, complements and lactoferrin. For instance,
lactoferrin and lysozyme together provide cooperative antimicrobial properties against
Staphylococcus epidermidis (S. epidermidis) in vitro (Leitch and Willcox, 1999). These
researchers demonstrated that lactoferrin increases the penetration ability of lysozyme
into the cell matrix of S. epidermidis by binding to lipoteichoic acid. However when their
antibacterial effect was assessed independently, no apparent effect was observed (Leitch
and Willcox, 1999). Nevertheless, lysozyme is found in low concentrations in bovine
milk (13 µg of lysozyme/100 ml) relative to that observed in human milks (10 mg/100
ml); therefore, lysozyme is not considered a significant defense component of the bovine
mammary gland, as reviewed by Rainard and Riollet (2006).
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The Rosette of Fürstenberg is a lymphocyte ring located at the inner side of the
teat canal and has been shown to be an important structure in providing protection against
pathogens (Tetens et al., 2010). These researches found expression of antimicrobial
peptides (bovine β-defensin-1) to be highly expressed in this lymphoid tissue as well as
in the cisternal epithelium. These antimicrobial peptides are substantial components of
the innate immune system and display direct antimicrobial activity against a wide range
of pathogens (Tetens et al., 2010). In addition, the lymphocyte cells located at the Rosette
of Fürstenberg detect invading bacteria and stimulate an immune response (Blowey and
Edmondson, 2010). The activity of these cells plays an imperative role during the early
stages of mastitis pathogenesis.
Cell mediated immunity of the bovine against invading microorganims
Body temperature, particularly fever, provides another obstacle against pathogens
by limiting their optimal replication rate. The normal core body temperature of healthy
dairy cattle ranges from 38.3 to 39.4° C. However a body temperature of 39.5° C from
calves, excitable cattle or cattle exposed to high environmental heat or humidity can also
be considered normal (Divers and Peek, 2008). In this regard, unless exogenous
hyperthermia is suspected, rectal temperatures above 39.1° C should be considered to be
associated with an immunological response to a disease (Porth, 2011). Fever is an
adaptive mechanism of the mammalian host essential its survival during infections
caused by pathogenic bacteria (Porth, 2011). For instance, many of the pathogenic
microorganims grow better at normal body temperature and their growth is inhibited by
temperature in the fever range, favoring the immune cells to overcome the bacterial
invasion (Porth, 2011). In addition, the immune response is more efficient at elevated
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body core temperature. For example, elevated body temperatures increase motility and
activity of white blood cells, stimulation of interferon production, and activation of T
cells (Porth, 2011). During bacterial pathogenesis, induction of fever is mediated by the
action of pyrogenic cytokines such as tumor necrosis factor alpha (TNFα), interleukins
(IL)-1β and IL-6 into the bloodstream (Netea et al., 2000). These cytokines are released
by activated macrophages and leukocytes in response to exogenous pyrogenes such as
PAMPs, which in turn orchestrate non specific and specific immune cascade of events,
causing central nervous system mediated effects (Langhans, 2000). Furthermore,
cytokines stimulate the anterior hypothalamus to increase the set point of the
hypothalamic thermoregulatory center through the action of prostaglandin E 2 (PGE2;
Netea et al., 2000). In response to this, the hypothalamus initiates heat production
behaviors such as cutaneous vasoconstriction which reduce heat dissipation, eventually
causing an increase in body core temperature.
In addition to the proinflammatory properties of pyrogenic mediators, such as
TNFα, IL-1β and IL-6, these molecules are also known to induce anorexia (Kanra et al.,
2006; Langhans, 2000). Although in short terms anorexia provides beneficial features to
the host, the outcome of long-term reduction in nutrient intake may result in health
disturbances to the host. Anorexia may represent a behavioral adaptation as a means to
confer protection to the host against pathogenic microorganisms as well as a preventive
way to spread diseases. The suppression of hunger, as an evolutionary point of view
according to Kanra, et al. (2006) eliminates the need to find food, therefore saving energy
and reducing the heat loss from the body that otherwise would be lost by convection. In
addition, anorexia appears to prevent the undesirable metabolic effects of some
proinflammatory cytokines that are observed when food intake is not hindered in sick
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animals. For instance, Matsui et al. (1993), reported metabolic anomalies such as
hyperglycemia, dehydration, renal and hepatic dysfunction in rats that were continually
infused with TNFα and orally fed. However, these metabolic anomalies were not
observed in rats that were deprived from food, suggesting that nutritional intake sufficient
to maintain normal growth intensified the undesirable metabolic effects of TNFα.
Moreover, anorexia enhances the activity of monocytes and macrophages, and reduces
the availability of food-derived micronutrients required by bacteria to grow such as iron
and zinc (Langhans, 2000). Therefore, these factors demonstrate the short term benefits
to the mammalian host during bacterial infection. However, chronic anorexia
compromises host defenses and delays recovery (Langhans, 2000).
Bacterial components such as the peptidoglycan layer of Gram positives and LPS
in Gram negative bacteria are excellent activators of the innate antigen-non specific
protective response, particularly the alternative complement pathway. Activation of the
complement system by the alternative pathway or via the mannose-binding protein during
bacterial insult is an early and important antibacterial defense (Murray et al., 2005).
During the early stages of bacterial invasion, macrophages and dendritic cells express
PAMP receptors, including the Toll-Like Receptors (TLRs). These receptors recognize
bacterial structures and activate cytokine production and protective responses, leading to
the induction of pro-inflammatory cell signalling proteins resulting in recruitment of
somatic cells into the mammary gland (Bannerman et al., 2004a). As mentioned above,
among the cytokines released by activated macrophages are IL-1 and IL-6, TNF-α, and
chemokines. These cytokines enhance the inflammatory response by further activating
more macrophages (Murray et al., 2005). Furthermore, TNFα and IL-1 are involved in
the mediation of the inflammatory response locally and systemically level. Locally these
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cytokines promote neutrophil recruitment by acting as chemoattractans and by inducing
upregulation of vascular adhesion molecules (e.g., adhesions) required for neutrophils to
migrate from the bloodstream to the site of insult. According to Bannerman et al.
(2004a), once neutrophils arrive at the site of infection they are further mediated by
chemoattractans such as IL-8 and complement cleavage product C5a.
In combination with ILs, complements work as an alarm and a weapon against
infection, especially those caused by bacterial pathogens. Complements are also
categorized as part of the soluble defenses of the innate response and are comprised by a
serie of proteins circulating in serum as well as in milk that function independently or in
coordination with specific antibodies to cause lysis of bacteria (Sordillo et al., 1997).
There are three pathways through which the complement system can be activated, the
alternative, classical, and leptin pathway; where the C3 component of these three
pathways is the common junction point. The alternative pathway is more important
during early pathogenesis of infection since it can be activated before the establishment
of an immune response by bacterial components. In contrast, the classical and leptin
pathways make their contribution late during the immune response due to their antibiotic
dependent properties (Murray et al., 2005). When the alternative pathway is activated it
can operate in two forms, deposition of opsonic C3b and C3bi components on bacteria
membranes, and generating the pro-inflammatory fragment C5a (Rainard and Riollet,
2006). As reviewed by Sordillo et al. (1997), concentration of complements are higher in
colostrum, inflamed mammary glands, and during mammary gland involution, but are at
the lowest during lactation and, therefore it is thought to play only a minor bactericidal
role in the mammary gland. However, as reviewed by Bannerman et al. (2004a), the
cleavage complement product C5a is a potent stimulator of the phagocytic function of
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neutrophils, which could contribute to the efficacy of phagocytosis in milk during
infection and therefore could represent a significant component of the defense
mechanism of the mammary gland, particularly when vascular epithelial permeability is
increased, allowing complement components to gain access to the mammary gland where
it can be activated by bacteria and leucocytes.
If bacteria penetrate the teat sphincter and the teat end canal, the second line of
defense consist of somatic cells, where they recognize bacterial components and initiate
the inflammatory response (Oviedo-Boyso et al., 2007). Milk somatic cell counts (SCC)
are constituted of several cell types, including neutrophils, macrophages, lymphocytes,
and a smaller percentage of epithelial cells (Sordillo et al., 1997). The activities of the
resident and newly recruited leukocytes during the early stages of bacterial progress are
crucial in the establishment of intramammary infection (Simianer et al. 1991). In lactating
cows with mammary glands free of infection, SCC are often less than 105 cells/ml,
however during bacterial insult the number of somatic cells can increase to 10 6 cells/ml
of milk rapidly (e.g., within a few hours). The severity and duration of intramammary
infections (IMI) is critically related to the promptness of the leukocyte migratory
response and the bactericidal activity of SCC at the site of infection (Grommers et al.,
1989; Sordillo et al., 1997). As bacteria replicate inside the mammary gland, they either
release membrane components such as LPS (Gram negative) or release toxins (Gram
positive) serving directly or indirectly as chemoattractants for leukocytes, causing a rapid
immune response. If SCC move rapidly from the blood stream and are able to eliminate
the bacterial insult, chemoattractants messaging stops, recruitment of leukocytes ceases,
and the level of SCC returns to normal (Sordillo et al., 1997). In contrast, if bacteria are
able to elucidate this second line of defense and persists in the mammary gland tissue,
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inflammation continues resulting in SCC migration between adjacent mammary secretory
cells towards the alveolar lumen that, when prolonged, can result in damage to the
parenchymal tissue resulting in permanent damage (Sordillo et al., 1997).
Although the teat end skin and the natural barrier immune components normally
exclude the majority of the organisms, they are not impermeable. Consequently,
pathogenic microorganims can usually gain access deeper into the mammary gland tissue.
Bacteria that survived are then targeted by antimicrobial peptides or complements, but
the majority is phagocytized by immune cells (Tizard, 2009). As mentioned earlier, when
macrophages circulating in the healthy mammary gland recognize bacterial structures
through their TLRs, they induce a pro-inflammatory cell signally resulting in the
recruitment of SCC, such as neutrophils. During early development of infection,
neutrophil migration from the bloodstream results in a significant shift on the rate of
somatic cells, increasing from 5 to 20% in a healthy mammary gland to up to 90% of the
total content of leukocytes in infected mammary glands.
Neutrophils migrate from the circulation to the site of infection to phagocyte and
kill bacteria by either respiratory burst, oxygen radicals, releasing of antimicrobial
peptides, and/or defensins (Murray et al., 2005). Once they perform their bactericidal
functions, neutrophils do not reenter the circulation but rather die by apoptosis (Burton et
al., 2005). If the microorganism entity persists after the neutrophil attack, the neutrophil
population is soon replaced by T lymphocytes and monocytes, changing the rate of
neutrophil infiltration from 90-95% to 70-80% of the leukocyte cell population (Rainard
and Riollet, 2006). Irrespectively of the vast number of neutrophil cells the dairy cow
mobilizes to the infected mammary gland (e.g., ~108 cells/ml), the importance of the
neutrophils as the main immune defense of the mammary gland toward the elimination of
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pathogenic microorganisms is uncertain. This could explain the reduced phagocytic
capacity of neutrophils on milk, relative to that observed in neutrophils in blood. As
reviewed by Rainard and Riollet (2006), glucose and oxygen in the bovine mammary
gland are found in limited quantities relative those found in blood. Therefore, reduced
glycogen stores may limit the availability of energy to be used by the neutrophils cells
whereas low oxygen stores may result in a reduced ability to produce reactive oxygen
species.
Although neutrophils represent the first line of defense of the cellular immune
response, mobilizing rapidly, phagocytizing and killing the invading microorganism, they
cannot eliminate microbial invaders alone, therefore the body uses a backup system by
employing macrophages (Tizard, 2009). Unlike neutrophils, which are specialized in
eliminating invading microbial agents, macrophages, in addition to this, have diverse
functions such as triggering the inflammation response through production of cytokines
and eliminating by phagocytosis debris post bacterial elimination. Macrophages, as
neutrophils, destroy bacteria by both oxidative and non oxidative mechanisms. In
addition to this, macrophages release proteases such as collagenases, elastases and
plasminogen activators that generate plasmin, therefore can penetrate into connective
tissue and phagocyte internalized bacteria (Tizard, 2009). As described above,
neutrophils arrive to the site of insult several hours prior to macrophages, attack foreign
material first, and as they die they attract macrophages. Once macrophages arrive, they
phagocyte apoptotic neutrophils limiting further tissue damage caused by neutrophil
enzymes (e.g., collagenases, elastases and plasminogen activators). In addition to the
functions described above, macrophages also present antigens from destroyed bacteria to
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T cells to initiate specific immune responses and produce cytokines to activate and
promote innate immune responses (Murray et al., 2005).
While macrophages and neutrophils are effective phagocytes, their indiscriminate
ingestion of fat, casein and other milk components make them less effective at
phagocytosis than are blood leukocytes (Sordillo et al., 1997). Their phagocytic activity
and bactericidal activities are further diminished during the periparturient period. For
example in a series of studies reported by Burton and collaborators (2005), gene
expression signatures of blood neutrophils collected during the natural surge of
endogenous glucoccorticoids in parturient dairy cows were studied. Differences in
neutrophil recruitment, activation and function were found. These researchers further
suggested that during the periparturient period the reproductive tract has a more urgent
demand for long lived neutrophils with elevated tissue degrading capacity (required for
uterine tissue remodeling post partum) than peripheral tissues, which might be related to
the increased incidence of mastitis during parturition.
Generation of functional specific immunity involves antigen presenting cells, such
as macrophages as well as lymphocytes. There are two major classes of lymphocytes, B
cells and T cells, which differ in function and protein products. The primary function of
B cells is to produce antibodies, although these also can internalize, process, and present
antigens to T cells to initiate or enhance the host immune response (Murray et al., 2005).
Antigens from ingested bacteria are also processed by macrophages, and through the
expression of class II major histocompatibility complex on their membrane, these can
further present the antigen to T cells to initiate the immune response.
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Immune components of the bovine reproductive tract
As in the mammary gland, the uterus is protected from environmental
contamination by its physiological barriers which include the vulva, vestibular sphincter,
and cervix (Youngquist and Threlfall, 2007). The vaginal skin plays a major role in
preventing entry of microorganisms through a variety of non immunological means,
including the secretion of sebum from sebaceous glands, which maintains a low pH, and
secretion of enzymes that are not conducive for the invading pathogens. In addition, the
genital tract is colonized by its own bacterial flora playing an important role in providing
protection against pathogenic bacteria (El-Moez et al., 2008). These researchers found
that Lactobacillus was isolated more often from genital tracts from normal cyclic buffalocows relative to animals suffering from ovarian inactivity. Vaginal epithelium is rich in
glycogen which promotes growth of lactic acid-producing Lactobacilli. Lactic acid
produced by these bacterial spp. cause a decrease in pH (< 4.7) creating an unfavorable
environment for the growth of other pathogenic bacteria and consequently promoting
further growth of acidophilic protective microflora. Therefore, Lactobacilli spp. function
as an endogenous bactericidal through the production of lactic acid and hydrogen
peroxides. These findings support the beneficial effects of the genital tract flora and
highlight the importance of using management practices, such as the use of appropriate
antimicrobials that do not perturb this balance. As suggested by El-Moez et al. (2008),
Lactobacilli spp. provided probiotic effects against the most predominant bacteria
associated with ovarian inactivity.
The uterine cervix of cattle is composed of a series of mucosa-lined collagenous
rings, serving as a barrier against invading pathogens, and cervico-vaginal mucus that
acts like a physical trap against microorganisms (Singh et al., 2008). In addition to this,
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the circular and longitudinal uterine muscular layers provide a means of physical
expulsion of microorganism trapped in the mucus (Singh et al., 2008). However, during
the periparturient period, dilation of the cervix allows entry of microorganism from the
cow’s skin surface to the vaginal cavity therefore contaminating the uterine cavity and
causing infection. This phenomenon has been described to occur in more than 90% of
cows during the first three weeks post-partum (Hillman and Gilbert, 2008; Sheldon et al.,
2006). Due to the continuous cycles of bacterial contamination, clearance and
recontamination, bacterial populations fluctuate for about 2 months after parturition
(Singh et al., 2008). However, persistence of bacteria in the uterus activates the immune
response, resulting in the early symptoms of uterine infections which often occur in less
than 9% of post partum cows (Singh et al., 2008). At this point, TLRs found in uterine
endometrial cells communicate the presence of the invading microorganism to the
immune cells, initiating a signalling cascade stimulating cytokine release (Williams et al.,
2008). Soon after invading pathogens have been detected by TLR system, TNFα and
other proinflammatory cytokines, including IL-6 and IL-8, are synthesized locally by
contracting uterus, placenta and fetal tissues (Singh et al., 2008). At this point, TLRs
found in endometrial cells communicate the presence of the invading microorganism to
the immune cells, initiating a signalling cascade stimulating cytokine release (Williams et
al., 2008).
Synthesis of specific antibodies by local antibody-secreting cells located in the
bovine uterus also contributes to the local immunity of the uterus. These antibodies are
important in neutralizing bacteria by acting directly at the bovine uterine and cervicovaginal secretions (Singh et al., 2008). Different Ig classes (e.g., IgA, IgG, IgM) have
been identified in bovine uterine secretions and have been described to act by directly
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lysing bacteria, enhance phagocytosis, and by stimulating the complement pathways
(Butler, 1983). Secreting concentrations of these Ig varies according to the segment of the
reproductive tract and provide different modes of protection. For example, IgG is thought
to predominate in the uterine lumen acting by opsonizing bacteria and stimulating
phagocytosis, whereas IgA predominates in the vaginal cavity, preventing bacterial
adhesion to mucosal surfaces (Butler, 1983).
The mechanism of action among the different Ig found in the reproductive tract
can be seen as an evolutionary adaptation to prevent over activation of the immune
system and prevent the negative effects on fertility associated to activation of
proinflammatory molecules. Microorganisms, such as opportunistic bacteria, are in
continual close contact with the vagina through fecal and/or other organic materials found
in the environment (e.g., mud, bedding material); frequently contaminating the vaginal
cavity. Action of IgA will play an important role in preventing bacteria to adhere to the
vaginal wall, therefore during urination or normal contractions of the vaginal cavity these
microbes are expelled preventing further colonization and avoiding frequent activation of
the immune system. On the other hand, recognized uterine pathogens are equipped with
specialized virulence factors that allow them to overcome the anatomical components of
the reproductive tract and the actions of IgA. If these pathogens overcome the immune
components of the distal portion of the reproductive tract (vaginal cavity), IgG found at
the anterior portion of the genital tract will then enhance bacterial phagocytosis, exposing
bacteria to the actions of natural killers (by opsonization), therefore providing a rapid
inflammatory response as a means to prevent further contamination into the uterus and
the negative effects associate with persistence action of the immune system.
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As described above, the immune system of cattle is exceptionally efficient against
invading microorganims. Tissues that are continually exposed to environmental
contaminants have developed many immune structures and cellular components to
provide protection to the host. However, the bovine immune response against invading
microorganims is dependent on factors such as stress, bacterial pathogenicity and
frequency of exposure, previous exposure to the invading microbe (development of
adaptive immunity), age, number of lactations and metabolic status, among others.
Although these factors predispose the cow to new diseases, mainly by disrupting
homeostasis of the host and/or shifting immune cell subpopulations, postpubertal heifers
kept under conditions free of these stressors can also have a suppressed immune
response. This is due to changes in the endocrine status observed during the normal
reproductive cycles of cattle, which disrupts the normal function of the immune system.
Steroidal regulation of the mammalian immune system
In mammals, resistance to infections is modulated by the endocrine status of the
host. It has been postulated that ovarian hormones, such as estrogen and progesterone,
modulate the efficiency of the immune system to respond and overcome infection
(Lamote et al., 2006; Sheldon et al., 2009). For example, increased incidence of mastitis
as well as endometritis in dairy herd is observed during the postpartum period in dairy
cows. Particularly, the reproductive tract of cattle is resistant to uterine infections when
progesterone concentrations are basal and susceptible when progesterone concentrations
are elevated (Lewis, 2003; Sheldon et al., 2009). During the luteal phase where
progesterone levels are high, the incidence of non-specific uterine infections in cattle,
pigs and ewes is higher. It has been proposed that pathogens residing in the exterior of
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the genital tract get access into the uterus when cows are assisted during births and/or
when retained placentas are removed manually. Bacteria introduced into the uterine
cavity apparently reside in the uterus without establishing infection. However, after
ovulation when the corpus luteum produces high concentrations of progesterone, the
immune function of the reproductive tract is inefficient to overcome proliferation of
bacteria. At this point, bacteria are able to proliferate and establish infection (Lewis,
2003).
As discussed previously, polymorphonuclear (PMN) cells such as neutrophils are
the initial response sent by the immune system to counter attack bacteria that invade
sterile body cavities; thus, their ability to respond is a critical component of the host to
overcome infection. However, it has been proposed that the endocrine and metabolic
changes observed during the periparturient period in cattle disrupt the functionality of
these cells (Lamote et al., 2006; Seals et al., 2003; Sheldon et al., 2009). For instance, the
uterine immune function of ewes under different estrous cycle phases was studied (Seals
et al., 2003). Uteri of ewes during the follicular- or luteal-phase were inoculated with
saline or a mixed inoculum of E. coli with Arcanobacterium pyogenes (A. pyogenes) and
blood samples collected to determine concentrations of progesterone, PGE2, and PGF2α.
Lymphocyte proliferation under the influences of PGE2, and PGF2α were studied using in
vitro techniques. All the bacterial-treated ewes under the influence of progesterone
developed uterine infections, whereas none of the ewes with basal levels of progesterone
developed infection (Seals et al., 2003). In addition, lymphocyte collected from
follicular-phase ewes had greater ability to proliferate in response to mitogens than did
lymphocytes collected from luteal-phase ewes (Seals et al., 2003). In addition, PGE2
decreased proliferation of lymphocytes whereas PGF2α increased the ability of
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lymphocytes to proliferate when activated with mitogens (LPS and concanavalin A).
Progesterone seems to reduce proliferative response to mitogens and neutrophil
chemotaxis, superoxide anion production, and final destruction of pathogens are reduced
(Seals et al., 2003). These findings highlight the negative effects of progesterone on the
of the host’s reproductive tract ability to respond to bacterial infections and suggest that
eicosanoids play an important role by regulating secretion of progesterone.
Although the immunological actions of PGF2α have been directly associated with
its luteolytic properties, such as structural and functional degradation of the corpus
luteum therefore removing the immune-suppressive actions of progesterone, and its role
as stimulating contraction of the uterus, which is widely used to physically expel uterine
fluids containing bacteria, its effects on uterine immunity have been demonstrated to be
independent of progesterone concentrations. This hypothesis is supported by the fact that
exogenous PGF2α has been reported to resolve uterine infections in sows with absence of
luteal activity and in studies conducted in ovariectomized ewes supplanted with
exogenous progesterone; where PGF2α treatments were reported to facilitate the uterus to
eliminate bacterial infections (Lewis, 2003; Wade and Lewis, 1996). Eicosanoids,
including prostaglandins and leukotrienes, belong to a family of compounds that are
synthesized from arachidonic acid through the cyclooxygenase and lipoxygenase
pathways (Lewis, 2003). During early development of uterine infection, prostaglandins
and leukotrienes act as direct mediators of inflammation. While progesterone downregulate the uterine immune function, for example by suppressing the production of
different cytokines such as the chemoattractan IL-8, proinflammatory cytokines such as
IL-6, as well as IL-12, which induces INFγ production and enhances natural killer-cell
cytotoxicty, PGF2α as well as leukotrienes can up-regulate the immune status of the uterus
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by providing early chemoattractant activity and therefore an earlier immune response
essential to prevent bacteria to further colonized the uterus.
While mammalian organs and tissues have developed many anatomical and
cellular immune components to protect the host, bacteria can also adapt and evolve to
overcome these. Among the vast number of pathogens that have been isolated from
mastitic mammary quarters and uterine infections from dairy cattle, S. aureus and E. coli
are important etiological pathogens, respectively. The high incidence of infections caused
by these pathogens is due to the many virulence factors these have developed by either
horizontal gene transfer or by random mutations. In addition to this, some strains have
evolved to be highly adapted to the bovine and therefore produce critical virulence
factors that allow them to overcome the cow’s immune system and establish an infection.
Staphylococcus aureus pathogenesis of bovine mastitis
Staphylococcus aureus is one of the most important etiological causes of bovine
subclinical mastitis. Although antibiotic therapy can be effective in the control of mastitis
from a variety of organisms, it is only moderately efficacious for S. aureus infections
(Daley et al., 1991). Mastitis infections associated with streptococcal and staphylococcal
bacteria can be considered as a three-stage process according to Frost et al. (1977), which
include 1) entry, where contaminating organisms behave essentially as inert particles and
the chance of entry depending on factors such as degree of contamination or colonization
of the streak canal; 2) specific adherence, which would prevent the microorganism being
washed away during milking and; 3) invasion of tissue, producing inflammation and the
clinical or subclinical features of the disease, depending on the degree of tissue damage.
These stages are regulated by specific bacterial virulence factors including those
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associated with adherence to host tissues, evasion of the immune response, toxin
secretion and regulation of the expression of virulence genes such as those found in S.
aureus (Lindsay et al., 2006).
According to van den Borne et al. (2010), bovine strains of S. aureus may differ
in mastitis symptom outputs due to the differences in virulence factors among strains.
Examples of these are cases of S. aureus mastitis where clinical signs are commonly
observed, whereas other cases are mostly subclinical, which could account for the
difference in genetic subsets between strains. For example, clones with distinctive genetic
backgrounds may be responsible for the majority of the infections within a host type, as
in the case of S. aureus ET3-1, also known as Rf-122, which is the most common clone
group associated with bovine mastitis worldwide and accounting for 29% of the total
isolates recovered from cattle (Herron-Olson et al., 2007). The S. aureus genome consists
of a core genome and a variable genome that includes mobile genetic elements such as
plasmids, phages, pathogenicity islands, and genomic islands. According to van den
Borne et al. (2010), the virulence of S. aureus strains are encoded by toxins or resistance
genes located at these mobile genetic elements. The clinical manifestations of some
staphylococcal diseases are almost exclusive to the toxin’s activity, such as that of super
antigens.
As mentioned above, defense of the mammary gland against invasion of
pathogens into the teat cistern is mediated by several anatomical, cellular, and soluble
protective factors. However, S. aureus can overcome this first line of defense and gain
access to the interior of mammary gland by progressive bacterial colonization of the teat
canal from the infected teat epidermis or by influx of contaminated milk entering the
mammary gland due to poor management practices during milking (Sutra and Poutrel,
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1994). Given that milk is an excellent nutrient medium (high in casein and lactose) for
bacterial growth and due to the high infective capacity of S. aureus (e.g., surface proteins
for attachment to selected host surfaces via tissue matrix molecules), only a small number
of colonies are needed to induce an intramammary infection (< 100 cfu; Newbould and
Neave, 1965). According to Sutra and Poutrel, (1994) the first step in the colonization of
the mammary gland by S. aureus seems to be adhesion to epithelial cells, which is
facilitated by the numerous surface proteins expressed by this pathogen.
Once the physical and chemical barriers of the mammary gland have been
breached, S. aureus confront a great challenge due to the drastic change in environmental
conditions. However, S. aureus adapts to this by altering the expression of several genes,
induced specifically when having contact with milk allowing it to adapt, survive in the
new environment and replicate inside the mammary gland. Expression of these factors
are thought to contribute to the persistence and replication in the bovine mammary gland
once this pathogen starts growing in milk, which is essential for establishing an infection
(Lammers et al., 2000). The adhesive ability of most S. aureus isolated from bovine IMI
have a high surface hydrophobicity, which favors the fixation of bacteria to host cells
through hydrophobic interactions with cell membranes and extracellular proteins such as
collagen and fibronectin (Sutra and Poutrel, 1994). Moreover, S. aureus contains
membrane surface components that enable it to bind to membrane proteins of bovine
milk fat globules and mammary epithelial cells which allow this pathogen to be buoyant
and ascend into the upper regions of the duct system (Lindahl et al., 1990). At this point,
cell components of S. aureus, such as lipoteichoic acid and peptidoglycan, major
components of the cell wall of Gram positive bacteria, activates a variety immune cell
populations that contribute to elimination of the intruder. Bovine macrophages are
36

present in the non-infected mammary gland and are the major cellular based anti
staphylococcal component during early stages of infection (Fox et al., 2002). In addition,
chemotactic proteins, such as TLR, recognize PAMPs, activate the immune cell response
and recruit leucocytes from blood through the mammary parenchyma into milk. Thus,
bacterial colonization results initially in an inflammatory reaction characterized by
recruitment of neutrophils through the usual mechanisms involving host derived or
bacterial derived chemotactic factors.
As mentioned previously, the process of bacterial phagocytosis is more efficient
when it is mediated by opsonins. Opsonisation of S. aureus involves binding of
antibodies to its peptidoglycan epitopes, and to the C3b complement component attached
to the bacterial cell wall (Sutra and Poutrel, 1994). For example, antibodies bind first to
the bacterial surface antigen attracting the C3b complement to it and coating the bacteria
cell wall. This marks the presence of bacteria to the phagocyte cell to engulf the
bacterium by phagosome where later is digested by lysozymes and proteases inside the
phagocyte. However, S. aureus possesses the capacity to produce mucoid-type capsules
that prevent opsonins, such as C3b, to bind S. aureus cell wall components thereby
preventing recognition of bacterial cells by receptors on phagocytic cells (Peterson et al.,
1978). In addition to confer protection against opsonisation, S. aureus capsular
polysaccharides can also modulate abscess formation. Tzianabos et al. (2001), studied
this phenomenon and concluded that S. aureus may possess one or more cell wallassociated polysaccharide with a zwiterionic charge motif that could help modulate
abscess induction. Abscess formation is thought to confer additional protection to
bacteria by acting as a barrier avoiding antimicrobial agents to diffuse deep into the
abscesses.
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Staphylococcus aureus possess an extensive repertoire of virulence factors that
modulate its adaptation to the extreme conditions within the mammalian host (e.g.,
immune components). During the different stages of infections (e.g., colonization,
invasion, etc.) many genes are regulated in an orchestrated manner by accessory genes.
Staphylococcus aureus accessory genes include those involved in pathogenesis and are
controlled by a complex regulatory network involving the accessory gene regulator (agr),
among other transcription factors. These global regulatory genes have been described to
act in a time and density dependent manner to integrate signals received from the
environment and with the internal metabolic system of the bacterium, as a means to
achieve the production of particular virulence factors appropriate to the needs of the
organism during the infection progress (Novick, 2003). The agr system utilizes an
octapeptide (quorum sensing regulatory molecule) produced by the organism itself to
regulate the production of extra cellular and cell-wall associated proteins (Ji et al., 1995).
Extracellular diffusible toxins, or exotoxins, are thought to be involved in evasion of the
bovine defense system and mutants producing these toxins are associated with persistent
cases of mastitis. Examples of these are the toxic shock syndrome toxin-1 (TSST-1), a
family of superantigens that are involved in modulating the host immune response by
superantigen mediated release of cytokines (Haveri et al., 2005). Staphylococcus aureus
also produces several pore-forming toxins, or hemolysins, involved in degradation of
endothelial cells membranes into nutrients required for bacterial growth (Haveri et al.,
2005). Once S. aureus has reached a certain level of bacterial density inside the
mammary gland, a shift in gene expression occurs that results in the production of
exoproteins involved in tissue degradation (Fox et al., 2002). For example,
microabscesses associated with staphylococcal mastitis could provide a barrier for rapid
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accumulation of octapeptide, thus leading to bacterial exoproteins production in localized
regions of the mammary gland. According to Fox et al. (2002), this will promote the
progression of the disease at localized regions of the mammary gland and, if unchecked,
potentially lead to the acute or gangrenous forms of the disease.
Escherichia coli pathogenesis of bovine uterine infections
Among the wide spectrum of bacteria that have been isolated from the early
bovine post partum uterus, E. coli, A. pyogenes, Prevotella melaninogenica,
Fusobacterium necrophorum and Proteus spp., are recognized as major uterine pathogens
(Williams et al., 2008). These pathogens are associated with clinical endometritis and
more severe signs of clinical uterine disease, relative to other microorganism isolated the
bovine uteri. Among these, E. coli is the most commonly isolated pathogen from the
bovine uterus in post partum cows and is associated with an increase in susceptibility of
the endometrium to subsequent infections with A. pyogenes (Williams et al., 2007;
Williams et al., 2008). Uterine diseases such as puerperal metritis, clinical endometritis,
and subclinical endometritis are of important attention to farmers due to their negative
impact on animal welfare and significant economic losses associate with infertility such
as increased days open and decreased conception rate, among others (Sheldon et al.,
2006). Puerperal metritis is characterized by swelling of the uterus accompanied by fetid,
watery, red-brown uterine discharge as well as systemic illness with fever greater than
39.5 °C, usually observed within 21 d post partum (Sheldon et al., 2006). Several factors
related to the cow have been reported to increase the risk of metritis. For example,
Bicalho et al. (2010), found that cows giving birth to twins were 4.4 times more likely to
be infected with E. coli. Other factors such as assisted parturition, and retained placenta
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have been described to increase risk of uterine infections by facilitating access of
environmental bacteria, such as E. coli, into the uterine lumen (Sheldon et al., 2006).
Escherichia coli aside from being the most common isolated bacterium from uteri
of post partum cows, contamination with further establishment of infection by this
pathogen only occur in a small proportion of infected animals and will depend on the host
immune status, type and virulence of the strain, and environmental conditions. Although
E. coli is considered an environmental opportunistic pathogen, the acquisition of an
arsenal of several virulence factors has allow it to adhere with specificity to different
mammalian tissues, mobilize toward favorable host environments and/or away from
adverse ones (E. coli pili positive isolates), and create biofilms to allow attachment to
host surfaces, providing tolerance to antimicrobial agents. In general pathogenicity traits
of E. coli include adhesion to epithelial cells mediated by fimbriae and motility mediated
by flagella, and toxins such as shigatoxin heat stable and labile toxins, and LPS (Sheldon
et al., 2010).
A small proportion of E. coli strains are pathogenic and are further categorized
based on the factors and the mechanisms employed by these to cause disease. Most of the
virulence factors associated with pathogenic E. coli are encoded by plasmids,
bacteriophages, or pathogenicity islands. These include the plasmid-encoded genes for
entertoxins and fimbriae (the phage-encoded genes for the attaching and effacing lesion
in E. coli) and enterohemorrhagic E. coli as well as several genes found in uropathogenic
E. coli (pap, hly and cnf1; Gyles and Fairbrother, 2010). The most significant strains of
E. coli that affect mammalian species are enterotoxigenic E. coli, enteropathogenic E.
coli, Shiga toxin-producing E. coli, uropathogenic E. coli and extraintestinal pathogenic
E. coli (Gyles and Fairbrother, 2010).
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Evaluation of genetic variations between strains allows the identification of clonal
types that may be associated with specific diseases (Silva et al., 2009). In a recent study
(Bicalho et al., 2010), uterine swabs for E. coli isolation were collected in 374 lactating
cows with 625 different isolates analyzed. A total of 32 virulence factors genes were
identified with 6 being significantly associated with an increased incidence of metritis
and endometritis. The isolation of the virulence factor genes finH astA, cdt, kpsMII, ibeA,
and hlyA were found to be associated with an increased risk of uterine disease and
reproductive failure (Bicalho et al., 2010). The fimH fimbriae virulence factor in E. coli
facilitate adherence to the urinary tract, preventing it from being washed out during
urination, which is essential for colonization of the urinary tract (Murray et al., 2005).
Escherichia coli is the most predominant facultative anaerobic bacterium in the
intestinal tract of most mammalian animals species and it is typically found in feces with
bacterial numbers ranging from 107 to 109 cells/gram (Gyles and Fairbrother, 2010). In
fact, it is thought that uterine infections caused by uropathogenic E. coli isolates are
initiated by contamination of the urethra and bladder by fecal material. The virulence
factor fimH was highly prevalent in E. coli isolates recovered from uteri and was an
important factor used as a predictor of metritis and endometritis (Bicalho et al., 2010).
Other virulence factors such as ibeA, kosMII and astA were also reported to provide some
benefit toward colonization of the bovine reproductive tract by E. coli. However, when
these virulence factor genes were detected in conjunction with fimH it resulted more
likely to develop postpartum metritis and/or endometritis (Bicalho et al., 2010). Other
virulence factors found in E. coli, such as the agn43 gene, which codify the surface
protein antigen 43 (Ag43), have been postulated to promote persistence and tolerance to
antimicrobial agents by forming biofilms (Sheldon et al., 2010). According to Van Houdt
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and Michiels (2005), the antigen 43 forms autoaggregation of cells through Ag43-Ag43
interaction by an intercellular handshake mechanism, promoting bacterial biofilms
formation by its ability to induce microcolony formation, enhancing colonization of the
mammalian intestine and bladder.
Contamination of the uterine cavity with E. coli is detected by host cells
expressing the TLR-4, CD14 and myeloid differentiation factor 2 (MD-2) recognizing
LPS, leading to an inflammatory response. In addition, LPS absorbed from the uterine
walls is detected by the TLR-4 complex in endometrial epithelial and stromal cells
stimulating secretion of cytokines, which is accompanied by the negative effects
observed in reproductive performance. Of particular association with E. coli uterine
infections is the accompanied switch of prostaglandin secretion from PGF2α to PGE2.
Activated endometrial cells (through their TLR-4 complex) release IL-8 and PGE2 rather
than PGF2α as a means to control the inflammation. In contrast to PGF2α, PGE2 is
luteotropic, preventing the corpus luteum from undergoing apoptosis and therefore
causing prolonged luteal phase and its associated elevations in progesterone
concentrations (Herath et al., 2009). This scenario of prolonged episodes of progesterone
might be associated with persistence episodes of uterine infections since, as discussed
earlier, progesterone down regulates the immunity of the bovine uterus.
Aside from the direct effect of bacterial toxins on endometrial health and, in the
case of chronic infections, damage of mammalian cells by the own host immune enzymes
(e.g., free radicals, proteases) resulting in further tissue damage associated with
infertility, infections may also interfere with the overall functions of the mammalian host.
When bacteria are able to overcome the mammalian immune response and establish an
infection, many of the immune cells that are released to modulate the immune reaction at
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the site of bacterial insult can also disrupts the host homeostasis. Moreover, toxins and
bacterial immunogenic components detected by organs locally and/or distally from the
site of infection (through systemic circulation) can also modulate and alter organs normal
physiological function. Therefore, understanding not only the direct effect but also the
indirect effects of bacterial infections on the overall function of mammals can provide
with information regarding the virulence of the etiological pathogen as well as the degree
of infection (chronic, subclinical, etc.). The multifcatorial effects of bacterial infections
on the mammalian host welfare highlight the importance of management practices that
ensure an environment free of favorable conditions for bacterial niches and/or those that
could result in the spreading of bacteria between animals.
Mastitis and uterine infections and their association with metabolic disorders and
neuroendocrine function of the hypothalamic-pituitary-ovary axis of the bovine
As previously discussed, during the infection process, bacterial components
activate the immune system inducing release of cytokines, mediating all the systemic and
local symptoms of illness. When these products reach the central nervous system, they
cause neural and endocrine alterations leading to systemic symptoms such as fever, pain,
lethargy, anorexia and many catabolic changes in energy, protein and mineral metabolism
(Huszenicza et al., 2004b). In addition to these symptoms, infection or bacterial products
have been associated with disturbances of the reproductive performance in cattle. The
presence of bacterial products, such as LPS and Peptidoglycan, in the circulation have
been associated with suppression of pituitary LH secretion, inhibition of folliculogenesis,
decreased expression of estrus, extended periods of anestrus, abnormal luteal phase and
decreased pregnancy rates (Hockett et al., 2005; Williams et al., 2008). Furthermore,
systemic symptoms can be aggravated during more severe infection scenarios, causing
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simultaneous alterations in cardiovascular, respiratory and gastrointestinal systems
(Huszenicza et al., 2004b).
In high milk producing cows, the transition from pregnancy to lactation is
associated with considerable physiological challenges. This is true when considering that
during this transition period, feed consumption decreases while demands to support the
growth of the calf and energy for milk production by the mammary gland increase. In
order to adapt to these immediate changes, the rate of secretion and elimination of
endocrine regulatory molecules is important. However, this adaptation can be
compromised during episodes of post parturient infections such as mastitis and uterine
infections (Nikolić et al., 2003; Novick, 2003). The presence of bacterial components as
well as toxins release into sterile body sites often provoke a multitude of local and
systemic immunological alterations such as the acute phase response (APR). The APR, as
reviewed by Exton (1997), is a physiological mechanism that involves immunological,
neuroendocrine, metabolic and behavioral changes as a means to provide substantial
benefit to the host; and anorexia is one of these mechanisms. The APR involves a drastic
increase of local and systemic defensive mechanism to provide rapid and efficient
protection to the host during stressful conditions such as illness. However, for the APR to
be beneficial it must be acute, must destroy and/or limit bacterial growth, and limit and
repair tissue damage within a short time (Borghetti et al., 2009). When the
neuroendocrine responses associated to the APR manifest for prolonged episodes, it can
influence the hypothalamus causing a decrease in food intake, and consequently
disrupting the energy balance, causing a drastic increase in tissue catabolism and nutrient
utilization (Borghetti et al., 2009). These processes involve complex interactions between
cytokines, glucoccorticoids and somatotropin hormones resulting in alterations of the
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growth hormone (GH)/Insulin Growth Factor-1 (IGF-1) axis (Carroll, 2008). Infection
and the immunological cascades of events such as the release of proinflammatory
cytokines TNFα and IL-6, and cortisol are involved in reduction of feed intake, skeletal
muscle degradation and suppression of growth in livestock. In cattle, during the
proinflammatory response, circulating concentrations of IGF-I decrease. The decreased
growth rate associated with infections is likely caused because target tissues, such as liver
and skeletal muscle, become GH-resistant (Borghetti et al., 2009). Consequently, loss of
anabolic stimuli due to GH resistance along with the catabolic effect of pro-inflammatory
cytokines drives the metabolic balance of skeletal muscle toward a net loss of mass and
function, usually seen in chronically infected animals.
Impact of mastitis and uterine infections on the bovine reproductive performance
It is well known that the reproductive cycles of mammals, including cattle, are
regulated by hormones produced by the hypothalamus, pituitary and ovaries. Among
these hormones, gonadotropin releasing hormone (GnRH, secreted in the hypothalamus),
is responsible for stimulating the pituitary to secrete follicle stimulating hormone (FSH)
and LH. In addition, the ovaries play an important endocrine role by secreting, in a
feedback fashion with the hypothalamus, estradiol (E2) and progesterone (P4). Briefly,
FSH stimulates initial growth of follicles in the ovaries whereas LH is responsible for
maturation of follicles. In addition, later in the estrous cycle, LH secretion peaks causing
ovulation. This increase in LH concentrations is responsible for stimulating production of
progesterone by the CL. Estradiol is produced specifically by the follicles and is
responsible of stimulating the peak production of LH that is required for ovulation, while
P4 stimulates the embryo growth and maintenance of pregnancy. Therefore, any
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interference in the secretion of any of these reproductive hormones can translate into
dramatic disturbances to the normal physiology of reproduction. In this regard, cytokines
and/or toxins released during bacterial insult have been reported to interfere with the
normal secretory pattern of the hypothalamic-pituitary-ovary axis.
Uterine infections as well as infections outside the reproductive tract, such as
mastitis, have been associated with interference of reproductive performance in cattle
(Lavon et al., 2010; Silanikove et al., 2005; Williams et al., 2008). It has been reported
that differences in cytokine expression between Gram positive and Gram negative
bacteria exist (Bannerman et al., 2004b; Williams et al., 2008). These differences in
cytokine expression might account for the large variety of TLRs (i.e., 10 members of the
TLR family) capable of recognizing distinct PAMPs and activating different cellular
responses. For example, IMI with Gram negative bacteria, such as E. coli, elicited
expression of TNFα and IL-1β, whereas IMI with Gram positive bacteria, such as S.
aureus, did not elicited an increase in the expression of TNFα, and a delayed expression
of IL-1β was observed (Bannerman et al., 2004b). These differences might be responsible
for the delayed and diminished febrile response and the delayed induction of APR found
in S. aureus IMI, relative to that observed in E. coli which are acute and of short duration.
However, regardless of the mastitis type (e.g., clinical vs subclinical) and the differences
in immunological responses between Gram positive and Gram negative pathogens, all
these forms of mastitis have similar detrimental effects on the reproductive performance
of bovine (Lavon et al., 2010). Cows with mastitis have significantly higher days to first
service, days open, and services per conception relative to non infected cows or in which
infection occurred after pregnancy (Schrick et al., 2001).
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Studies have suggested that fertility disorders associated with mastitis are mostly
related to the actions of cytokines, particularly TNFα, PGF2α, cortisol, reactive oxygen
species and inflammatory mediators (Soto et al., 2003b). Researchers have shown
evidence suggesting that the pituitary represents an important site for reproductive
inhibition in response to severe illness (Williams et al., 2001). This theory is supported
by the fact that systemic endotoxins, such as LPS, suppress responsiveness to GnRH,
even when GnRH was administered exogenously. These investigators further concluded
that systemic illness can block the expression of GnRH receptors at the pituitary level
(Williams et al., 2001). Moreover, others have demonstrated that cytokines and/or toxins
produced during clinical and subclinical mastitis are associated with impairments of
adrenohypophyseal induced LH release (Schrick et al., 2001). Clinical mastitis during the
follicular phase reduced pulsatile LH secretion, causing low estradiol concentrations,
delayed LH surge and ovulation (Hockett et al., 2005).
Cortisol has been found in increased levels in blood during the stressful
conditions associated with mastitis and activation of the immune response (Hockett et al.,
2005). Cortisol has been linked with the disruption of follicular growth and its endocrine
function as well as interference with LH secretion. In addition, cortisol has been
implicated in lower GnRH pulse amplitude and GnRH and LH concentrations in ewes
(Battaglia et al., 1997). In contrast, inhibition of cortisol synthesis during an LPS
challenge did not prevent the suppression of pulsatile GnRH and LH secretion. Therefore,
although cortisol may be involved in the LPS-induced suppression of circulating
concentrations of LH, other factors are likely involved in this process (Whitlock et al.,
2008).
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Studies have been conducted to elucidate the effects of immunomodulators
activated during the immune response over reproductive neuroendocrine function and
ovarian cyclicity of cattle at the molecular level. In severe mastitis, such as that caused by
Gram negative bacteria, high concentrations of LPS in the circulation can be detected
which often result in infertility. This is in part by the pathophysiological responses
associated with the deleterious effects in reproductive steroidal secretion. Although these
effects are observed at the ovarian level (suppression of estradiol production), follicles
have never been reported to possess immunological activity. Nevertheless, a recent study
has shown that follicles in fact can act as immune cells by expressing the TLR-4 complex
and detect LPS from E. coli (Herath et al., 2007). These investigators reported that
granulosa cells express TLR-4, CD4 and MD-2 through the different follicular stages,
therefore are capable of detect bacterial components and respond to these by downregulating transcription for aromatase, inhibiting follicle steroidogenesis.
Uterine infections can be detrimental to endometrial cells by either the direct
effect of toxins or indirectly by the persistence action of radical oxygen species produced
by PMN and neutrophils, reducing the cow’s conception rate (Sheldon et al., 2009).
Endotoxins such as LPS have been detected in the uterus, peripheral plasma and ovarian
follicular fluid of post partum cows (Herath et al., 2007). Endotoxins absorbed from the
reproductive tract of post partum cows into the peripheral circulation suppress formation
of the preovulatory LH peak and induce cystic degeneration of dominant follicles
(Huszenicza et al., 2004a). High doses of endotoxins perturbed the follicular phase rise in
peripheral plasma estradiol concentration and the LH surge. In addition, post partum
uterine infections have been associated with higher incidence of cystic ovarian disease,
smaller ovarian follicles in the first post partum follicular wave, and lower oestradiol
48

production (Williams et al., 2008). Most of the effects of uterine infections are similar to
those seen in mastitis. In general, cytokines such as IFN-β has been reported to decrease
secretion of LH, whereas endotoxins appear to disrupt the phase of proestrus
development in ruminants and the preovulatory estradiol rise, therefore delaying or
blocking the LH surge and the subsequent ovulation.
Impact of mastitis and uterine infections on embryo development in the bovine
Immunomodulators such as TNFα and IL-1β mediate the inflammatory responses
associated with fever. Elevated body temperatures, caused either by heat stress or fever,
are associated with reduced pregnancy rates. As reviewed by Hansen and collaborators
(2004), the effect of hyperthermia on embryo survival is due to the direct effects of
elevated temperatures on oocyte and embryo function, which reduces development to the
blastocyst stage. Eicosanoids, such as PGF2α, have also been reported to have detrimental
effects on embryo development in the bovine. Elevated levels of the PGF2α metabolite
(PGFM) during mastitis were followed by a subsequent drop in progesterone levels,
which speculates the role of prostaglandins in early luteal regression during mastitis.
Prostaglandin F2α in the bovine is produced by endometrial cells and is responsible for
luteolysis of the corpus luteum which occurs at the end of the estrous cycle if the
conceptus does not produce Interferon τ and maternal recognition is not established.
Nonetheless, in the past decades it was not completely elucidated if infections at the
mammary gland level could cause a significant increase in PGF2α during pregnancy to
induce luteolysis. However, studies conducted by Hockett, et al. (2000) where endocrine
profiles of dairy cows were monitored during experimentally induced mastitis reported a
higher peak level of PGFM in clinical mastitic cows, relative to control cows. Therefore
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mastitis leads to the production of several immunological modulators that stimulate the
production of PGF2α. Increased levels of this eicosanoid can result in early luteolysis
which in pregnant cows could result in embryonic or fetal loss. In addition, a different
study conducted by Hockett (1998), also indicated that PGF2α may have detrimental
effects on embryonic development besides its well known effects on the corpus luteum.
These conclusions are based in studies were beef cattle administered with PGF2α resulted
in detrimental effect in embryo development, even when supplemented with exogenous
progestogen (Hockett et al., 1998).
In a study conducted by Soto et al. (2003a), the effects of TNFα on the different
bovine oocyte maturation stages and embryo development were studied. They reported
that TNFα intervened with the actions of oocyte maturation, compromising the ability of
the resultant embryo to develop to the blastocyst stage. These researchers also found that
although exposure of fertilized embryos to TNFα did not prevent these from developing
to the blastocyst stage, an increased percentage of blastomeres undergoing apoptosis was
observed when embryos on the 9-cell stage were exposed to TNFα. In addition to
cytokines, PGF2α and reactive oxygen species, such as nitric oxide, have been related to
interfere with oocyte and embryo function (Soto et al., 2003b). Synthesis of these
molecules increases in response to LPS challenge in uterine arteries, endometrium and
placenta tissues. When 50 or 100 ng/ml of PGF2α was added to cell cultures during in
vitro oocyte maturation, a decreased proportion of oocytes to blastocysts were observed
(Soto et al., 2003b). These researchers also found that addition of nitric oxide disrupted
embryonic development after fertilization.
These findings demonstrate the importance of monitoring a cow’s health status,
such as sub-clinical mastitis and/or mild endometritis, which could play an important role
50

associated with early embryo losses in post-partum dairy cattle. For example, the
metabolic stress linked with the periparturient period can predispose cattle to mastitis by
suppressing their immune system (Nikolić et al., 2003). During early stages of mastitis,
or in its subclinical form, low levels of immunomodulators are found in the circulation;
nevertheless, cows likely will have no physiological difficulties in achieving conception
or disrupted early embryo development, as described by Soto et al. (2003a), where TNFα
did not prevent embryos from developing to the blastocyst stage. However, after the
infection further progresses due to the persistence levels of progesterone associated with
the presence of a corpus luteum during pregnancy, the developing embryo may undergo
the deleterious actions of cytokines being released by the immune system as a means to
overcome the developing infection. Increased levels of circulating TNFα and PGF2α are
associated with early embryonic deaths in cattle by either increasing the percentage of
blastomeres undergoing apoptosis or interfering with oocyte and embryo function,
respectively, which are mostly observed during the first 2 weeks of gestation (Soto et al.,
2003a, b).
Translating this to dairy farm management practices, as that of artificial
insemination; it could represent a significant economic impact to dairy farmers. For
instance, taking in consideration that cows are inseminated around 45 d post partum, loss
of the developing embryo 2 weeks post gestation will increase the number of days open
by ~60 d. In addition, about one week is lost while luteolysis is triggered by PGF2α
secreted by the uterine endometrium once maternal recognition is no longer
communicated to the uterine environment. In addition, it has been documented that cows
previously recovered from infectious diseases, as that of mastitis, have significantly
higher days open and services per conception relative to healthy cows or in which
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infection occurred after pregnancy (Schrick et al., 2001). This, according to Williams et
al. (2007), is attributed the effect of pro-inflammatory cytokines such as TNFα and acute
phase proteins, acting locally and systemically by perturbing ovarian growth and
function, resulting in smaller postpartum dominant follicles, lower estradiol plasma levels
and smaller corpus luteum with reduced progesterone production, which could eventually
cause loss of the embryo, further increasing the number of days open.
In addition, even with a good prevention mastitis program, some mastitis
pathogens can pass undetected and cause complications further in early pregnancy. It has
been shown that mastitis infections caused by S. aureus (Newbould 305) resulted in
absence or delayed expression of cytokines such as IL-10 and TNFα (Bannerman et al.,
2004b). However, as mentioned above, TNFα treatment beginning after fertilization
caused no effect on the proportion of embryos that reached the blastocyst stage of
development (Soto et al., 2003a). This might be explained by the fact that loss of cell
numbers by apoptosis at this early stage of development does not compromise further
development of the embryo (Soto et al., 2003a). Nevertheless, it is possible that embryo
survival beyond the blastocyst stage could be compromised by TNFα-induced apoptosis
as shown in a study where mouse blastocysts exposed to TNFα had reduced number of
cells in the inner cell mass lineage and reduced the ability of embryos to differentiate into
fetuses after implantation (Wuu et al., 1999). In this regard, reproductive parameters such
as increased days open, services per conception and decreased conception rate can be
further aggravated, resulting in culling of high genetic animals. Implementation of
management practices that ensure a continual monitoring of the health status of cattle
such as routinely bacteriological analysis of milk samples along with the use of Dairy
Herd Improvement program provide a great strategy tool for the early detection of
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bacterial presence that will allow the farmers to act early and prevent further
dissemination of bacteria within the herd population.
Regardless of the site of bacterial insult, bacterial infections result in down
regulation of the neuroendocrine function associated with normal modulation of the
reproductive tract performance. This suggests that evolution plays an important role in
ensuring homeostasis in the mammalian host and proper metabolic condition required to
nurse the developing fetus for the entire pregnancy. The direct effects of bacterial toxins
and/or the indirect effects of immunomodulator molecules released during the bacterial
insult on the normal physiology of the mammalian reproductive performance and/or
behavioral responses imply that these systems are regulated by similar molecules. As
suggested by Borghetti et al. (2009), interconnection between immunological and
behavioral responses is due to the fact that the nervous, immune and endocrine systems
share the same proteins that are able to act as immunomodulators and metabolic
regulators. Among the immunological molecules shared by these systems, TNFα and
PGF2α have been associated to interfere with embryonic development by acting either on
the oocyte, disrupting the source of the hormone required for maintenance of pregnancy
and/or on the developing embryo (Hansen et al., 2004).
Others have suggested that, bacterial infections are associated with a reduction in
the capacity of the ovaries to respond to FSH, rather than disrupting secretion of FSH
itself (Williams et al., 2007). Therefore, even if the infection is established outside the
reproductive tract near the end of the follicular phase where estradiol levels are elevated
and therefore the anterior pituitary is secreting FSH and LH in increased frequency and
amplitude, bacterial toxins in the bloodstream can down regulate the capacity of the
ovaries to respond to FSH, and therefore final maturation and therefore ovulation will not
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occur. Moreover, these authors also reported that post partum cows with uterine
infections that were able to ovulate, had smaller corpus luteum and produce less
progesterone (Williams et al., 2007). In this scenario, even if the cow ovulates and
pregnancy is established, low levels of progesterone will cause early fetal loss. These
mechanisms will ensure that energy sources will be exclusively directed for the animal’s
maintenance in order to survive and to ensure enough nutrients to resolve the infection.
Although the animal’s genetic factors and its immunity status play an important
role in the establishment and persistence of infection, the severity of the infection is
dependent on the pathogenicity of the etiological agent (Williams et al., 2007), therefore,
reducing exposure to pathogens is an essential practice to prevent the negative effects
associated to bacterial infections. All this evidence underlines the importance of
providing a clean and healthy environment such as one that prevent mastitis and/or
uterine infections in order to prevent all the negative effects diseases imply to the
neuroendocrine balance of cattle. In view of the fact that mastitis rate has drastically
increased due to the practices associated to modern dairy farm management practices
(selection, higher density pressure) the dairy industry needs to accommodate these
obstacles in order to become in one more efficient industry.
Understanding the negative effects of bacterial infections in livestock production,
it is therefore of great importance to develop methods that are practical and efficient to
better understand pathogenesis of bacteria in order to either evaluate management
practices toward control of bacterial spreading and/or the development of more efficient
therapeutic strategies that ensure a rapid and complete elimination of the infectious
etiological organism. Due to the systemic disorders related with bacterial infections,
which are mostly associated with the chronic forms, methods for early detection and
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identification of the etiological microorganims are indispensable for modern livestock
production systems. In addition, providing a rapid identification and therefore a faster
intervention will reduce the incidence of new infections in the population by removing
the focus of infection and therefore decreasing bacterial dissemination, which has cause
many outbreaks worldwide, resulting not only in economical looses and animal death but
the loss of many human life.
The use of biophotonic imaging as an approach to study pathogenesis of bacterial
infections in the bovine
Biophotonic Imaging
In vivo optical imaging is emerging as a powerful technique for investigation of
biological processes, representing today an important technique in biomedical imaging
due to high sensitivity detection, low cost and practicability for clinical translation
(Kosaka et al., 2011; Zhao et al., 2005). Optical imaging technologies involve the use of
biological or chemical gene reporters coupled with light sensitive imaging systems to
detect the light expressed by these probes as a means to provide rapid and non invasive
approach to monitoring biological processes. This technology includes two classes of
imaging compounds: those containing luciferase proteins and those containing
fluorescent compounds (Close et al., 2010). Although both systems involve the same
process to produce light (electrons in the exited state emitting photons as they go back to
the ground state), differences exists in the way the excited state is generated. For
example, fluorescence requires an exogenous excitation to emit light at a given wave
length while luminescence proteins are capable of producing light without exogenous
excitation (Close et al., 2010). Therefore, bioluminescence has an advantage over
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fluorescence as an in vivo reporter due to its autonomous properties as an optical
biomarker. In addition, the use of luciferase proteins as a tool for in vivo optical imaging
is highly attractive because they generate a controllable light signal in cells with little to
no background bioluminescence, relative to fluorescence imaging, therefore allowing for
sensitive detection (Close et al., 2010).
The luciferase system includes the bacterial luxAB genes from Photorhabdus
luminescences (P. luminescences) marine Vibrio sp., as well as the eukaryotic luciferase
luc genes from the firefly Photinus sp. (Wiles et al., 2009). Bacterial luminescence
reactions involve the oxidation of a long-chain aldehyde (luciferin) and reduced FMNH2
resulting in the production of oxidized flavin, a long-chain fatty acid and the emission of
light at a wavelength of 490nm (Wiles et al., 2009). The multi-enzyme complex
composed of the genes luxC, D and E are responsible for regeneration of the aldehyde
substrate from the fatty acid produced during the reaction. Arrangement of these genes
into a single operon, luxCDABE, code for the luminescent reaction catalyzed by the
luciferease luxAB and the regeneration of a fatty acid reductase complex involved in the
fatty aldehyde substrate encoded by the luxCDE (Winson et al., 1998). Incorporation of
this system into a bacterial host results in an autonomous bioluminescent construct
providing a continual production of light without the need for exogenous addition of
substrates.
In contrast, the eukaryotic luciferase luc genes from the firefly, involve oxidation
of a benzothaiazoyl-thiazole (luciferin) and ATP resulting in the production of
oxyluciferin, AMP, CO2 and light at a wavelength of 560 nm, while the eukaryotic
copepod reaction system is mediated by oxidation of an imidazolopyrazine derived
(luciferin) to produce CO2, coelenteramide and light at 470 nm (Wiles et al., 2009).
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Although these two eukaryotic luciferase systems have been traditionally used to
transform eukaryotic cells for whole animal bioluminescence imaging, they have as a
drawback the lack of genes required for the regeneration and recycling of the substrates,
therefore exogenous substrate is required during imaging (Rice et al., 2001). However, a
modified bacterial luciferase gene cassette able to express light in mammalian cells in
culture or in whole animal bioluminescence imaging have been recently developed
(Close et al., 2010). This novel approach overcomes the limitations found in the luc
system used to infect eukaryotic cells allowing whole animal bioluminescence imaging
coincident with bacterial host and without the need of using exogenous substrates.
Quantification of light expressed by optical probes described above is
accomplished by the use of standard photomultiplier tubes or charge couple device
cameras. Charge couple device cameras detect optical signals (photons) and convert these
to optical energy (electrons). When coupled with a computer for imaging acquisition,
optical energy is transformed to digital signals (pixels) which electrical charge patterns
generate an image with information associated with the intensity of photons and the
spatial distribution from the imaged object/subject. Due to the high sensitivity of charge
couple device cameras, small levels of light produced by bioluminescent organisms,
luminescent probes or fluorescent compounds can be detected. This technology, for
example, has been largely used to study biological processes such as gene expression,
toxicology, viral infections, in real time monitoring of bacterial infections process and
evaluation of antimicrobial agents. According to Rice et al. (2001), biophotonic imaging
offers a more practical approach (lower cost), has relatively short imaging time periods (<
5min) and can image multiple subjects at once, relative to traditional structural imaging
methods such as magnetic resonance imaging or computed tomography.
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Due to the semitransparent nature of mammalian tissues, light emitted by
bioluminescent and/or fluorescent probes can be detected through tissues using charge
couple device cameras and obtain a semiquantitative estimation of molecular and cellular
events. For instance, the course of an infection can be monitored in real time as
bioluminescent bacteria expand and migrate through different tissues in the animal (e.g.,
mouse) by collecting photonic emissions diffused from the infection site and projecting
on the surface of the animal. However, optical imaging detection through animal tissues
is limited and wavelength-dependent. As a general rule, approximately 10-fold of light
intensity is lost for each centimeter of tissue depth. This is mainly due to the fact that
optical scattering and absorption properties of biological tissues cause laser bean
broadening and eventual decay as it travels through mammalian tissues (Tuchin, 2007).
In addition, since biological tissues are optically inhomogeneous and with absorbing
properties with refractive index higher than that of air, partial reflection of the radiation at
the tissue/air interface occurs (Tuchin, 2007). Therefore, light detection through
biological tissues depends on the level of light expressed by the lux-labeled
cell/molecule, depth of the lux-labeled cells within the body and refractive properties
relative to the tissue ground substance. Although biophotonic imaging techniques provide
a feasible and powerful methodology for detection of biological events using in vivo
models, understanding of optical properties of the studied organism (light emitting probes
and/or imaged subject tissue scattering properties) as well as specific validations for each
specific application is necessary to generate accurate data. While this technology has
been extensively used in laboratory animals (e.g., rodents such as mice and rabbit) due to
the thin and semitransparent nature of these mammalian species (Contag et al., 1995), its
application in large animals (e.g., livestock) represent a challenge. However,
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Willard/Ryan laboratory have developed a series of pilot studies to validate this system in
livestock production and have demonstrated its capabilities and advantages over
conventional bacteriological techniques to studying bacterial infections in large animals.
Whole animal biophotonic imaging to study infectious diseases in livestock
Several decades of research conducted with the objective of better understand
diseases in humans and animals has resulted in an increased understanding of
pathogenesis of bacterial infections. However, traditional methods employed back then
were performed using external analysis on biopsy or postmortem samples (Burns et al.,
2001). These techniques where limited to the collection of information from a single
point in time; therefore requiring the use of large numbers of animals to monitor temporal
distribution of bacterial infection over time. By using different animals at each sampling
point, differences in the immune responses and/or metabolic status between animals, as
examples, would increase the variation and therefore causing misinterpretation of results.
Therefore, time course information in individual animals is vanished since each point is
represented by a different set of animals (Burns et al., 2001). As mentioned earlier, the
use of bioluminescent bacteria coupled with biophotonic imaging systems provide
temporal spatial distribution data of bacterial infections as well as an estimation of
bacterial cell numbers from each animal, therefore reducing variability. Since
biophotonic imaging involves collection of data using computerized equipment,
determination of bacterial numbers in several or single subjects at each sampling point is
performed in a short period relative to traditional bacteriological procedures, such as the
timeframe required from euthanasia of the subject (s), collection of samples, and plating;
therefore providing a more accurate estimation of bacterial numbers at the time of data
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collection. Additionally to this, collection of data can be performed in vivo using the
same animal as its own control over time. Collectively, these characteristics position
biophotonic imaging as superior research tool providing improved statistical quality of
data and reduced variability (by obtaining data from the same animal over time; Contag,
2002), and therefore decreasing the time required for the development of new drugs
and/or understanding bacterial pathogenesis determinants. Although this is true for
laboratory animals, due to their tissue thickness nature, density, organs depth and animal
size, application of this technology in large farm animals seems to be limited to ex vivo
imaging.
Several studies have applied biophotonic imaging techniques to monitor bacterial
presence in large farm animals (Moulton et al., 2009a; Ryan et al., 2010; Willard et al.,
2003). Although in these studies detection of bacterial presence was limited to ex vivo
imaging, the data gathered in these studies collectively provide key information regarding
the spatial distribution of bacterial infections in different organs in real time. For
instance, amniotic fluid of late gestation ewes was inoculated with bioluminescent E. coli
as a means to induce preterm delivery and monitor bacterial presence ex vivo on collected
lambs to assess whether preterm delivery is triggered as a consequence of a direct effect
of bacteria or indirectly by an inflammatory response (Moulton et al., 2009a). When
lambs were collected and imaged, in real time presence of bioluminescent E. coli was
detected in uterine and amniotic fluids of the ewe as well as from lungs, gastro-intestinal
fluids and various tissues and orifices of lambs. However, when the fetal lamb’s cranial
cavity was exposed and imaged, no photonic emissions were detected; indicating that
although the lambs ingested and aspirated bacteria from contaminated amniotic fluids
with E. coli, bacteria did not contaminated the brain.
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Absence of photonic emissions in the brain could alternatively be attributable to
plasmid loss and/or low bioluminescent E. coil cell numbers in the brain at the time of
imaging. Plasmid loss could occurred due to the fact that E. coli was conferred with
bioluminescent properties by incorporation of plasmid pAK1-lux, which uses a selectable
antibiotic resistance marker to be maintained in the bacterial cell population (no
antibiotics were used during the course of infection; Moulton et al., 2009a). In addition,
the absence of photonic emissions in the brain could be attributable to low numbers of
bioluminescent E. coli cells, and therefore not enough light was produced to be detected
by the imaging system. However, bacteriological techniques to determine actual bacterial
numbers in brain tissues were not reported to confirm this.
In a similar study conducted by Ryan and collaborators (2010), amniotic fluid of
late gestation mares was inoculated with bioluminescent E. coli with the purpose of better
understanding pre-term delivery in mares with uterine infections. When aborted foals
were collected and imaged in real time, heavy contamination with of E. coli in fetal
membranes as well as in nares was evidently due to the high levels of photonic emissions
collected in these tissues. To further investigate internal contamination with E. coli, heart,
lungs, liver, bladder, gastro-intestinal tract and the brain were dissected from collected
aborted foals and imaged. In real time detection of E. coli in the excised tissues revealed
heavy contamination of not only the lungs but also the gastro-intestinal tract and kidneys,
indicating that not only are the pathogens inspired but also ingested as the fetus consumes
amniotic fluid (Ryan et al., 2010). Interestingly, although heavy contamination with E.
coli was observed in the nares and sinuses of preterm foals, indicated by the detection of
bioluminescent signals collected in these tissues, no bioluminescence signals where
detected in the brain when the cranial cavity was exposed and imaged. Observations
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collected in these studies (i.e., Moulton et al., 2009a, Ryan et al., 2010) suggest, as
previously shown in human infants (Grether et al., 1999), that neurological injuries are
more likely due to the pro-inflammatory cytokines rather than pathogen invasion of the
cerebral cavity, which is consistent with absence of light from fetal lambs’ and foals’
brain (Ryan et al., 2010).
Traditional bacteriological procedures to determine bacterial presence and spatial
distribution in similar studies as the one mentioned here (Moulton et al., 2009a, Ryan et
al., 2010) would require prolonged period of time and miss used of resources, such as
collection of tissues/fluids, processing and bacteriological procedures to determine
bacterial numbers in tissue samples that not necessary were contaminated with bacteria
(contrary to in real time detection of lux-bacteria). Additionally, misinterpretation of
results (e.g., false negative results for a specific bacterium) exists during collection and
manipulation of samples (Sears et al., 1990), as well as cross contamination of samples
from different tissues can lead to misinterpretation of culture results (Cowell and Tyler,
2002). Moreover, these studies demonstrated the use of biophotonic imaging as novel,
efficient, and practical research tool to study pathology of bacterial infections, not only in
laboratory animals but also in livestock production animals.
Another study conducted by our research group aiming toward the development
of new models to improve the current bacteriological techniques used for contamination
prevention programs during harvesting of swine destined for human consumption
(Moulton et al., 2009b). This study demonstrated the feasibility of detecting the presence
of bacteria in real time through the different portions of the intact intestine of swine
during different stages of infection. For example, when pigs where orally inoculated with
bioluminescent Salmonella and the gastrointestinal tract imaged post mortem 6 h post
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inoculation, detection of light emissions were higher in the proximal relative to the distal
portion of the gastrointestinal tract (small intestine segments vs. large intestine,
respectively). On the other hand, when gastrointestinal tract segments were imaged 12 h
post inoculation, higher photonic emissions were detected in the distal portion of the
gastro intestinal tract relative to the duodenum (Moulton et al., 2009b). In both imaging
time periods, digesta was collected from corresponding imaged intestinal segments and
plated to determine the actual bacterial load. Bacterial numbers in the 6 h post bacterial
challenge time point imaging correlated to levels of photonic emissions detected through
each of the segments imaged. However, photonic emissions collected from intact
segments correlate only with the jejunum and large intestine in the 12 h imaging point.
The lower photonic emissions collected at 12 h post challenge, relative to 6 h, even when
the number of Salmonella cells recovered was relatively the same (See Table 1 in
Moulton et al., 2009b), and in some cases higher 12 h post challenge, suggest that
plasmid loss occurred, which could in addition explain the lack of correlation between
photonic emissions and CFU.
Moulton and collaborators (2009b), suggested that biophotonic technology may
not be directly applicable to on-farm testing but could improve analysis of bacteria in
experimental research models aimed to evaluate quality standards and effectiveness.
However, due to recent advances in optical imaging technologies, development of an on
farm test for bacterial identification could be developed. Nanoparticles with optical
properties modified to specifically and exclusively bind to cell wall components of a
particular pathogen may represent a novel approach for on-farm determination of
bacterial contamination in agricultural products destined for human consumption. For
instance, samples collected from swine carcasses can be processed and mixed with
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antibody-modified optical nanoparticles that bind, for example, a cell wall component of
Salmonella. Samples are then exited with a light source and imaged to collect light
emissions. Samples with fluorescent levels higher than background fluorescent levels
could be then presumptively identified to be contaminated with Salmonella. However,
this technology still relatively new, but through validation studies such as those reported
here, this system could eventually represent a valid approach and be developed for
abattoirs on line testing of bacterial contamination.
As shown in the studies described above, imaging of bioluminescent bacteria in
large animals was limited to ex vivo imaging, and due to the bacterial bioluminescent
constructs used (lux operon retained in plasmids) inoculation periods were relatively
short. To circumvent these drawbacks, the use of bioluminescent constructs maximized
for greater tissue penetrations (broad spectral emitters; as suggested by Zhao et al., 2005),
coupled with chromosomal insertion of luciferase genes could allow for detection of
lower CFU numbers through intact tissues and monitoring of bacterial infections for
prolonged periods of time, respectively. Bioluminescent bacterial constructs bearing the
luciferase enzymes from the click beetle display broader spectral profiles (480 to 750 nm)
and therefore light expressed at these wavelengths are less absorbed and have greater
penetration when imaged through biological tissues (Zhao et al., 2005). In vitro studies
conducted in our laboratory (Curbelo et al., 2010), where characterization of photonic
emissions of E.coli-Xen14, a bioluminescent transformant bearing the lux genes of P.
luminescences chromosomally inserted (Caliper Life Sciences), showed nearly 100%
stability when grown with or without antibiotic selection for a period of 8 d (99.98 % for
LB only and 99.93 % for LB plus KAN). Therefore, bioluminescent bacterial
transformants bearing luciferase genes chromosomally inserted provide a stable and
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continual production of light through each generation of bacteria with or without
antibiotic selective pressure. This make these constructs suitable for in vivo studies where
antibiotics are being tested or continued antibiotic presence is not feasible or practical
(e.g., with in vivo pathogenesis models; Curbelo et al., 2010). In addition, improvements
in the stability and light intensities of bioluminescent plasmids, such as pKA4-lux used in
bioluminescent S. aureus RF122 reported in Chapter 4, can also provide better tools to
improve current biophotonic imaging techniques.
Moreover, this system can be further maximized for in vivo imaging of livestock
when bioluminescent bacteria bearing these characteristics are coupled with
instrumentation that allow non invasive imaging of internal organs via the animal’s skin.
The use laparoscopic imaging coupled with biophotonic techniques could allow for in
real time imaging of bioluminescent bacteria from intact organs from the same animal
over time by using non invasive techniques (intra-rectum imaging) or relatively non
invasive techniques (quirurgical incision of the abdominal area, followed by laparoscopic
insertion to monitor presence of bacteria through the intact gastrointestinal wall).
However, trials conducted in our laboratories as a means to evaluate the imaging
capabilities of a rigid laparoscope in the transmittance of light from bioluminescent
bacteria suggest that this technology might not be feasible for in vivo imaging, of light
transmittance that was lost during imaging (~ 99 %; data not shown). However, this could
be attributed to the optical properties of the laparoscope (not optimized for
bioluminescence imaging), resulting in a significant scattering of photons while they
traveling from opening of the laparoscope to the imaging system and/or the
instrumentation used to couple the laparoscope to the imaging system. However,
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optimized bioluminescence instrumentation could eventually surrogate the drawbacks
described above.
Near infrared optimized laparoscopic imaging techniques have been recently used
for detection and removal of prostate cancer cells labeled with fluorescent properties in
humans (van der Poel et al., 2011). Others have reported incorporation of imaging
systems (SPOT RT2 camera) for laparoscopic bioluminescent imaging (BioLume, Inc.
online reports), suggesting that with the appropriate instrumentation, the proof of concept
for this approach can be available in a near future and be implemented in our laboratories
to improve our current imaging techniques. Therefore, using bioluminescent bacteria
bearing chromosomally inserted luciferase genes optimized to produce broader spectral
light profiles and imaged using optimized bioluminescent laparoscope coupled to CCD
cameras can allow for continuous in vivo assessment of bacterial progress over the course
of infection in the same animal and relatively non invasive. This would be the route for
translation of biophotonic imaging in large animals, resulting in the development of more
accurate models toward the development of therapy and or drug development in livestock
production. New advances in the field of optical imaging have emerged and seem to be
promising approaches to improve current techniques and therefore could eventually
overcome the disadvantages of imaging biological processes ex vivo.
Methods to improve transmittance of photonic emissions through mammalian
tissues
Despite the limitations mentioned above, different applications can be
implemented to improve detection of light through biological tissues. The use of
chemical agents to enhance transmittance of light through tissues, increase intensity of
light-producing probes, and/or using more sensitive imaging systems with more
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sophisticated software tools for interpreting images are some examples. As mentioned
above, scattering properties of light is a detrimental factor that limits optical imaging. To
increase photon collection, the multiple scattering of tissues must be reduced, and this
can be achieved by the use of optical clearing agents (OCA; Tuchin, 2007). The use of
OCA in biological tissues permits delivery of near-collimated light deeper into tissue;
therefore, OCA could potentially improve the capabilities of optical imaging diagnostics
(Rylander et al., 2006). Dimethyl Sulfoxide (DMSO), glycerol, and other hydrophilic
sugars are some examples of OCA agents. According to Rylander et al. (2006), OCA
agents when applied to biological tissues reduce scattering of photons by three
hypothesized mechanisms, 1) dehydration of tissue constituents, 2) replacement of
interstitial or intracellular water with an agent that better matches the higher refractive
index of the proteinaceous structures and 3) structural modification or dissociation of
collagen. Studies have tested the synergistic optical clearing properties of DMSO and
glycerol as an approach to enhance light penetration depth in mammalian tissues (Xu and
Wang, 2004). These researchers previously reported that high concentrations of glycerol
(80%) and DMSO (50%) were very effective in enhancing light penetration depth in
porcine gastric tissue (23% increase of light transmittance and 24% decrease of diffuse
reflectance;Wang et al., 2003). However, high concentrations of glycerol can cause
significant tissue shrinkage whereas DMSO can induce alterations in the chemical
structure of tissues. In addition, high concentrations of DMSO have been reported to
cause side effects on humans such as skin reaction, insomnia, sedation and nausea
(Lockie and Norcross, 1967). For these reasons, Xu and Wang (2004) studied the effects
of lower OCA concentrations and concluded that 50% glycerol with 30% would be an
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effective approach to optically clear porcine tissues for optical imaging techniques and
reduce the sides effects associated when higher concentrations are used.
Enhancement of light intensity from bioluminescent/fluorescent probes
As described previosly, photonic signal intensity detected through biological
tissues depends on the optical characteristics of the tissue and the photonic properties of
the light emitting probe. Although tissue scattering is not significantly affected in the
visible wavelength spectrum (~400 to 760nm), absorption; however, can have a sharply
contrasted spectral signature mostly by the chromophores present in the mammalian
subject being imaged (Mobley et al., 2011). Chromophores such as hemoglobin and
melanin significantly contribute to absorption of light within tissue in the visible
spectrum; however, absorption of wavelengths longer than 600 nm was reduced, allowing
transmission of red light through several centimeters (Zhao et al., 2005). Therefore, the
spectral properties of the bioluminescent probe source should represent an important
factor on the amount of photons being propagated to the surface and could be used to
increase efficiency of detection of photonic emissions in deep tissue models.
Luciferase enzymes (commercially available as codon optimized luciferases) from
firefly (Fluc), click beetle (CBGr68, CBRed) and Renilla reniformis (HRluc) are
frequently used as gene reporters for in vivo studies conducted with small laboratory
animals (e.g., mice). Spectral peaks of these luciferase enzyme systems are observed at
37 °C and correspond to 480, 543, 612 and 615 nm for hRLuc, CBGr68, Fluc and
CBRed, respectively (Zhao et al., 2005). According to these authors, bioluminescent
signals with spectral peaks in the blue/green wavelengths (~475 to 515 nm) are strongly
absorbed by chromophores such as hemoglobin, whereas those with peaks in the
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orange/red wavelengths (~590 to 650 nm) are less absorbed and have greater penetration
properties when imaged through biological tissues. For these reasons Zhao et al. (2005)
developed broad spectral emitters by gene fusions between CBGr68 and CBRed.. They
found that the dual CBGr68/CBRed luciferase fusion displayed broader spectral profiles
(480 to 750 nm) than FLuc when expressed in mammalian cells. Since light attenuation is
higher in the region of hemoglobin absorption range (530 to 580), the use of the dual
CBGr68/CBRed might represent a more useful reporter for optical imaging of biological
events in deep tissue models (Zhao et al., 2005).
Detection of photonic emissions through biological membranes is affected by the
intensity of light emitted by the source and this at the same time is influenced by
temperature. Determination of the optimal temperature for imaging bioluminescent
probes is also necessary when developing studies using biophotonic imaging techniques
in cultures and/or in vivo. As suggested by Zhao et al. (2005), determination of the
emission spectrum and its thermal stability are crucial determinants to maximize
sensitivity of detection of emitting probes when selecting an appropriate reporter.
Activity of luciferases CBGr68 and CBRed were found to increase when room
temperature (25 °C) was shifted to physiological temperature (37 °C; 6.4 vs 7.8 fold,
respectively; Zhao et al., 2005). In the mentioned study, spectral profiles were also found
to be dependent of the temperature used during imaging. Spectral emission peak (λ max) of
Fluc+ was found to be red shifted from 578 nm to 612 nm when temperature was
increased from 25 °C to 37 °C, respectively. Therefore, temperature not only play an
important role in the activity of luciferases but also influences the spectral profiles,
particularly shifting these to the red orange/red wavelengths (~590 to 650 nm) were light
is less absorbed and have greater penetration within biological tissues.
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Another approach used to enhance detection of light producing probes during
deep tissue in vivo imaging is the conjugation of non-biological particles to
bioluminescent probes. Nanoscale technology has been extensively used in the
biomedical field, for instance, for detection of diseases, diagnosis, treatment, prevention
and for targeting gene delivery for tumor treatments (Xing and Rao, 2008). Metal and
semiconductor nanoparticles in the 2-6 nm size range are being targeted for intensive
research toward their implementation in biomedical applications due to their unique sizedependent properties and dimensional similarities with biological macromolecules such
as peptides, nucleic acids and proteins (Chan et al., 2002; West and Halas, 2003). Due to
these characteristics researchers have been able to combine the functionalities of
nonbiological (nanoparticles) with biomolecules as a means to improve current
techniques in cellular and molecular biology, such as optical probes (West and Halas,
2003). Of particular interest is that some nanoparticles pose optical properties, and these
are known as quantum dots. Quantum dots are semi conductor light-emitting nanocrystals
with optical and electrical properties. When these nanocrystals are bioconjugated to
optical bioparticles (e.g., luciferases), they provide optical properties that are highly
controllable and superior to current optical probes; such as higher quantum efficiencies,
greater scattering or absorbance cross sections and greater chemical stability (West and
Halas, 2003). This is the principle used to develop bioluminescence resonance energy
transfer (BRET).
Bioluminescence resonance energy transfer is a nonradiative process that involves
energy transfer from a donor (e.g., biochemical energy generated by bioluminescent
proteins) to an acceptor (e.g., fluorescent protein such as fluorescent proteins or quantum
dots; Xia and Rao, 2009). The light emitted by the acceptor is detected by the low light
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imaging systems and used to estimate the donor’s light emission intensities. According to
Xia and Rao (2009), quantum dots are well suited for BRET acceptors due to their high
quantum yields, large Strokes shifts and long wavelength emissions. This system takes
advantage of the brighter signals observed in fluorescent probes relative to
bioluminescent probes, but without the drawback of having superior signals to noise
ratios associated with the use of fluorophores. This is because the donor from BRET does
not require extrinsic excitation to release energy, therefore significantly reducing
autoluminescence and autofluorescence from biological tissues associated to the use of
external light sources during in vivo imaging.
Bioluminescence resonance energy transfer requires blue light for efficient
excitation. During the early development of this technology, an extrinsic light source was
used to excite quantum dots. However, as previously described above, signals with
spectral peaks in the blue/green wavelengths are strongly absorbed by hemoglobin and
produces high background owing to excitation of endogenous fluorophores, therefore did
not fit well for in vivo deep tissue models. Researchers, Rao and Gambhir lab (described
in So et al., 2006), then decided to bioconjugate the fire fly luciferase with quantum dots
and use the luminescent light expressed by the luciferase to excite the quantum dot.
However, the firefly luciferase was reported to be sensitive to chemical modifications,
such as that of being conjugated to nanocrystals. Furthermore, these researchers
developed a variant of Renilla reniformis luciferase (denoted Luc8) that provided
significant advantages such as greater stability to chemical modifications and improved
efficiency, relative to other luciferase systems. The latter, due to the fact that Luc8 emits
shorter-wavelength light spectrum compared to the firefly luciferase providing greater
quantum efficiency when used with quantum dots. Therefore, bioluminescent quantum
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dot conjugates such as that described by So et al. (2006), where quantum dot QD665 was
covalently coupled to a BRET donor such as Luc8 produced light by the following
process: in the presence of oxygen Luc8 catalyzes the transformation of coelenterazine
(Renilla reniformis luciferase substrate) and emit bioluminescent light at as spectrum of
480 nm wavelength whereas this energy is then transferred to the quantum dot resulting
in quantum dot emission in the near infra red spectrum (~655 nm) which as mentioned
before, is less absorbed and have greater penetration through biological tissues.
Applications of biophotonic imaging to better understand pathogenesis of mastitis in
dairy cattle
To date, traditional culturing techniques are used for the determination of
bacterial numbers in infection diseases models (Viguier et al., 2009). Determination of
antimicrobial activity in vivo typically requires that infected animals be killed at each
sampling point, followed by extraction of the infected organ (s), tissue processing (e.g.,
tissue homogenization) and culturing techniques as a means to estimate the pathogen
burden. Although this is true for small animal laboratory models, it is not necessary the
case in antimicrobial mastitis and/or uterine infection bovine models. For example,
studies conducted to determine efficacy of intramammary antibiotic therapies for the
treatment of experimentally-induced and/or naturally occurred Gram positive mastitis in
dairy cows required extensive culturing techniques and identification tests in order to
estimate bacterial numbers to confirm and/or identify the pathogen being studied
(Gillespie et al., 2002; Oliver et al., 2003; Oliver et al., 2004). In these studies milk
samples collected from infected quarters with S. aureus were plated into differential
media plates (e.g., blood agar plates to determine hemolytic reaction), followed by
incubation and observations for three days. Primary culture medium were tentatively
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identified by colony morphology and hemolytic features observed in the plates and a
catalase test was performed to confirm the presence of staphylococci spp. Then, isolates
presumptively identified as staphylococcus spp. were tested for coagulase using the tube
coagulase method. On the other hand, isolation of streptococcal organism required
different tests. This is a clear example of the labor-intensive procedures required for
estimation and/or identification of the etiological microorganism to confirm that mastitis
symptoms were associated to the presence of the bacterial pathogen studied.
In contrast, bacteria labeled with bioluminescent reporter genes may represent an
efficient model to study pathogenesis of mastitis infections in vivo. Pathogens labeled
with the lux gene can provide in real time information of mastitis pathology, such as
confirmation of bacterial presence and estimation of bacteria cell numbers in a single
milk sample. For instance, milk samples collected from inoculated quarters with
bioluminescent bacteria can be imaged in real time where the presence of light in the
sample will confirm the presence of the etiologic pathogen, therefore eliminating labor
extensive microbiological procedure used for bacterial identification. In addition, levels
of light collected by charge couple device cameras provide an estimation of the bacterial
load, since levels of PE highly correlate with numbers of bacteria presence
(Kadurugamuwa et al., 2005). However, limitations exist regarding the sensitivity of
detection, such as detection of very low bacterial cell numbers.
Traditional methods to investigate the presence and spatial distribution of bacteria
and/or the expression of virulence factors during tissue colonization in situ required
extensive histology and microbiology procedures (Hensen et al., 2000). In the mentioned
report, the expression of the Capsular polysaccharide type 5 (CP5) in CP5 positive S.
aureus required extensive immunohistological techniques to specifically label CP5 in
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bovine udder tissue sections. For example, to develop an effective antibody for
immunochemical staining of CP5 in udder tissue sections, bovine udder tissues from
healthy animals were processed to prepare udder acetone powder. To create antisera that
exclusively bind to CP5, chickens were immunized for a period of 75d with bacterin
made from CP5 positive bacterial strains. Sera from immunized chickens was then
absorbed with the udder acetone powder, as a means to eliminate cross-reactivity with
udder tissue antigens during immunochemical staining of CP5 in infected bovine udder
tissues with S. aureus. Then, the absorbed chicken sera was further purified with an
ELISA to absorb other CP types and eliminate cross reaction with these molecules during
immunochemical staining of infected bovine quarters. Cow’s mammary gland quarters
were inoculated with CP5 positive S. aureus and tissue samples collected post mortem. In
order to identify the presence of Gram positive staphylococci in different mammary gland
sections (e.g., teat canal, teat sinus, udder cistern, etc), Gram staining techniques were
performed along with microscopy examination. Immunochemical staining of CP5 was
then performed in the adjacent areas where Gram-positive cocci were observed, in order
to increase chances of immunochemical staining of CP5-postive bacteria (i.e., S. aureus
Newbould 305). Secondary antibody was required to label the CP5 chicken antisera as
well as other staining techniques.
Mastitic pathogens conferred with bioluminescent properties could surrogate the
intensive procedures used to monitor bacterial distribution in tissues as well as expression
of bacterial virulence factors in mastitis models. For example, whole tissue imaging of
the mammary gland ex vivo can provide information regarding to specific areas of
bacterial contamination. In addition, degree of bacterial colonization can be determined
in a single imaging (e.g., areas with higher levels of PE will have higher numbers of
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bacterial cells), and with histology analysis, colonized areas can be correlated with degree
of necrosis as previously reported in cases of S. aureus mastitis (Chandler and Reid,
1973). However, imaging of bacteria conferred with bioluminescent properties might not
always represent an efficient technique to estimate bacterial numbers in vivo models. This
due to the different gene constructs used to confer bacteria with bioluminescent
properties (eukaryotic vs prokaryotic luciferases) and the different vectors used to
incorporate these into bacterial cells (plasmids vs transposons).
Staphylococcus aureus has been conferred with bioluminescent properties by
incorporating genes coding for luciferases from naturally-occurring light-emitting
organisms such as the North American firefly, Photinus pyralis (Steidler et al., 1996;
Tenhami et al., 2001). Although the use of the firefly luciferase marker gene (luc) offers
many advantages, such as high quantum yield and its wide use as a biomarker in
prokaryotic and eukaryotic cells, which translates in a higher accessibility of reagents and
vectors, it requires the addition of exogenous substrate to allow production of
bioluminescent emission. Another approach has been the transformation of S. aureus
with DNA containing the P. luminescens lux operon (Francis et al., 2000). Transformants
carrying this construct are capable of producing both the luciferase enzyme and substrate
biosynthesis enzymes, thus emitting light when bacteria are metabolically active.
Although this system overcomes the need of adding exogenous substrate to allow
emissions of light, this construct was maintained on a plasmid, allowing the expression of
light for a limited period of time (24 h; Francis et al., 2000).
On the other hand, Kuklin and collaborators (2003), integrated a modified lux
operon from P. luminescence into S. aureus’ chromosome (designated S. aureus-Xen8.1),
allowing continuous production of bioluminescence for prolonged period of time (21
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days; no studies have been conducted to evaluate longer periods). This system, in contrast
to the use of the luc constructs or the lux operon contained in plasmid copies, permitting a
continuous evaluation of the pathogenesis of bacteria for an extended period of time,
which is required to evaluate potential vaccine candidates (Kuklin et al., 2003). Another
important advantage of using chromosomal insertion of the lux operon for pathogenesis
models is that these constructs do not require to be grown under antibiotic pressure to
keep continuous and prolonged production of light, relative to constructs using plasmids.
This makes it more suitable for studies where antibiotics are being tested or continued
antibiotic presence is not feasible or practical (e.g., with in vivo pathogenesis models).
Bioluminescent genes fused with virulence factor could, in addition, represent an
efficient model to better understand pathogenesis of mastitis. According to Winson et al.
(1998), the use of luxCDABE operon from P. luminescens provide a relatively easy
method for labeling bacteria and provide and efficient way to quantify gene expression
with high sensitivity over large dynamic range in real time and non-destructively. In
addition, the use of the luxCDABE cassettes allow for the screening of genes expressed at
a particular bacterial phase growth, or in response to a specific physical, chemical or
culture condition (Winson et al., 1998). Timmins and Holland (1999), using a luciferasebased reporter system monitored the expression of the TSST-1 from S. aureus to
determine the association of bacterial cell densities with the regulation of TSST-1 gene
expression (tst) in vitro. In contrast to the use of conventional methods to monitor gene
expression of virulence factors in bacteria, as those described previously (Hensen et al.,
2000), the use of the luciferase system is a relatively easy process to label genes of
interest (promoter site of a gene fused with the lux gene) and monitor levels of
transcription or translation as well as localization of these events in cells (Griffiths,
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2000). Furthermore, Timmins and Holland (1999), reported that incorporation of the lux
AB in S. aureus did not affect the general physiology of the bacterium and that the use of
this system resulted in a sensitive reporter to test tst expression. Therefore, translating
this system to in vivo mastitis models would result in a more efficient model, relative to
traditional methods, since different processes can be determine simultaneously in real
time and in a single imaging. For example, imaging of virulence factors expression in real
time and in vivo (e,g., from milk samples collected from infected quarters) and detection
of bacterial presence and gene expression in tissue samples ex vivo by monitoring
bioluminescence emissions from the luciferase reporters. Therefore, detection of light
from these reporters will demonstrate spatial distribution of the pathogen of interest as
well as levels of gene expression.
Moreover, simultaneous quantification of different cellular activities using optical
imaging technology has been proposed (Unge et al., 1999). These investigators developed
a dual marker system composed of the luxAB and genes encoding the green fluorescent
protein (gfp) as a means to chromosomally label bacteria as a means to monitoring
bacterial metabolic status and cell density simultaneously. Simultaneous determination of
different cell activities in single cell is possible due to the differences in biomarker
expression requirements of this dual marker. For example, green fluorescent protein used
as markers in bacteria does not require any substrate or cofactor produced by the bacterial
host to produce light, but only external light excitation. In contrast, bacterial lux system
requires metabolization of molecules such as FMNH2 and aldehyde produced by the
bacterial host in order to produce light. Since cellular metabolism requires energy, the
bioluminescent levels of lux bacteria are directly related to the metabolic status of the
cells while levels of fluorescence will correlate with bacterial numbers (Unge et al.,
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1999). Therefore, combination of this duel optical reporter can be used, in addition to the
mentioned approaches, to monitor multiple bacterial cell processes such as bacterial cell
density and metabolic activity.
In vitro techniques coupled with optical imaging could provide further
information to investigate pathogenesis during the different stages of mastitis infection.
Labeling bacterial genes associated with virulence factors using the lux gene system and
bacterial density using the gsp system allow for in real time determination of the
association between expression of virulence factors and bacterial densities (i.e., quorum
sensing dependent virulence factors). Dual labeled bacteria together with cell culturing
techniques (e.g., mammary gland cell cultures) could provide qualitative as well as
quantitative information regarding the association of the expression of specific virulence
factor activities upregulated by the different mammary gland cell populations present in a
medium. As mentioned earlier, establishment of mastitis infection requires that the
bacterium enter the teat canal and survive, adhere, colonize and multiply in the new
mammary gland environment (Sutra and Poutrel, 1994). During early phases of infection,
regulation of specific genes is required to overcome the anatomical, non specific and
adapted immune defenses of the bovine host. For instance, in the case of S. aureus
mastitis, specific adhesion to epithelial cells is essential for colonization (Sutra and
Poutrel, 1994). As suggested by Lammers et al. (1999), the use of bovine mammary
gland cell cultures can provide information regarding to bacterial adhesion and invasion
of specific cell types (e.g., elongated vs. cubic mammary gland cells). More recently,
mammalians cells have been conferred with autonomous bioluminescent properties by
introduction of the lux cassette allowing for real time monitoring of bioluminescence
from cell cultures without exogenous substrate addition (Close et al., 2010). Therefore,
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labeling mammalian cells with bioluminescent properties can be used for rapid
identification of mammalian cell types in cultures. This approach coupled with the
bacterial lux gene system can facilitate the development of in vitro research toward the
investigation of virulence factors that are up regulated under the presence of a particular
mammary gland cell population and their molecular crosstalk between these during
mammary gland infection. Although the identification of mammalian target cells and
bacteria interactions required extensive procedures when standard methods were
employed (e.g., tissue and bacterial cells antibody staining techniques, tissue processing
and light microscopy; Lammers et al., 1999), the use of optical imaging could overcome
these extensive labor techniques and provide efficient models for the development of
antimicrobial agents and/or vaccine candidates and therefore speed the process of
screening compounds leading to more rapid drug discovery of antimicrobial agents (Rice
et al., 2001).
Of particular interest, regarding the development of vaccine candidates is the
addition of a lux promoter adjacent to virulence factors associated to the expression of
bacterial adhesins. According to Wizemann et al. (1999), to initiate infection, most
bacterial pathogens must first have their first encounter with their host by attachment to
an appropriate target tissue. In mammary gland infections, as those caused by S. aureus,
bacteria initially must gain access to the mammary gland through the teat canal and
adhere to the epithelial cells as a means to avoid being flushed out during milking
(Zecconi, 2007). Staphylococcus aureus possesses specific adhesins to bind a variety of
host proteins mainly in the host extracellular matrix, such as collagen, fibrinogen, and
fibronectin (Brouillette et al., 2003). Adherence of S. aureus to the teat canal is mediated
by fibronectin-binding protein-A (FnBP-A) which mediates bacterial attachment to
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immobilized fibronectin adherence to udder epithelial cells, whereas collagen adhesions
(Cna) induces bacterial adherence to collagen substrates and cartilage (Zecconi, 2007).
Therefore FnBP-A and Cna are essential virulence factors for successful colonization of
the mammary gland (Brouillette et al., 2003). According to Zecconi (2007), these
molecules are potential antigens to be considered for vaccine production. By preventing
adherence of bacteria to the mammalian epithelial cells will prevent bacteria to adhere
and colonize, therefore exposing bacteria to the phagocytic action of natural killers with
further presentation of antigens to lymphocytes and antibody production by B-cells.
Therefore, targeting virulence factors required by bacteria for early colonization could
provide a more attractive method for vaccinations, since the immunity provided using
this approach is naturally acquired (active immunity).
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CHAPTER II
PHOTONIC CHARACTERISTICS AND EX VIVO IMAGING OF ESCHERICHIA
COLI-XEN14 WITHIN THE BOVINE REPRODUCTIVE TRACT
ABSTRACT
The objectives were (1) to characterize the photonic properties of E.coli-Xen14,
and (2) to conduct photonic imaging of E.coli-Xen14 within bovine reproductive tract
segments (RTS) ex vivo. E.coli-Xen14 was grown for 24 h in Luria Bertani medium
(LB), with or without kanamycin (KAN). Every 24 h, for an 8 d interval, inoculums were
imaged and photonic emissions (PE) collected. Inoculums were sub-cultured and plated
daily to determine the CFU and ratio of photon emitters vs non-emitters. In the second
objective, abattoir-derived bovine reproductive tracts (n=9) were separated into posterior
and anterior vagina, cervix, uterine body, and uterine horns. Two concentrations (3.2 x
108 and 3.2 x 106 CFU/200 µL for relative [High] and [Low], respectively) of E.coliXen14 were placed in translucent tubes for detection of PE through RTS. CFU did not
differ (P = 0.31) over time with or without KAN presence; they remained stable with
99.93 and 99.98% photon emitters, respectively. However, PE were lower (P < 0.0001)
in cultures containing KAN than no KAN (629.8 ± 117.7 vs 3,012.0 ± 423.5 RLU/s,
respectively). On average, the percentage of PE between RTS, for both concentrations,
was higher (P < 0.05) in the uterine body. In summary, E.coli-Xen14 remained stable
with respect to the proportions of photon emitters with or without KAN (used to
selectively culture E.coli-Xen14). However, KAN presence suppressed photonic activity.
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The ability to detect PE through various segments of the reproductive tract demonstrated
the feasibility of monitoring the presence of E.coli-Xen14 in the bovine reproductive tract
ex vivo.
Keywords: Escherichia coli, Biophotonics, Uterus, Reproductive tract

INTRODUCTION
The rate of uterine infections in cattle has been estimated to be from 2.2 to 37.3%
(Kelton et al. 1998), with economic losses to this as high as $236 per case (Bartlett et
al.1986). These economic losses include: reduced fertility, decreased milk yield,
treatment costs and increased culling rate (Kelton et al. 1998). Escherichia coli (E.coli) is
the most common isolated bacteria in post partum uterine infections in cattle (Huszenicza
et al. 1999), and one of the few uterine pathogens associated with clinical signs (Williams
et al. 2005); specifically inflammation of all layers of the uterine wall, edema,
myometrial degeneration and infiltration by leukocytes (Sheldon et al. 2006). In addition,
it has been shown that chronic infections caused by E. coli can retard ovarian follicle
growth, lower peripheral plasma concentrations of estradiol and contribute to an inability
to form a competent corpus luteum (Williams et al. 2007).
Conventional models to estimate bacterial populations and invasiveness in vivo
would typically require extensive sampling procedures at each sampling time-point, and
considerable time and labor to establish cultures, etc. Another approach has been the use
of luciferases (e.g., photonic emissions) to label pathogens and monitor their progress
during infections in small and/or large animals (Contag et a.l 1995; Willard et al. 2003;
Ryan et al, 2005; Moulton et al. 2008). This feature is being used as a detection system
for various kinds of expression models, acting as a reporter for the activity of regulatory
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elements that control its expression (Paulmurugan and Gambhir, 2005). The use of
biophotonic imaging allows biological processes of infective state of eukariotic cells to
be monitored longitudinally, in vitro and in vivo, in real-time and non-invasively (Contag,
2002). The lux operon has been modified for bacterial incorporation using plasmids, via
transponson mutagenesis and chromosomal insertion, routinely carry antibiotic resistance
selection markers for cultivated as monocultures under controlled environment conditions
(Herrero et al. 1990). E. coli has been conferred with bioluminescent properties by
providing it with the lux genes of Photorhabdus luminescences on its chromosome (e.g.,
lux operon in E.coli-Xen14; Caliper Life Sciences). This lux operon system encodes all
proteins required for bioluminescence, including the luciferase, substrate, and substrateregenerating enzymes which can be expressed within the bacterial host (Luker and Luker,
2008). This feature compared to plasmid integration, exhibits a continuously and stable
luciferase expression over time and without antibiotic pressure; since theoretically they
should be as stable as a chromosomal gene (Herrero et al. 1990). The use of
bioluminescent bacteria, such E.coli-Xen14, coupled with photonic imaging technologies
may represent an efficient model for achieving a greater understanding of the
pathogenesis of uterine infections. Some studies have established positive relationships
between photonic emissions (PE) and bacterial populations for gram-negative bacteria (r
= 0.99; Kadurugamuwa et al. 2005), and our laboratory have previously described and
validated both in vitro (Moulton et al. 2006) and ex vivo (Moulton et al. 2008)
bioluminescent bacterial models.
Studies have examined, for example, models for infection in the mouse (Kuklin et
al. 2003), ex vivo imaging of gestating ewes (Moulton et al. 2008), real-time monitoring
of Salmonella in swine (Willard et al. 2003) and screening of pathogens in living fish
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(Karsi et al. 2006). Monitoring bioluminescent bacteria through tissues of small animals
(e.g., rats or mice) is feasible due to the thin and semitransparent nature of mammalian
tissue (Contag et al. 1995). An obstruction of photonic transference from bioluminescent
bacteria as signal pass through tissues is due to the scattering and absorption of photons
associated with tissue thickness and the type of tissue acting as the barrier (Rice et al.
2001). To date, this technology has not been reported in large animals (e.g., bovine or
equine) in vivo or ex vivo. Thus, the objectives of this study were (1) characterize the
photonic properties of bioluminescent E.coli-Xen14 in vitro, with respect to operon
stability and bacterial growth curves; and (2) to conduct photonic imaging of E. coliXen14 from within the bovine reproductive tract ex vivo as a first step towards
development of an in vivo large animal model.
MATERIALS AND METHODS
Operon stability evaluation
To evaluate the stability of the lux operon in E. coli-Xen14, one colony was
inoculated in 20 mL of Luria Bertani medium (LB) and grown at 37 ºC in an orbital
shaker at 180 rpm for 24 h to produce fresh inoculums. Aliquots (100 L) were
transferred to tubes (three tubes/treatment) containing fresh 29.9 mL of LB or LB plus
kanamycin (KAN; Sigma-Aldrich, Inc. St. Louis, MO, USA) as the selective agent (30
µg/mL; i.e., KAN resistance is a characteristic of the transformed E. coli-Xen14 line for
selective growth in vitro) and incubated at 37 ºC in an orbital shaker at 180 rpm for 24 h.
Black 96-well plates (n = 3) were divided into two sections with n = 8 wells per
treatment. Each well was filled with 100 L aliquots and imaged (2 s) to collect photon
emissions (PE) using the XR/MEGA-10ZeroTM imaging system (Stanford Photonics, Inc,
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Palo Alto, CA, USA) and analyzed using Image J software (National Institutes of Health,
Bethesda, MD, USA) in which pixel intensities associated with PE were quantified within
regions of interest (e.g., individual wells of a 96-well plate, designated areas over
segments of the reproductive tract, etc.), and standardized to relative lights units per
second (RLU/s). Following imaging, the content of a well was used to re-inoculate the
corresponding tube containing fresh LB for the next day’s imaging. The content of the
other seven wells were serially diluted in 900 L of LB or LB plus KAN and plated on
LB or LB plus KAN agar plates (i.e., inoculums grown in KAN were plated on agar
containing KAN) to allow the number of colony forming units (CFU) to be compared to
levels of PE activity. Furthermore, each plate was imaged using the Nightowl imaging
system (Berthold Technologies, Oak Ridge, TN, USA) to determine the ratio of nonphoton emitting vs photon emitting colonies. This entire procedure was conducted over
eight consecutive days and independently repeated three times.
Escherichia coli-Xen14 growth characteristics
To evaluate the growth characteristics of E.coli-Xen14, a growth curve was
generated. Inoculum tubes (n = 3/treatment) were filled with 29.9 mL of LB or LB plus
KAN (30 µg/mL) and 100 L of exponential cultures of E.coli-Xen14 were added to
each tube and incubated at 37 ºC in an orbital shaker operated at 180 rpm. A black 96well plate was divided into six sections with n = 3 wells per treatment and a plastic
barrier was placed between treatments to avoid overlapping photonic noise. Immediately
after the addition of E.coli-Xen14 cultures into the inoculum tubes, 100 L aliquots (n =
3/tube) were taken periodically, from static cultures, and placed into its corresponding
wells for imaging (5 s), using the Stanford Photonic imaging system. Following imaging,
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each well’s contents was serially diluted and plated on LB or LB plus KAN agar plates to
determine the CFU and compare it with their corresponding levels of PE activity. This
entire procedure was continued until RLU/s decreased to baseline for two consecutive
sampling points.
Photon detection from E. coli-Xen14 within the bovine reproductive tract ex vivo
Bovine reproductive tracts (n = 9; collected at an abattoir) were separated (by
excision) into uterine horns (left and right) uterine body, cervix and vagina (posterior and
anterior). The thickness of each segment was measured using a sliding caliper to the
nearest 0.05 mm. Two concentrations of E.coli-Xen14 inoculums were used. A low
concentration was prepared by adding 100 L of E.coli-Xen14 exponential culture into a
sterile beaker containing 99.9 mL of LB, and a high concentration by adding 25 mL of
E.coli-Xen14 exponential culture into a sterile beaker containing 75 mL of LB broth.
Prior to imaging, each reproductive tract was placed in a plastic plate containing sterile
phosphate-buffered saline (PBS) warmed to 45 ºC. Translucent tubes filled with 200 L
of each of the two E.coli-Xen14 inoculum concentrations (3.2 x 108 and 3.2 x 106
CFU/200 L for relative High and Low concentrations, respectively) were used to
evaluate photon detection through the same reproductive tract segment with each
respective concentration to avoid contaminating the segment being imaged. A 30 s
acquisition time was used for the High concentration and 10 min acquisition time for the
Low concentration (based on preliminary imaging studies prior to this trial; data not
shown). All segments and tubes were imaged with the same Stanford Photonic imaging
system and emissions were standardized to RLU/s for analysis. The different acquisition
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times (High vs. Low) were needed to prevent pixel intensity thresholds from being
reached by high levels of PE.
The translucent tube designated to the reproductive tract segment being analyzed
and the segment itself were first imaged separately with the corresponding acquisition
time for background acquisition (and later for analysis with background subtraction), and
then the tube was inserted into the segment in a pre-determined area and re-imaged
through the segment (see Fig. 2.1). Before insertion every tube was warmed to ~ 45 ºC
for 2 min to acclimate the inoculums, and the reproductive tract segments were similarly
warmed prior to and during imaging. After imaging, a 100 L aliquot from each tube was
serially diluted in 900 L of LB and plated to determine CFU counts. The RLU/s
obtained from the segment imaged by itself were subtracted from the RLU/s of the
segment with the tube inserted and then divided by the RLU/s of the tube containing
E.coli-Xen14 inoculum to determine the percentage of transference of PE.
Statistical analysis
Observations in each sample were normally distributed (tested using a box-plot
diagram analysis) and the assumption of equal variances was tested using the Levene’s
test. The statistical analysis used to evaluate the bacterial population and PE in the
stability test and growth characteristics of E.coli-Xen14 were performed over time by the
PROC ANOVA function in SAS version 9.2 for Windows (SAS, Cary, NC, USA) with a
repeated measures design. An LSMEANS procedure was used to determine differences in
PE and bacterial populations between treatments by day and/or sampling point. For the
E.coli-Xen14 photon detection through reproductive tract segments, one-way ANOVA
was used to evaluate PE and bacterial populations, and an LSD test was performed to
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compare PE detected between reproductive tract segments. Correlation coefficients
between the transference of PE of E.coli-Xen14 and thickness of the reproductive tract
segment were determined using Pearson Correlations.
RESULTS
E.coli-Xen14 photonic stability and bacterial populations during 8 d with or without
antibiotic selection
The in vitro study to evaluate the photonic stability of E.coli-Xen14 showed
approximately 100% (99.98 ± 0.02 for LB only and 99.93 ± 0.03 for LB plus KAN)
photon emitters in the absence or presence of KAN when used as a selective agent during
the 8 d trial. Photon emissions (PE) of E.coli-Xen14 cultures containing LB and LB plus
KAN did not differ at the first 24 h comparison (P = 0.82; Fig. 2.2-A). However at 48 h,
a significant increase (P < 0.0001) in PE of E.coli-Xen14 cultured in LB only occurred,
whereas PE of E. coli cultured in LB plus KAN remained constant. Escherichia coliXen14 cultured in LB reached peak PE during Days 2 and 3, decreased by Day 4, and
then remained constant until the end of the 8 d trial (Fig. 2.2-A). Conversely, E.coliXen14 PE cultured in LB plus KAN was lower (P < 0.0001) than LB alone and remained
constant during the 8 d trial (Fig. 2.2-A). Unexpectedly, for both treatments, bacterial
populations remained similar (P = 0.96) during the entire trial (Fig. 2.2-B).
Escherichia coli-Xen14 photonic and growth characteristics
A growth curve analysis was generated and PE were compared with bacterial
populations until PE decayed in E.coli-Xen14 cultures containing LB and LB plus KAN.
Photon emissions of E.coli-Xen14 cultured on LB and LB plus KAN at the first sampling
point (Time 0) did not differ (P = 0.99) with 1.64 ± 0.45 vs 1.21 ± 0.34 RLU/s,
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respectively (Fig. 2.3-A). After 6 h of incubation, an increase in PE (29.8%; P = 0.01) for
E. coli-Xen14 cultured without KAN compared to cultures with KAN was observed
(2,491.87 ± 263.9 vs. 1,749.0 ± 253.6 RLU/s; Fig. 3A). Photon emissions of E. coliXen14 without KAN increased up to 51% after 9 h compared to cultures with KAN
(9,264.7 ± 252.5 vs. 4,487.4 ± 252.5 RLU/s; P < 0.0001), and remained similar until 31 h
post-inoculation (8,488 ± 252.2 vs. 8,106.2 ± 252.2 RLU/s; P > 0.05; Fig. 2.3-A). After
31 h, E. coli-Xen14 cultures containing KAN reached similar PE (P = 0.19) than those
emitted by E. coli-Xen14 cultures without KAN (8,488.9 ± 253.6 vs. 8,106.27 ± 253.6
RLU/s; Fig. 2.3-A). Photon emissions declined at 45 h to 151.0 and 145.0 RLU/s for
cultures with and without KAN, respectively, and remained similar (P > 0.90) at 48 h
(143.7 vs. 172.4 RLU/s, respectively; Fig. 2.3-A). Bacterial populations, again, remained
constant between both treatments from the initial sampling point to the decay of PE (P =
0.70; Fig. 2.3-B).
Photon detection of Escherichia coli-Xen14 within the reproductive tract ex vivo
The age and reproductive cycle phase of the animals used for these studies were
not available (as they were abattoir-derived tissues). Some studies have reported changes
in tissue composition and thickness due to age, number of parturitions, stage of estrous
cycle, connective tissue, etc. (Hawk et al. 1964), which might need to be considered in
future studies (see Table 3.1 for mean thicknesses of the reproductive tract segments used
in this study). The CFU in each translucent tube containing E.coli-Xen14 inoculums were
constant during evaluation of all segments of the reproductive tract for Low and High
concentrations (P = 0.05; P = 0.15, respectively), as well as the RLU/s in both
concentrations (High: P = 0.82; Low: P = 0.92, respectively). On average, the percentage
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of PE between reproductive tract segments, for both concentrations (e.g., High and Low)
were higher in the uterine body; however, reproductive tract segments varied in order
with respect to levels of PE detected between both concentrations. The correlation
between tissue thickness of reproductive tract segments and the percentage of photon
transference (actual values reported in Table 2.1) was negative for both High and Low
concentrations used for reproductive tract segment PE detection with E.coli-Xen14 (r = 0.52, P < 0.0001 and -0.46, P < 0.001, respectively).
DISCUSSION
As expected, using a chromosomal insertion of the lux operon resulted in a stable
population of photon-emitters over time; since theoretically they should be as stable as a
chromosomal gene (Herrero et al. 1990). Previous work using E.coli-MM294 transiently
transformed with a plasmid containing the lux gene cassette (E.coli-pAK1-lux) also
showed a 100% photon-emitting population when E.coli-pAK1-lux was grown with
antibiotic selective pressure (Moulton et al. 2008). However, when E.coli-pAK1-lux (a
non-chromosomal insertion) was grown without antibiotic selection, a 30% loss in
emitting bacteria occurred within 3 d (Moulton et al. 2008). An advantage of using
E.coli-Xen14 for pathogenesis models is that this transgenic strain contains a stable copy
(chromosomal insertion) of the lux operon and does not need to be grown with antibiotic
pressure for a continuous production of light. This makes it more suitable for studies
where antibiotics are being tested or continued antibiotic presence is not feasible or
practical (e.g., with in vivo pathogenesis models). However by adding KAN for selective
growth, there was a significant decrease in PE. It appears that KAN may interfere with E.
coli-Xen14’s mechanism of producing PE, but not bacterial replication ability; for both
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treatments, there was no significant difference in bacterial populations, but clear
differences in PE intensities. Perhaps KAN has a subtle effect on intracellular pH, as
there is evidence suggesting that pH significantly reduces intensity of light emitted by the
luciferase-luciferin reaction. Viviani et al. (2008), reported that changes in pH and
temperature may modulate bioluminescence colors by disrupting interactions of structural
elements in the firefly luciferase pH active site. Further investigations are needed to
evaluate light absorbency changes in the culture medium by monitoring changes in pH
following KAN addition to E.coli-Xen14 cultures. Nevertheless, when pH was measured
by the authors over time in tubes containing sterile LB and LB plus KAN (30 µg/mL),
and also tubes with E. coli-Xen14 containing LB and LB plus KAN, no differences in pH
were detected (data not shown).
Escherichia coli-Xen14 photon emission and growth characteristics
The growth curve generated in this study demonstrated a clear early effect of
KAN on PE of E. coli-Xen14. Again, by adding KAN to E.coli-Xen14 cultures, photon
production was somehow hindered (suppressed) after 6 h. However, later in the curve (31
h), E. coli-Xen14 cultures containing KAN reached similar PE than those emitted by E.
coli-Xen14 cultures without KAN. This may be explained by faster oxygen depletion in
absence of KAN for E. coli-Xen14 cultures (West, 2006), or a depletion of ATP in the
medium, since samples were taken from static cultures. It is well known that light
produced by the luciferin-luciferase system depends on the presence of ATP as a cofactor to undergo oxidation (Greer and Szalay, 2002). Perhaps E.coli-Xen14 modulates
its mechanism in the presence of a depleted energy state to remain viable while shutting
down reactions like the luciferin-luciferase interactions by mediating co-factors; this
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requires further study to substantiate. In a previous study (West, 2006), using various
concentrations of ampicillin to identify environmental factors affecting the light output of
Vibria fischeri (V. fischeri), differences in intensity of PE with different antibiotic
concentrations were noted. Higher concentrations of ampicillin (100 µg/mL) in the media
resulted in a higher yield of light intensities; however, the length of the constant intensity
was shortened. In our study, we used a single concentration of antibiotic for bacterial
selection (30 µg/mL; based on manufacturers recommendations) and the intensity of light
produced by E. coli-Xen14 were lower when cultured under antibiotic pressure than no
antibiotic pressure (Fig. 2.2-A). West (2006), concluded that cultures of V. fischeri with
higher concentrations of antibiotic would grow at a greater rate than those with a lower
concentration of antibiotic. In this study, cultures containing LB only might be compared
with those cultures with the lowest ampicillin levels used in the study made by West
(2006). To this end, one might speculate that E. coli-Xen14 cultured in LB plus KAN
should have a greater light intensity at the beginning of the growth curve than E. coliXen14 cultured in LB only. Conversely, the intensities of light by E. coli-Xen14 were
higher in LB alone than LB plus KAN. This observation could be bacteria-dependent, or
antibiotic-specific, or associated with gene cassette incorporation differences, and thus
requires further study.
Photonic detection of E.coli-Xen14 within the reproductive tract ex vivo
Rice et al. (2001) determined the amount of bioluminescent bacteria required for
detection through animal tissues at various thicknesses and reported two to nine orders of
bioluminescence magnitude reduction when the bioluminescence source was located 1
cm deep in the tissue. In addition Willard et al. (2003), using bioluminescent Salmonella
106

to evaluate the influence of tissue depth on photon detection in neonatal pigs, reported
that up to 99% of PE was lost through the ventral surface. In the present study, PE was
detected from within translucent tubes containing 200 L of E.coli-Xen14 through
reproductive tract tissues as thick as 7.63 mm, with a 5.43 % of PE recovery using 2.9 x
108 CFU/tube (200 L). In addition, we were able to recover 30.5% of PE through the
uterine body (e.g., Tract # 9) with a thickness of 4.90 mm and bacteria population of 1.7
x 108 CFU/tube (200 L). These apparent differences in photon recovery (detection)
through tissues between previous research (Willard et al. 2003) and the present study
may be due to different bioluminescent labeling technique (plasmid vs. chromosomal
insertion), bacteria specific photonic properties, higher bacterial concentrations used in
the present study and/or type, thickness, or absorptive properties of the different tissues
analyzed. However, the low to moderate correlations found between the transference of
PE of E. coli-Xen14 through reproductive tract segments and its thickness suggests that
other factors besides thickness are affecting the transference of PE. The level of light
attenuation due to absorption and scattering in tissues may change due to tissue
composition (Rice et al. 2001), and further studies are needed to evaluate the significance
of tissue composition on light attenuation to enhance imaging capabilities. Additionally,
the use of optical clearance methodologies may be used as a scattering reduction agent
(Kuklin et al. 2003) to manipulate tissue integrity of the bovine reproductive tract to
enhance photon transference for improved sensitivity of bacterial detection.
In summary, by adding KAN to E. coli-Xen14 cultures for selective growth, a
decrease in PE (but not bacterial populations) occurred. Whereas log phase growth at 45
h was similar regardless of the presence of KAN, PE declined markedly. A possible
explanation for these findings may be the suppression of the operon luxCDABE. In order
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to determine what factors may be involved in this negative effect on the PE properties of
E.coli-Xen14, further investigation is needed; for example regarding the possible effects
of pH or other metabolic factors (e.g., ATP depletion) and/or the direct or indirect
interactions of antibiotics on incorporated regulatory elements. The negative correlation
between the percentage transference of PE and thickness of the reproductive tract
suggests further study is needed to elucidate interfering factors involved in the
transference of PE through bovine reproductive tissues and ways to overcome these.
Nevertheless, the successful detection of PE through the reproductive tract segments
investigated in this study demonstrate the feasibility of monitoring the presence of E.coliXen14 and suggest in vivo or in situ models, with further site-directed photonic probe and
detection advancements, may be feasible.
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Table 2.1

Mean ± SEM percentage transference of photon emissions and tissue
thickness among segments of bovine reproductive tracts.

Photon emissions detected (%)1
Reproductive tract segment High
Low
Thickness (mm)2
Posterior vagina
0.98 ± 0.19a
2.66 ± 0.75a
11.77 ± 1.15a
bc
abc
Anterior vagina
10.53 ± 2.76
9.08 ± 1.12
6.05 ± 0.47bc
Cervix
7.88 ± 2.20b
4.91 ± 1.10ab
7.46 ± 0.91b
c
c
Uterine body
17.23 ± 3.18
12.83 ± 4.40
4.75 ± 0.34bc
Left uterine horn
9.24 ± 2.63b
10.36 ± 2.24bc 4.24 ± 0.26c
b
Right uterine horn
8.58 ± 1.75
9.09 ± 1.12abc
4.06 ± 0.23c
a-c
Within a column, values without a common superscript differ (P < 0.05).
1
The percentage of transference was calculated by subtracting the relative light units per
second (RLU/s) obtained from background imaging of the tissue alone from the RLU/s of
the same tissue containing the translucent tube inserted in the tract segment and dividing
this number by the RLU/s obtained from the translucent tube containing E. coli-Xen 14
inoculums. Designations of “High” and “Low” refer to the concentration (CFU) of
bacteria in the tube placed in the various tract segments (3.2 x 108 and 3.2 x 106 CFU/200
µL for relative High and Low concentrations, respectively).
2
Thickness of the reproductive tract segments (n = 9) were measured with a sliding
caliper, to the nearest 0.05 mm.
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Figure 2.1

Intrauterine photon emission (PE) detection from Escherichia coli-Xen14
presence within the bovine reproductive tract.

A translucent tube filled with 200 µL of E. coli-Xen14 (tube-lux; 3.5 x 108 CFU/200 µL;
Panel A) was placed in the left uterine horn (4.17 mm thickness, Tract # 8; Panel B) and
each imaged separately, using the Stanford Photonic imaging system, prior to insertion of
the tube-lux into the horn segment. Following imaging of the tube and segment for
background subtraction, the corresponding tube-lux was inserted inside the uterine horn
and imaged (Panel C). In this representative example, the translucent tube-lux emitted
24.21 RLU/s, the left horn by itself emitted 0.115 RLU/s (background) and the tube-lux
inserted inside the segment emitted 5.79 RLU/s for a percentage of transference of PE of
23.92%. The images shown in A and C are equivalent intensity of pseudocolor used for
representation purposes.
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Figure 2.2

Photon emissions (PE; Panel A) and bacterial populations (Panel B) of
Escherichia coli-Xen14 over time.
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Figure 2.3

Photon emissions (PE) of Escherichia coli-Xen14 (Panel A) and bacterial
growth curve analysis (Panel B).

Panel A: E.coli-Xen14 was grown on LB broth with or without kanamycin (KAN) over
eight consecutive days. Day 0 represents the mean photon emissions (relative light units
per s; RLU/s) of E.coli-Xen14 after 24 h of culture. Data are shown as mean RLU/s ±
SEM. Differences were found after 24 h between treatments (P < 0.0001). Panel B:
E.coli-Xen14 aliquots were serially diluted and plated on agar plates with its
corresponding treatment and counted to determine bacterial populations (expressed in
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CFU/mL). Data are shown as mean log10 CFU/mL ± SEM. No differences were found
between treatments over the 8 d interval (P = 0.96).
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CHAPTER III
APPLICATIONS OF BIOPHOTONIC IMAGING FOR DETECTION OF BOVINE
MASTITIS IN EXPERIMENTAL SETTINGS
ABSTRACT
We investigated (1) the photonic characteristics of bioluminescent Staphylococcus
aureus (S. aureus-Xen8.1), (2) the dynamics associated with photonic emissions (PE) of
this pathogen imaged in milk, and (3) the feasibility of detecting S. aureus-Xen8.1 PE
through the mammary gland tissue in vitro; as a first step towards the development of
models to monitor mastitic infections in vivo using similar systems. Initially, as a means
to determine stability of the lux operon in S. aureus-Xen8.1, cultures were grown with or
without antimicrobial pressure (Kanamycin) and aliquots imaged in a 96 well plate
followed by surface plating to compare ratios of non-photon emitting vs. photon emitting
colonies over time. To evaluate the photonic dynamics of S. aureus-Xen8.1 in bovine
milk, serial dilutions of S. aureus-Xen8.1 cultures were imaged in milk and in Lysogeny
Broth (LB; used as control) and colony forming units counted to determine the
differences in PE outputs between these mediums. Detection of light emitted by S.
aureus-Xen8.1 through excised bovine mammary gland tissue (i.e., teat end segments; n
= 20) was performed in an in vitro setting. Our findings indicated that the lux operon in S.
aureus-Xen8.1 remained stable with respect to the proportions of photon emitter colonies
with or without kanamycin (used to selectively culture S. aureus-Xen8.1). However,
cultures grown under kanamycin pressure had lower overall PE than those grown in LB
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only (P < 0.05). Mean PE detected from S. aureus-Xen8.1 imaged in milk were higher (P
< 0.05) than LB, apparently caused by the higher reflective properties of milk. Detection
of S. aureus-Xen8.1 transmittance through the bovine mammary gland teat tissue is
questionable due to the low PE detected, even when highly concentrated S. aureusXen8.1 culture was used (e.g., 3.5 x 1014 CFU). Therefore, S. aureus-Xen8.1 is a very
stable transformant with or without kanamycin, however light intensity is decreased by
kanamycin and further studies are needed to evaluate the effects of kanamycin on PE of
S. aureus-Xen8.1. This study suggests that it is possible to develop models that facilitate
real-time monitoring of pathogen presence in milk samples from the infected mammary
gland in vivo; however detection of bioluminescent signals through the mammary gland
teat tissue may be restricted due to tissue thickness and superphysiological concentration
of bacteria needed to detect photonic activity indicative of S. aureus-Xen8.1 presence.
Keywords: Biophotonic Imaging, bioluminescent Staphylococcus aureus, mastitis

INTRODUCTION
Mastitis is an important disease in dairy herds primarily due to its negative effects
on animal welfare and its association with decreased farm profitability, by increasing
milk production costs. Although the causative agent of this disease can be of fungal, algal
or mycoplasmal origin, bacterial infections are responsible for the majority of the cases;
as reviewed by Kerr and Wellnitz (2003). Staphylococcus aureus (S. aureus) is one of the
most common causes of mastitis in US dairy herds. According to Barkema, et al. (2006)
the prevalence of mastitis pathogens can be greatly reduced through the implementation
of the National Mastitis Council Recommended Mastitis Control Program (National
Mastitis Council, 2011). Failure or partial accomplishment of these recommendations
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may translate in an increased incidence of S. aureus in dairy farms (Barkema et al.,
2006). In addition to this, an increased incidence of methicillin-resistant S. aureus
(MRSA) isolated from mastitic cows has been reported worldwide (Otter and French,
2008; Spohr et al., 2011; Vicca et al., 2008). This has created expectations of S. aureus
mastitis infections being reservoirs of MRSA, which could increase the incidence of
transmission of this S. aureus strain between cows and humans; especially on-farm
personnel. Fortunately, according to Virgin et al. (2009), bulk tank milk in the US is not a
common source of MRSA. However, as described previously, cases from around the
world have been reported, which suggests the potential for MRSA infected animals to be
observed in the US sometime in the future.
Early detection and/or diagnosis of mastitis are the most important tools for
preventing its development and further parenchymal damage. Traditionally, diagnosis is
based on observations of clinical signs of the udder, use of the California Mastitis Test
and/or measurement of somatic cell counts (SCC) in milk. In addition, measurement of
specific enzymes released during tissue damage (e.g., N-acetyl-β-D-glucosaminidase
and/or lactate dehydrogenase) caused by either the host immune response lysosomal
content and/or bacterial toxins are alternative strategies for the early detection of mastitis
(Viguier et al., 2009). The determination of the causative agent is of significant
importance for the selection of an appropriate treatment and evaluation of herd
management practices against the identified agent (Sears et al., 1990). Conventional
methods for determination of cell numbers of mastitis-causing bacteria typically require
extensive time, work, and costs (Viguier et al., 2009). This is true when taking into
consideration laboratory procedures such as growth medium preparation, dilution,
surface-plating and waiting periods for bacteria incubation, which could take up to 72 h
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(e.g., fastidious bacteria). Additionally, misinterpretation of results (e.g., false negative
results for a specific bacterium) exists during collection and manipulation of milk
samples (Sears et al., 1990). An alternative approach has been the use of luciferases (e.g.
photon-emitting indicators) to label pathogens (Contag et al., 1995; Curbelo et al., 2010;
Willard et al., 2003). The use of biophotonic imaging system allows biological processes
of an infective state of eukaryotic cells to be monitored longitudinally, in vitro and in
vivo, in real-time and non-invasively (Contag et al., 1995).
The lux operon, which is commonly used to incorporate bioluminescent properties
to prokaryotic cells, has been modified for bacterial incorporation using plasmids, via
transposon mutagenesis and chromosomal insertion, and routinely carries antimicrobial
resistance selection markers for cultivation as monocultures under controlled
environmental conditions (Herrero et al., 1990). For instance, S. aureus has been
conferred with bioluminescent properties by incorporating the lux genes of Photorhabdus
luminescences (P. luminescences) on its chromosome (e.g., lux operon in S. aureusXen8.1; Caliper Life Sciences, Hopkinton, MA) which can then be selected by using
antimicrobials to maintain pure cultures. The lux operon system chromosomally
incorporated in S. aureus-Xen8.1 encodes all proteins required for generating
bioluminescence including the luciferase, substrate, and substrate-regenerating enzymes
essential for the continual production of light within the bacterial host (Luker and Luker,
2008). This feature, compared to plasmid integration, exhibits a continuous and stable
luciferase expression over time and without antimicrobial pressure; theoretically, they
should be as stable as a chromosomal gene (Herrero et al., 1990). Given the fact that
expression of the inserted lux operon is dependent on the metabolic status of the
construct, quantification of the degree of impairment by any substance or environmental
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factor that alter the physiological balance, can be quantified in real time by monitoring
the levels of light expressed by the organism bearing this biomarker. Thus, the use of
bioluminescent bacteria, such as S.aureus-Xen8.1, coupled with photonic imaging
technologies may represent an efficient model for achieving a greater understanding of
the pathogenesis of mastitis infections (e.g., bacterial clearance under antimicrobial
treatments).
Studies have established positive relationships between levels of bioluminescence
and bacterial populations using bioluminescent S. aureus (r = 0.99; Tenhami et al., 2001),
and our laboratory has previously described and validated both in vitro (Curbelo et al.,
2010; Moulton et al., 2006) and ex vivo (Moulton et al. 2009) bioluminescent bacterial
models. Studies have examined, for example, models for infection in the mouse (Kuklin
et al. 2003), ex vivo imaging of gestating ewes (Moulton et al. 2009), real-time
monitoring of Salmonella typhimurium (S. typhimurium) in swine (Willard et al.2003),
screening of pathogens in living fish (Karsi et al. 2006), and uterine infections in the
pregnant mares (Ryan et al., 2010) and detection of bioluminescent E. coli from within
the excised bovine reproductive tract (Curbelo et al., 2010).
Monitoring lux-transformed bacteria through tissues of small animals (e.g., rats or
mice) is feasible due to the thin and semitransparent nature of mammalian tissue (Contag
et al. 1995). Any obstruction of photonic transference generated from the lux-transformed
bacteria as signals diffuse through mammalian tissues is likely due to scattering and
absorption of photons associated with tissue type and thickness acting as the barrier (Rice
et al., 2001). Nevertheless, detection of photonic emissions (PE) from bioluminescent
bacteria (i.e, Escherichia coli-Xen14; E.coli-Xen14) through large animals tissue (i.e.,
uterine cervix with thickness of 7.46 ± 0.91mm) in an in vitro setting has been previously
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reported to be a promising translational approach for modeling bacterial progress in vivo
(Curbelo et al., 2010). Thus, the objectives of this study were (1) to characterize photonic
properties of a stably transformed bioluminescent S. aureus strain; (2) evaluate photonic
detection of S. aureus-Xen8.1 in inoculated dairy milk; (3) to conduct photonic imaging
of S. aureus-Xen8.1 through the bovine mammary gland tissue as well as to evaluate the
significance of an optical clearing agent (OCA; corn syrup, 75%) in increasing detection
of PE through the mammary gland tissue; and (4) to determine whether the biophotonic
imaging system could be adapted to allow comparisons of intramammary antimicrobial
efficacy against S. aureus
MATERIAL AND METHODS
Staphylococcus aureus-Xen8.1 operon stability evaluation
To evaluate the stability of the lux operon in S. aureus-Xen8.1, a single colony
was used to inoculate 20 mL of fresh/sterile LB only and grown at 37 ºC in an incubating
orbital shaker at 180 rpm for 24 h to produce a fresh culture. Tubes containing 29.9 mL
of fresh/sterile LB only (n=3) or LB plus kanamycin (n = 3; KAN; Sigma-Aldrich, Inc.
St. Louis, MO, USA) as the selective agent (200 µg/mL; i.e., KAN resistance is a
characteristic of the transformed S. aureus-Xen8.1 line for selective growth in vitro) were
inoculated with 100 µL taken from fresh S. aureus-Xen8.1 cultures and incubated under
the conditions mentioned above. Every 24h, aliquots (100µL; n=8) from each treatment
tube were transferred to black 96-well plates (n = 3; each plate having each treatment)
and imaged independently for 2 s to collect PE using the XR/MEGA-10ZeroTM imaging
system (Stanford Photonics, Inc., Palo Alto, CA, USA). Following imaging, the content
of a well was used to re-inoculate the corresponding tube containing 29.9 ml of
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fresh/sterile LB or LB plus KAN for the next day’s imaging. The content of the other
seven wells were serially diluted 1:10 ratio in fresh/sterile LB or LB plus KAN,
according to the treatment, and plated on LB or LB plus KAN agar plates (i.e., inoculums
grown in KAN were plated on agar containing KAN) to allow the number of colony
forming units (CFU) to be compared to levels of PE activity. Photonic emissions
collected were analyzed using Image J software (National Institutes of Health, Bethesda,
MD, USA) in which pixel intensities associated with PE were quantified within regions
of interest (e.g., individual wells of a 96-well plate), and standardized to relative lights
units per second (RLU/s). Furthermore, each plate was imaged using the Nightowl
imaging system (Berthold Technologies, Oak Ridge, TN, USA) to determine the ratio of
non-photon emitting vs. photon emitting colonies. This entire procedure was conducted
over eight consecutive days and independently repeated three times.
Imaging of Staphylococcus aureus-Xen8.1 in bovine milk
To study the bioluminescent characteristics of S. aureus-Xen8.1 within bovine
milk, 29.9 mL of bulk tank milk (BTM) and/or LB (used as control media) were
inoculated with 100 µL of an exponentially growing S. aureus-Xen8.1 culture and grown
over a 24 h period at 37°C in an incubating orbital shaker at 180 rpm. After 24 hours, a 1
mL aliquot from each culture (i.e., BTM and LB) was transferred to microcentrifuge
tubes (n = 6). The content of each centrifuge tube was then serially diluted 7 times by
transferring a 500 µL aliquot into 500 µl of fresh/sterile BTM or LB. Then, an aliquot
(100 µl) from each dilution tube (dilution factor from 1:1 to 1:7) was placed in black 96well plates for imaging (n = 6 replicates). Photon collections were conducted for 3-min
acquisition time and quantified in photons/pixel/seconds (Ph/pix/s) using the
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Berthold/Nightowl camera with a 25 mm and f = 0.95 camera lens positioned at 245 mm
above the imaging area (96 well plate format) using WinLight 32 version 2.51.11901
software (Berthold Technologies, Oak Ridge, TN). Immediately after imaging, the
content of each well was serially diluted to allow the number of CFU to be compared to
companion levels of PE activity.
Effects of media color on photonic activity of Staphylococcus aureus-Xen8.1
In order to determine the differences previously found in photonic activity from S.
aureus-Xen8.1 imaged in milk relative to LB, S. aureus-Xen8.1 PE were collected under
different media colors. Beakers (n = 3) containing sterile LB (20 mL) were assigned to
either LB with white food color (200 µL; Wilton Enterprise Woordrige, IL), LB with
black food color (200 µL; Mc Cormik & Co., Inc, Huntvalley, MD) or LB only. Each
beaker was then heated at 65 °C and stirred at 360 rpm on a hot plate until the coloring
agent was evenly distributed. Aliquots (500 µL; n = 3) from a S. aureus-Xen8.1 overnight
culture were diluted 6 times with tubes containing 500 µL of the corresponding coloring
agent (i.e., black, white or LB only). Then, aliquots (100 µL; n = 4 per treatment) from
each dilution tube were placed in black 96-well plate for collection of PE (10 sec
acquisition time) using the Berthold/Nightowl camera and analyzed using WinLight
software in which pixel intensities associated with PE were quantified within regions of
interest. Immediately after imaging, the content of each well was serially diluted to allow
the number of CFU to be compared to companion levels of PE activity.
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Photonic imaging of Staphylococcus aureus-Xen8.1 through bovine mammary gland
tissue
To determine the feasibility of detecting photonic emissions from S. aureusXen8.1 through the bovine mammary gland tissue (i.e., teat end), mammary quarters
(n=10) with intact teats were excised in half (longitudinal section; n = 20 sections).
Different concentrations and volumes of S. aureus-Xen8.1 cultures as well as several
acquisition times, were tested to determine the minimum amount of bacteria required and
acquisition time for detection through the dense mammary gland tissue (data not shown).
Five ml of concentrated S. aureus-Xen8.1 inoculum (3.5 x 1014 CFU) were placed inside
a black plastic box with an opened top. The mentioned settings were used as a means to
mimic volume and size of the intact teat end when performing in vivo imaging of
bioluminescent bacteria through the mammary gland end. The box containing the
bacterium was imaged (2 min) to quantify the PE emitted by the concentrated bacterial
inoculum (Fig. 3.1-A). Then, teat ends were positioned with the lateral portion facing up
over the opening of the box, one at a time, and imaged to determine the percentage of
transference of PE emitted from S. aureus-Xen8.1 (Fig. 3.1-B). Finalizing imaging of the
20 segments, the lateral portion of one teat of each teat pair was immersed with an optical
clearance agent (OCA; 75% corn syrup; n = 10 teat ends) for 3 h while the other teat
segment was immersed with PBS (used as control). Before imaging, each teat segment
was dried (to prevent reflection of light by the fluids on the teat skin (OCA and/or PBS)
and then placed over the opening of the black box for imaging.
Evaluation of biophotonic imaging as an approach to evaluate mastitis antibiotic
preparations against Staphylococcus aureus-Xen8.1
In this study we evaluated whether the biophotonic imaging approach could be
adapted to compare antimicrobial efficacies of commercial intramammary antibiotic
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preparations against S. aureus-Xen8.1 grown in bovine milk in an in vitro setting. To
mimic in vivo conditions (e.g., interaction of milk components with S. aureus-Xen8.1 PE
detection and/or antimicrobial properties, relative to traditional growth media (e.g., LB),
whole bovine milk (500 ml per treatment) contained in glass bottles (n = 4), were pre
warmed at 37 °C in an incubating orbital shaker at 100 rpm. After reaching the desired
temperature, each bottle was inoculated with S. aureus-Xen8.1 to reach a concentration
of ~1 x106 CFU/ml. To avoid nutrient shock due to abrupt changes of media (i.e.,
transferring S. aureus-Xen8.1 grown in LB to fresh sterile milk), the S. aureus-Xen8.1
inoculum used to inoculate milk bottles was grown in milk. Previous trials conducted in
our laboratory have shown that when S. aureus-Xen8.1 is grown in LB and then
transferred to milk, PE collected immediately after inoculation (< 5 min) correspond to
numbers of CFU recovered. However, a drop in PE is observed 30 min post inoculation
even when CFU remained unchanged (data not shown). Several hours (i.e., 6h) were
required to have an increase in light emission that corresponded to CFU recovered. In
addition, after inoculating milk with S.aureus-Xen8.1 previously grown in milk, a drop in
light was also found 30 min after inoculation, with further progressive increase in PE
after 3 h. For these reasons, after inoculation of sterile/fresh bovine whole milk with S.
aureus-Xen8.1, aliquots were taken to monitor PE over time, as a means to establish
bacterial exponential growth.
Once two consecutive samples demonstrated a progressive increase in PE, bottles
were assigned to n = 3 different commercial intramammary antibiotics preparations,
labeled for treating major mastitis pathogens such as S. aureus (i.e., Cephapirin sodium
(Fort Dodge Animal Health, Iowa), Hetacillin potassium and Pirlimycin hydrochloride)
and one bottle to be left untreated. The minimal inhibitory concentration required to
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inhibit the growth of 90% of the organism (MIC90) was tested by each antibiotic (adapted
from De Oliveira et al., 2000). The volume of milk used in this study (i.e., 500 mL) was
selected to eliminate the need for diluting the antibiotic preparations in order to reach the
intended MIC. For example, 12.5 µl of Cephapirin sodium preparation (200 mg/10 ml
syringe) were added to 500 ml of milk in order to reach the intended MIC90 (0.50 µg/ml).
When these antibiotics preparations were diluted, when smaller volume of milk was used
(i.e., 30 ml), poor or no effect was observed against S. aureus-Xen8.1, apparently due to
improper extraction of the active ingredient, which could cause misinterpretation of their
efficacy. Immediately after the addition of antibiotics to the inoculated milk, aliquots
were collected from each treatment (100 µl; n =5), placed on a black 96-well plate and
imaged using the XR/MEGA-10ZeroTM imaging system. After imaging, the content of
each well was serially diluted and plated to allow the number of CFU to be compared to
companion levels of PE activity.
Statistical Analysis
The statistical analysis used to evaluate bacterial population and PE in the operon
stability analysis of S. aureus-Xen8.1 was performed by day using the PROC ANOVA
function in SAS version 9.2 for Windows (SAS, Cary, NC, USA). An LSMEANS
procedure was used to determine differences in PE and bacterial populations between
treatments by day. To determine differences in PE and bacterial populations of S. aureusXen8.1 imaged in the different media colors (i.e., white, black, and LB) by dilution, a
one-way ANOVA was performed. A two sample t-test was performed to determine
differences in PE between bovine teat ends OCA treated vs. non-OCA treated and to find
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differences in PE and/or CFU between treatments by dilutions in milk samples vs. LB
samples.
RESULTS
Staphylococcus aureus-Xen8.1 operon stability evaluation
The in vitro evaluation of S. aureus-Xen8.1 photonic characteristics, as
determined by a visual count of colonies grown on petri dishes after 24 h incubation, with
further imaging and comparison of photonic emitting colonies vs. non emitting colonies,
over an 8 day period showed 100% stability of the lux operon in LB only and LB plus
KAN. Photonic emissions of S. aureus-Xen8.1 cultures grown on LB and LB plus KAN
did not differ at the first 24 h (P = 0.40; Fig.3.2-A). However at 48 h, a dramatic increase
in mean PE (P < 0.0001) was observed in cultures grown in LB only vs. LB plus KAN
(354.33 ± 3.34 vs. 44.22 ± 1.28 RLU/s, respectively). Moreover, mean PE from day 1 to
7 for LB only and LB plus KAN were 319.52 ± 6.59 and 41.91 ± 1.72 RLU/s,
correspondingly. While apparent differences were found in PE, (i.e, 88.5% increase in PE
in the LB only treatment), differences in bacterial population did not show the same
degree of disparity (55.1 % increase in CFU/ml in the LB only treatment), both same
degree of disparity (55.1 % increase in CFU/ml in the LB only treatment), both
treatments being in the same log scale (8.7 x 107 vs. 3.9 x 107 CFU/mL, respectively;
Fig.3.2-B); however aureus-Xen8.1 cultures were grown on LB only (8.5 x 107 CFU/ml)
and immediately transferred to LB plus KAN and then imaged, no differences were found
in PE when S. aureus-Xen8.1was imaged in both medium (data not shown). Levels of PE
collected from S. aureus-Xen8.1 grown in LB only remained elevated relative to those
collected in S. aureus-Xen8.1 grown in LB plus KAN during the study period.
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Imaging of Staphylococcus aureus-Xen8.1 in bovine milk
Mean pooled PE detected from S. aureus-Xen8.1 grown in milk were higher (P <
0.05) when compared with LB (141.1 ± 12.31 vs. 89.1 ± 10.37 Ph/pix/sec). However, PE
detected from S. aureus imaged in LB, relative to milk, were higher in dilution 0 (P =
0.0002; 247.77 ± 29.50 vs. 54.24 ± 15.23 RLU/s, respectively; Fig.3.3-A); although no
differences in bacterial counts (P = 0.6968) were found (3.7 x 108 vs. 3.4 x 108 CFU/mL,
respectively; Fig.3.3-B). Photonic emissions from S. aureus-Xen8.1 grown in LB were
declining as dilutions were increasing; following what normally occurs when numbers of
bioluminescent bacteria decrease (i.e., photonic emissions decrease). Light emissions of
S. aureus-Xen8.1 then reached similar Ph/pix/sec in the second dilution (P = 0.4557)
when imaged in LB compared with milk (99.92 ± 12.05 vs. 86.53 ± 12.34 Ph/pix/sec;
respectively). Furthermore, differences in PE were markedly higher (P < 0.05) from S.
aureus-Xen8.1 grown in milk, in a stepwise fashion, from dilutions factors 1:3 to 1:7.
Effects of media color on photonic activity of Staphylococcus aureus-Xen8.1
Photonic emissions and bacterial population of S. aureus-Xen8.1 between the
different dilutions by different medium colors (i.e., white or black coloring agent plus
LB, and LB alone) are shown in Figure 3.4-A and-B, respectively. In each dilution, PE
collected from S. aureus-Xen8.1 in LB plus white coloring agent were higher (P < 0.05)
compared with LB only and LB plus black coloring agent. Moreover, collection of
photons from S. aureus-Xen8.1 in LB alone, showed higher Ph/pix/sec (P < 0.05) than
those collected from LB plus black coloring agent. As intended, bacterial population did
not statistically differ (P > 0.05) in each of the 6 dilutions within treatments.
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Photonic imaging of Staphylococcus aureus-Xen8.1 through bovine mammary gland
tissue
Mean PE recovery from concentrated S. aureus-Xen8.1 through teat ends (not
OCA treated; n = 20) resulted in 2.98 ± 0.53 RLU/s. When teat ends were assigned to
OCA, as a means to increase light transference through the dense mammary gland tissue,
PE detected did not statistically increase, relative to the control group (1.29 ± 0.23 vs.
0.85 ± 0.20 RLU/s, respectively; P = 0.17). In addition to the low levels of PE recovered
through the mammary gland tissue, which in some cases was comparable to background
photonic noise, variation of PE collected between teat segments ranged from 0.31 to 8.63
RLU/s (CV % of 103.3). For this reason, the statistical analysis was modified to compare
PE between teat end skin color (i.e., white, black, and black and white; Fig.3.5-A).
Consequently, PE collected through black mammary gland teats (n = 9) were
significantly lower than black/white (n = 5) and/or white teats (n = 6) with PE recoveries
of 0.686 ± 0.086 vs. 3.77 ± 1.505 and 3.487 ± 0.786 RLU/s, respectively. Furthermore,
when teat ends (n = 20) were treated with OCA, a numerical, but not statistically increase
in photonic detection was observed (P = 0.18). However, when the significance of the
OCA was evaluated by color, differences in PE were only found in black/white teat ends
(P = 0.01; Fig.3.5-B).
Evaluation of biophotonic imaging as an approach to evaluate mastitis antibiotic
preparations against Staphylococcus aureus-Xen8
At Time 0, CFU between all n = 4 treatments were similar (P = 0.84; Fig.3.6-B).
However, PE detected from S. aureus-Xen8.1 were higher P < 0.001 in the Pirlimycin
hydrochloride (Pirlimycin) treatment, relative to the Cephapirin sodium (Cephaprin) and
Hetacillin potassium (Hetacillin) treatments and the control (Fig.3.6-A). Photonic
emissions from S. aureus-Xen8.1 increased in the Hetacillin and Cephapirin treatments in
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a paralleled manner with no differences in light outputs and CFU (P > 0.05) within these
treatments from 0 to 1 h post addition of antibiotic to the inoculated milk. However, PE
found in the Pirlimycin treatment declined with respect to the other treatments, during the
same period (P < 0.05). Differences in PE between Hetacillin and Cephapirin were first
observed at 1.5 h post antibiotic addition to the inoculated milk with bioluminescent S.
aureus (243.2 ± 3.0 and 236.8 ± 1.4 RLU/s, respectively; P < 0.0001), which
corresponded to the differences first observed in CFU between these two treatments at
1.5 h (3.4 x 107 ± 4.4 x 106 and 2.2 x 107 ± 1.1 x 106, respectively; P < 0.0001). These
differences were more evident at 4 h post treatment in both PE and CFU. As expected, PE
detected in the control group increased progressively from time 0 to 4 h, and remained
constant from 4 to 9 h post inoculation.
DISCUSSION
Staphylococcus aureus-Xen8.1 operon stability evaluation
As shown in this study, the single copy of the modified P. luminescens lux operon
inserted into S. aureus-Xen8.1’s resulted in a stable population of photon-emitting
colonies over the study period with or without the presence of KAN. These results concur
with a previous report by Curbelo et al. (2010) where the stability of the lux operon in E.
coli-Xen14 was evaluated over the same time period. Nevertheless, although both
bioluminescent bacteria remained stable relative to photon-emitter colonies over an 8-d
trial, when grown and imaged under the same conditions and with the same imaging
system, noticeable differences in light outputs were found between these two
bioluminescent constructs. For example, when E. coli-Xen14 and S. aureus-Xen8.1 were
grown for 24 h and aliquots imaged, PE detected were markedly different between these
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two constructs (2, 645.1 ± 315 vs. 354.3 ± 3.35 RLU/s, respectively). Interestingly,
bacterial populations were similar between both bioluminescent pathogens (7.9 x 10 7 ±
1.0 x 107 vs. 8.3 x 107± 5.9 x 106 CFU/ml, respectively; Curbelo et al., 2010).
The differences found in PE between these two lux constructs could be
attributable to the dissimilarities in genetic compatibility with the bacterium strain P.
luminescens, where the lux genetic system was cloned from (Kuklin et al., 2003). These
genetic discrepancies could have a direct effect in light output due to poor gene
expression from Gram positive bacteria relative to Gram negatives (Jacobs et al., 1991).
Another possible explanation for the differences in levels of light expression between
these two lux constructs could be explained by differences in cell membrane
compositions. Gram positive bacteria posses several peptidoglycan layers joined together
and forming a thick and rigid structure relative to that found in Gram negative bacteria,
which is composed of only a thin peptidoglycan layer (Murray et al., 2005). This could
alter the passage of PE emitted endogenously, causing a greater scattering and/or
absorption relative to the thinner cell membrane found in Gram negative bacteria.
Although 100% photon-emitting colonies over the study trial were observed when
S. aureus-Xen8.1 was grown with or without the presence of KAN, as the selective agent,
significant differences were found in PE between both treatments (P < 0.0001; Fig.3.2A). This behavior was reported previously, where photonic characteristics of E. coliXen14 were evaluated in the exact settings as the present study (Curbelo et al., 2010). In
our previous study, PE were significantly lower in cultures grown under KAN pressure
(30 µg/mL; as specified by Caliper Life Sciences), however the bacterial population
remained unchanged during the 8-d trial. Conversely from the results obtained with
E.coli-Xen14, statistical differences were found in bacterial populations between S.
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aureus-Xen8.1 grown in LB only vs LB plus KAN (P < 0.05). Discrepancies in the effect
of KAN over CFU numbers between these two bacteria could be explained by the
differences in antibiotic concentration used to selectively grow S. aureus-Xen8.1, relative
to that used on E. coli-Xen14 (200 vs 30 µl/mL; as recommended by Caliper Life
Sciences, respectively). Although the decrease in CFU found when S. aureus-Xen8.1 was
grown under KAN could account for the decline in RLU/s, we suggest, as we reported
with E. coli-Xen14, that KAN may suppress the operon luxABCDE, therefore causing a
decrease in the levels of PE.
Imaging of Staphylococcus aureus-Xen8.1 through bovine milk and different media
colors
The higher PE observed from S. aureus-Xen8.1 grown overnight in LB, relative
to milk (i.e., overnight culture; dilution 0), could be attributable to the differences in solid
content between these to grow mediums (e.g., fat micelles, proteins, etc.), which could
hinder light passage from milk samples through the imaging system lent. This pattern was
observed in several trials conducted to determine the reason of this discrepancy. For
example, different imaging methods (e.g., different acquisition time and/or settings),
bacterial concentrations, and/or sample temperature during imaging were tested (data not
shown). During dilution of inoculated milk with S. aureus-Xen8.1 clots were observed on
the surface of milk samples and pipette tips particularly in the first dilutions (0 to 1:1).
Milk contaminated with bacteria has been reported to have a higher proteolytic activity,
and formation of casein clots caused by proteolytic plasmin, which hydrolyzes caseins,
with further conglomeration of casein forming clots (Verdi et al., 1987). The amount of
clots found on the pipette tips were decreasing as dilutions were progressing. By diluting
inoculated milk with S. aureus-Xen8.1in fresh/sterile milk (500µl at each dilution tube),
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the number of milk clots were decreasing, allowing photons emitted by S. aureus-Xen8.1
to freely travel through the milk, therefore increasing the photonic count detection. Thus,
during evaluation of PE of bioluminescent bacteria, for example in vitro model to
evaluate antibiotic efficacy in inoculated milk or progression of bioluminescent bacteria
in the mammary gland in vivo, formation of casein clots in the milk need to be considered
during correlation of PE with CFU. Nevertheless, although similar bacterial numbers
between treatments were imaged in each dilution (Fig. 3.3-B), after dilution 2, higher
RLU/s from S. aureus-Xen8.1 were found in milk relative to LB (P < 0.05; Fig. 3.3-A).
Although several trials were performed to evaluate if differences in temperature,
acquisition time or imaging systems were responsible for the differences in PE between
milk and LB, this behavior did not changed. For these reasons, similar concentrations of
S. aureus-Xen8.1 were imaged in different media colors, to evaluate if the differences in
color between LB and milk accounted for the differences found in PE.
When PE from S. aureus-Xen8.1 were evaluated in the different media colors,
significant differences were found (Fig. 3.4-A). Therefore, differences in levels of PE
detected from S. aureus-Xen8.1 imaged in milk vs. LB, in dilutions 3 to 8 (Fig. 3.3-A),
could be explained by a mere physical property of milk i.e., its color. For example,
photons emitted S. aureus-Xen8.1 in a white medium travel in all directions and are
continually reflected (as an optical property of white materials, reflecting all
wavelengths), increasing the incidence of photons collected by the imaging system.
Conversely, as observed in Fig. 3.4-A, PE emissions collected from S. aureus-Xen8.1
were evidently lower when imaged in LB plus black coloring agent than both LB plus
white and LB alone. In this case, PE emitted by S. aureus-Xen8.1 in the black media
where nearly all light was absorbed and thus, the incidence of photons being detected by
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the imaging system was reduced. This approach (i.e., adding white solutions to
bioluminescent bacterial samples) could be used to enhance PE during imaging of
samples with low bacterial densities. For example, when a S. aureus-Xen8.1 aliquot
containing 1.0 x107 ± 1. 8 x 106 CFU/mL (Dilution 1:1; Fig.3.4-B) was imaged in LB
only, 74.8 ± 14.8 ph/pix/s were detected; however, when imaged in LB plus white
coloring agent with a bacterial concentration of 9.5 x 10 6 ± 2.7 x 106 CFU/mL (no
differences found in CFU between both treatments; P > 0.05), 125.2 ± 17.4 ph/pix/s were
detected. Thus, by adding white coloring agents to S. aureus-Xen8.1 cultures, PE can be
enhanced up to 60% without interfering with bacterial growth.
Photonic imaging Staphylococcus aureus-Xen8.1 through bovine mammary gland
tissue
During imaging of highly concentrated S. aureus-Xen8.1inoculum (i.e., within a
black box with opened top), as an attempt to detect PE through the bovine mammary
gland tissue, levels of PE detected reached the imaging system saturation point (i.e., ≥
65,000 RLU). When saturation is reached, determination of the exact levels of PE emitted
by the targeted sample is problematic. However, when lower CFU were imaged and
therefore lower levels of PE, no light was detected through bovine mammary gland
tissues (data not shown). Therefore, we used as a set point to estimate the percentage of
transference of PE a value of 65,000 RLU. After evaluating the percentage of
transference of PE through the dense mammary gland tissue (n = 20), only 0.000035 %
was recovered from the highly concentrated S. aureus-Xen8.1. When bioluminescent
bacteria was imaged within the different bovine reproductive tracts segments (E. coliXen14; Curbelo et al., 2010) up to 17.2 percentage of photonic transference was
recovered with a bacterial concentration of several log scales lower than the one utilized
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in the present study (3.2 x 108 CFU/200 L vs. 1.4 x 1013 CFU/200µL, respectively
(CFU/5mL were standardized to CFU/200µL to allow comparisons between the different
bacterial concentrations used in the mentioned studies). As previously mentioned earlier,
differences in the degree of PE produced by these two bioluminescent constructs were
observed in our laboratory. Genetic compatibility of the lux operon from P. luminescens
could account for the differences in the percentage of PE recovered in these two studies;
however, these differences were overcome by the significant increase in CFU used in the
present study (3.2 x 108 vs. 1.4 x 1013 CFU/200µL). Thus, the lower recovery of PE by S.
aureus-Xen8.1 reported in this study could be explained by the differences in tissue
composition between these two tissue types (i.e., bovine reproductive tract vs. mammary
gland). As suggested by Rice et al. (2001), attenuation of levels of light due to absorption
and scattering in tissues may change due to tissue composition.
For example, the bovine uterine wall is composed of three layers, the
endometrium (superficial zone composed of pseudostratified columnar and/or simple
columnar layers and loose connective tissue), the myometrium (thick inner layer and an
outer longitudinal layer of smooth muscle) and the perimetrium (loose connective tissue
covered by the peritoneal mesothelium; Priedkalns and Leiser, 2006). The thickness of
the uterine wall from multiparous cows (n=110; Mochow and Olds, 1966) averages 7.32
± 1.8 (SD) with 68 % of the wall thickness composed of muscle and 32% of mucosal
origin. On the other hand, the bovine teat sinus is composed of stratified cuboidal
epithelium tissue whereas the skin is composed of a thick, keratinized stratified squamous
epithelium and dermis (Priedkalns and Leiser, 2006) Therefore, further studies are
needed to evaluate the significance of tissue composition on light attenuation to enhance
imaging capabilities.
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Although detection of bioluminescence signals from S. aureus-Xen8.1 through
the dense bovine teats, as a non invasive approach to monitor bacterial progression in
vivo, might not be feasible due to the low levels of PE reported in the present study, an
alternative approach to circumvent these drawback is the use of bioluminescent
constructs maximized for greater tissue penetrations (e. g., broad spectral emitters; as
suggested by Zhao et al., 2005). According these investigators, bioluminescent bacterial
constructs bearing the luciferase enzymes from the click beetle display broader spectral
profiles (480 to 750 nm) and therefore light expressed at these wavelengths are less
absorbed and have greater penetration when imaged through biological tissues. In
addition, bacterial progress in vivo could alternatively be monitored in collected milk
samples from inoculated quarters, providing a rapid estimation of bacterial numbers
during the course of mastitis. Furthermore, due to the dense nature of the bovine
mammary gland tissue, the use of bioluminescent bacteria could be adapted to for wound
models and/or antimicrobial agents efficacy in teat end skin. Ex vivo biophotonic images
taken in our laboratory demonstrated promising results using this approach as a means to
monitor bacterial persistence in teat skin after teat dip application in intact (Fig.3.1-C and
-C) as well as in lacerated teat skin (Fig.3.1-E and -F).
Due to the scattering effect on PE by tissue thickness and composition, the use of
an optical clearance agent was evaluated as an approach to increase the percentage of PE
transference. Hyperosmotic compounds such as dimethyl sulfoxide, glycerol, and glucose
have been used as an OCA to alter the absorption and scattering properties of tissue (e.g.,
in hamsters; Vargas et al., 1999). In addition, Moulton, et al. (2006), studied different
optical clearance agents and doses as a means to increase photonic detection of
bioluminescent S. typhimurium through large animal skin (i.e., porcine). When the lateral
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portion of the teat ends were embedded with 75% corn syrup in our study, used as a nontoxic hyperosmotic compound (high glucose), no statistical differences were found in PE
detection relative to non-OCA treated teat ends. These differences could also be
attributable to differences in tissue composition and thickness (e.g., bovine udder vs.
porcine skin). Differences found in detection of PE through the different teat end skin
color could be explained by the same factors found when S. aureus-Xen8.1 was imaged
on milk. White colors reflecting PE emitted by S. aureus-Xen8.1 in all directions, than
otherwise would be undetected when absorbed by dark colors; therefore, increasing the
incidence of photons being collected by the imaging system.
Evaluation of biophotonic imaging as an approach to evaluate mastitis antibiotic
preparations against Staphylococcus aureus-Xen.8
Bioluminescent signals from S. aureus-Xen8.1 were monitored over time to
determine whether biophotonic imaging techniques could be adapted to allow
comparisons of antibiotic efficacy against mastitis pathogens, such as S. aureus.
Although higher PE were detected from S. aureus-Xen8.1 in the Pirlimycin treatment in
Time 0 (i.e., immediately post antibiotic addition to inoculated milk), relative to the other
treatments, CFU where similar. This could indicate that Pirlimycin by some means
enhances PE emitted from S.aureus-Xen8.1, since light outputs were even higher than
those detected in the non treated inoculated milk. This difference in PE could be
attributable to the differences in the physical and chemical characteristics of these
preparations such as those observed in Hetacillin and Cephapirin, vs. Pirlimycin (gel vs.
aqueous based, respectively).
The drop in light found in the Pirlimycin treatment, relative to the other
treatments, after 30 min of antibiotic exposure could be explained by differences in the
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mode of action between antibiotics. Pirlimycin is a bacteriostatic antibiotic which
interferes with protein synthesis by binding to the 50S ribosomal subunit of bacterial
subunit, therefore suppressing bacterial growth (Apparao et al., 2009). Production of light
involves that DNA from lux operon systems (e.g., lux ABCDE) gets transcribed into the
corresponded mRNA and then translated into the luciferase protein. When Pirlimycin is
added to the culture, light production is suppressed at the ribosomal level, by inhibiting
mRNA transduction into the luciferase/luciferin proteins; however, since it is a
bacteriostatic antibiotic CFU numbers did not decline. These findings show that it might
not be feasible to use biophotonic imaging systems to study the antimicrobial properties
of bacteriostatic antibiotics such as Pirlimycin against bioluminescent bacteria, since
apparently it interferes with S. aureus-Xen8.1 ability of producing light without
interfering with bacterial numbers. Nevertheless, it could be used as a monitoring tool of
bacterial metabolic activity, as shown in this report, by evaluating the pattern of light
production.
Conversely from what was observed in the Pirlimycin treatment, biophotonic
imaging of Hetacillin and Cephapirin activity against S. aureus-Xen8.1 in bovine milk
demonstrated to be a good model to estimate bacterial numbers by measuring levels of
PE. This was supported by statistical differences found in PE post antibiotic addition to S.
aureus-Xen8.1 cultures, which corresponded to the differences observed in CFU at the
same time point, between these two treatments. In contrast with lincosamide antibiotics
(e.g., Pirlimycin), β-lactams antibiotics, such as Hetacillin and Cephapirin, act by
mechanical and enzymatic inhibition of the peptidoglycan assembly of susceptible
bacteria resulting in weakened bacteria cell wall, consequently causing cell death
(Bayles, 2000). Therefore, the degree of impairment caused by these antibiotics against S.
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aureus-Xen8.1 corresponded to the changes in light output detected, which allows for the
quantification in real time of bacterial progression during in vitro and/or in vivo
antimicrobial studies.
Traditional methods for the estimation of bacterial population and standard
methods for in vitro susceptibility tests (e.g., determination of MIC or Kirby-Bauer disk
diffusion-zone inhibition method) which in vivo clinical mastitis studies do not
consistently predict outcomes for antimicrobial treatments (Apparao et al., 2009).
Therefore, the use of biophotonic imaging systems may offer a rapid and quantified
method for the screening of antimicrobial efficacies and that could consistently predict in
vivo outcomes. Moreover, biophotonic imaging might also provide improved statistical
power by allowing analysis of larger sample numbers per sampling time, relative to
traditional methods. For example, every imaging time point in this study was performed
by a single person and approximately required 1 min with n = 5 repetitions per treatment
(n=4; 20 observation per sampling point). However, laboratory procedures to determine
bacterial numbers such as sample dilutions, surface-plating, and CFU enumeration was
performed by 2 people and required approximately 45 min per sampling point. Therefore,
validating this system (i.e., development of models to predict bacterial numbers using
levels of photonics activity) could eventually allow for the collection of larger samples
and therefore increase observation numbers per sampling point.
However, a drawback of using S. aureus-Xen8.1 in developing in vivo infectious
models in the bovine is the fact that this pathogen is a human isolate (parental strain S.
aureus 8325-4), which may not be adapted to colonize and/or overcome the bovine
immune system (observation founds in in vivo mastitis trials conducted in our lab). In
additions, S. aureus-Xen8.1 has been extensively used in laboratory models which could
140

result in reduced ability to express virulence factors required for colonization of
biological tissues, such as the mammary gland. This phenomenon has been reported
previously in Bortadella spp (Fennelly et al., 2008). In this study, secretion of one of the
type III secretion system effectors proteins (i.e., Bsp22) was only observed in significant
proportion of clinical isolates of Bortadella pertussis (B. pertussis) but not in common
laboratory-adapted strains of B. pertussis (Fennelly et al., 2008).
In summary, imaging of S. aureus-Xen8.1 resulted in a higher intensity of PE
when imaged in bovine bulk tank milk relative to traditional laboratory medium,
suggesting that further development of this model may facilitate the monitoring of
pathogen presence in milk samples collected from mastitic mammary glands in vivo. In
addition, detection of PE from S. aureus-Xen8.1 imaged through the mammary gland teat
end segments is restrictive, due to the low levels of light detected by the imaging system.
The optical clearance agent used in this study did not increase PE overall; however when
teats where categorized by skin color, higher PE were found in black and white teats,
suggesting absorption or reflection exists based in skin color. Finally, the use of
biophotonic imaging might not be feasible to monitor bacterial progress during antibiotic
regimen when bacteriostatic antibiotics (such as Pirlimycin hydrochloride) are evaluated.
However, as shown in this report, this technology might represent a novel approach to
evaluate mastitis antibiotics, such as β-lactam antibiotics, which are bactericidal.
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Figure 3.1

Detection of photonic emissions (PE) of Staphylococcus aureus (S.
aureus)-Xen8.1 through bovine mammary gland tissue (Panels A and B)
and biophotonic imaging as a method to evaluate persistence of S. aureus
in bovine teat skin post teat-dip treatment in intact (Panels C and D) and
lacerated bovine teat ex vivo (Panels E and F).
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The box containing concentrated S. aureus-Xen8.1 inoculum (3.5 x 1014 CFU) was first
imaged separately (2 min; Panel A) for PE analysis. Then, teat end segments (n=20) were
placed over the opening of the box, one at a time (Panel B), and imaged to determine the
percentage of transference of PE emitted by S. aureus-Xen8.1. In this representative
example, the box containing concentrated S. aureus-Xen8.1emmited 541.7 relative light
units per sec (RLU/s) and after placing the teat end segment over the box opening, 1.97
RLU/s were detected by the camera (B), for a percentage of PE transference of 0.0036 %.
Imaging of bovine teat end skin, ex vivo, was performed by placing the XR/MEGA10ZeroTM imaging system under an excised bovine udder and targeting the area of
interest (i.e., teat end). Then the teat end was inoculated with S. aureus-Xen8.1 with a
cotton tip with ~1.0 x 1011 CFU/ml (Panel C) and imaged to collect PE pre teat dip
treatment. Immediately after imaging, the teat was dipped with the teat dip
(Chlorhexidine 1.0 %) and imaged to collect PE (Panel D). Using the same settings
mentioned above, one teat-end was lacerated, inoculated and imaged (Panel E).
Immediately after imaging, the teat was teat dipped with the same antimicrobial agent
and imaged (Panel F). In real time S. aureus-Xen8.1 presence was observed from the
lacerated skin areas, and not from intact skin, post treatment with teat dip.
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Figure 3.2

Photon emissions (PE; Panel A) and bacterial populations (Panel B) of
Staphylococcus aureus-Xen8.1 over time.

Panel A: S. aureus-Xen8.1 was grown on LB with or without kanamycin over eight
consecutive days. Day 0 represents the mean photonic emissions (in relative light units
per s; RLU/s) of S. aureus-Xen8.1 after 24 h of culture. Data are shown as mean RLU/s ±
SEM. Differences were found after 24 h between treatments (P < 0.0001). Panel B: S.
aureus-Xen8.1 aliquots were serially diluted and plated on agar plates with its
147

corresponding treatment and counted to determine bacterial populations (expressed in
colony forming units per ml; CFU/mL). Data are shown as mean log10 CFU/mL ± SEM.
Statistical differences were found in bacterial populations between treatments (P <
0.001).
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Figure 3.3

Photonic emissions (PE; Panel A) and bacterial population (Panel B) of
Staphylococcus aureus-Xen8.1 imaged in LB and bovine bulk tank milk
(BTM).

A sub-sample from an overnight culture of either S. aureus-Xen8.1 grown in LB or BTM
milk was serially diluted and aliquots placed in black 96-well plates for imaging (A).
Every dilution in Panel A represents the mean PE (Ph/pix/s; n = 6) of 100µL of S.
aureus-Xen8.1from the different dilution tubes (1 to 8). Data are shown as mean Ph/pix/s
± SEM. Different letters indicate statistically significant differences between treatment (P
<0.05). Higher PE were detected in LB relative to BTM in dilution 1 (P = 0.0002);
however, no differences were found between these two treatments in dilution 2 (P =
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0.4557). Higher bioluminescent levels from S. aureus-Xen8.1 were found in dilutions 3
to 8, when imaged in bovine BTM (P < 0.05). Immediately after imaging, the content of
each well was serially diluted and plated to determine the number of colony forming units
per ml (CFU/ml; panel B). Data are shown as mean log10 CFU/mL ± SEM. Although
bacterial populations between treatments within each dilution were intended to be similar,
in some dilutions statistical differences were found (i.e., 3, 6, 8; P < 0.05). Although
higher CFU/ml were found in LB in the mentioned dilutions (3, 6, 8; Panel B), PE were
higher in bovine BTM in each of these dilutions (Panel A; P < 0.05).
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A

Figure 3.4

Photonic emissions (PE; Panel A) and bacterial population (Panel B) of
Staphylococcus aureus-Xen8.1 imaged in different media colors.

Aliquots from an overnight culture of S. aureus-Xen8.1 grown in LB were diluted 6 fold
(dilution 1 being 500 µL straight from the overnight culture) with tubes filled with either
500 µL of LB plus black-, white-coloring agent or LB only. Aliquots (n = 4) from each
dilution tube were then placed in a black 96-well plate for imaging (A) using the
Berthold/Nightowl imaging system. Every dilution in Panel A represents the mean PE
(Ph/pix/s; n = 4) of 100µL of S. aureus-Xen8.1from the different dilution tubes (1 to 6).
Data are shown as mean Ph/pix/s ± SEM. Different letters indicate statistically significant
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differences between treatment (P <0.05). Immediately after imaging, the content of each
well was plated to allow the number of CFU (B) to be compared to levels of PE. Data are
shown as mean log10 CFU/mL ± SEM. Detection of PE from S. aureus-Xne8.1 imaged in
the white media were higher (P = 0.0001) relative to PE detected in LB and black media,
in each dilution. As intended, no differences in CFU/ml between treatments by dilution
were observed (P > 0.05); except for one treatment in dilution 1:3 (black coloring agent;
P = 0.02).
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Figure 3.5

Photonic imaging of Staphylococcus aureus-Xen8.1 through the bovine
mammary gland tissue classified by skin color (Panel A) and evaluation of
an optical clearing agent (OCA) as an approach to increase photonic
recovery through the dense tissue (Panel B)

Concentrated S. aureus-Xen8.1 inoculum (3.5 x 1014 CFU) was placed inside a black
plastic box with an opened top of the size of teat ends. Bovine mammary gland tissues
(teat end; n = 20), were placed over the box opening and imaged (2 min) to calculate the
percentage of PE recovery in each teat end. Each bar represents mean RLU/s ± SEM
collected from the different teat end sorted by skin color (e.g., black (n=9)), black and
white (mixed; n=5) and white (n=6). Finalizing the imaging of the 20 segments, the
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lateral portion of one of each teat pairs (n = 10) was submerged with OCA for 3 h while
the other half was submerged in the same way than its corresponding pair with PBS (used
as the control). Each teat was then placed over the opening of the black box for imaging
(Panel B).
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Figure 3.6

Photonic emissions (PE; Panel A) and bacterial population (Panel B) of
Staphylococcus aureus-Xen8.1 grown under antibiotics.

Whole bovine milk (500 ml contained in glass bottles; n = 4) were inoculated with S.
aureus-Xen8.1 to reach a concentration of ~1 x106 CFU/ml. Bottles were assigned to 3
different commercial intramammary antibiotics preparations, (i.e., Cephapirin sodium,
Hetacillin potassium and Pirlimycin hydrochloride) and one bottle to be left untreated
(control). The minimal inhibitory concentration required to inhibit the growth of 90% of
the organism (MIC90) were tested by each antibiotic. Immediately after the addition of
antibiotics to the inoculated milk, aliquots were collected from each treatment (100 µl; n
= 5), placed on a 96-black plates wells and imaged. After imaging, the content of each
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well was serially diluted and plated to allow the number of CFU/ml to be compared to
levels of PE activity. Every sampling point in Panel A represent mean PE ± SEM
expressed in relative light units per s (RLU/s) and bacterial populations shown as mean
log10 in CFU/ml ± SEM. Differences in PE between Hetacillin and Cephapirin were first
observed at 1.5 h post antibiotic addition to the inoculated milk with bioluminescent S.
aureus (243.2 ± 3.0 and 236.8 ± 1.4 RLU/s, respectively; P < 0.0001), which
corresponded to the differences first observed in CFU between these two treatments at
1.5 h (3.4 x 107 ± 4.4 x 106 and 2.2 x 107 ± 1.1 x 106, respectively; P < 0.0001).
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CHAPTER IV
IN VIVO IMAGING OF BIOLUMINESCENT STAPHYLOCOCCUS AUREUS IN
BOVINE MASTITIS
ABSTRACT
Conventional bacteriological methods to establish bacterial burden and
distribution in infected tissues in vivo animal models typically require extensive
procedures and therefore are time consuming. The present study aims toward the
validation of Biophotonic Imaging (BI) as a novel approach for in real time determination
of bacterial progress during early stages of experimentally induced mastitis as well as
clearance post intramammary infusion with a commercial antimicrobial. In addition,
thermography imaging (TI) was implemented as a tool for non invasive detection of early
mastitis. In order to accomplish these objectives, lactating cows (n=3) were challenged
with a highly adapted bovine mastitis pathogen (Staphylocoocus aureus RF122 (S.
aureus)) transiently transformed with bioluminescent properties (-lux). In real time
estimation of CFU was performed by imaging milk samples from challenged quarters
using a low light imaging system. Samples were then plated to correlate S. aureus-lux
photonic activity with CFU. In addition, mastitic mammary gland tissues were collected
post mortem and imaged as a means for in real time determination of spatial distribution
of S. aureus-lux. Furthermore, TI was performed pre and post challenged in the rear
mammary gland quarters with thermal pattern quantification conducted in the lower
region of the quarter and in the teat-end.
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Imaging of S. aureus-lux in milk samples provided a good indicator of CFU for
use in real time in vivo mastitis models, as demonstrated by the highly significant and
positive correlation found between CFU and photonic emissions (PE; r = 0.99; P <
0.0001). An increment in skin surface temperature in the teat-end of the challenged
quarter was observed as early as 12 h post bacterial challenged, suggesting that TI of the
teat-ends might represent a better target for early detection of mastitis. Finally, ex vivo
whole tissue imaging of mammary gland tissues provided in real time information of S.
aureus spatial distribution and burden. Collectively, this data provides evidence
supporting the use of BI and TI as tools to improve conventional bacteriological methods
to better understand pathogenesis of mastitis.
Keywords: Staphylococcus aureus RF122, Biophotonic Imaging, experimental mastitis

INTRODUCTION
Mastitis represents one of the most common and costly diseases in the dairy
industry. Among the wide array of pathogens that have been isolated from raw milk,
Staphylococcus aureus (S. aureus) is an important etiological agent of bovine mastitis
(Barkema et al., 2009), and the most frequently isolated pathogen in mastitic quarters in
heifers (Borm et al., 2006). Additionally, S. aureus, strain ET3-1 (RF122), is a common
cause of bovine mastitis-causing pathogen worldwide (Fitzgerald et al., 1997; HerronOlson et al., 2007). Despite the intensive research conducted to better understand bovine
mastitis, pathogenesis of S. aureus infections in bovine mammary glands remains poorly
understood.
To date, culturing techniques for the determination of bacterial numbers is still the
golden standard (Viguier et al., 2009). Determination of the causative bacterium, number
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of bacterial cells as well as their spatial distribution in infected tissues is essential to
study virulence determinants, pathogenesis and antibiotic efficacy during in vivo mastitis
studies. However, investigation of these parameters in previous in vivo mastitis studies
using conventional bacteriological methods required extensive culturing techniques and
identification tests (Gillespie et al., 2002; Hensen et al., 2000; Oliver et al., 2003; Oliver
et al., 2004). An alternative approach has been suggested to use optical markers, such as
luciferases (e.g. photon-emitting indicators) to label pathogens and monitor their progress
and distribution in real time (Contag et al., 1995; Curbelo et al., 2010; Willard et al.,
2003). The lux operon, which is commonly used to incorporate bioluminescent properties
to bacteria, has been modified for bacterial incorporation using several strategies, such as
plasmids (Herrero et al., 1990). This system encodes all proteins required for generating
bioluminescence including the luciferase, substrate, and substrate-regenerating enzymes
essential for independent and continual production of light within the bacterial host
(Luker and Luker, 2008). Bioluminescence produced by the lux operon requires
metabolization of molecules such as FMNH2 and aldehyde generated by the bacterial
host.
Given the fact that expression of the inserted lux genes are dependent of the
metabolic status of the bacterial host (Unge et al., 1999), quantification of the degree of
impairment by any substance or environmental factor that alters this balance, can be
quantified in real time by monitoring the levels of light expressed by the organism
bearing the optical marker. Thus, the use of bioluminescent bacteria, coupled with
photonic imaging technologies, may represent an efficient model for achieving a greater
understanding of the pathogenesis of bacterial infections. We are proposing to exploit the
use of this technology as a means to monitor in real time in vivo progression of S. aureus
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RF122-lux during early stages of mastitis and further monitoring of bacterial clearance
following antibiotic therapy. In addition, further information regarding bacterial
distribution in mammary gland tissues was evaluated in tissues collected post mortem
from treated animals to investigate bacterial pathogenesis.
MATERIALS AND METHODS
Animal management prior to bacterial challenge
Experimental Case Study 1 (Trial 1)
Animals were handled in accordance to the guidelines and recommendations
stipulated by the Mississippi State University (MSU) Animal Care and Use Committee
(IACUC Approval # 10-077). Non-bred Jersey cows (n =2) culled by reasons other than
mastitis (e.g., low fertility), were obtained from the MSU Bearden Research Dairy herd
population and placed into a lactation induction protocol (adapted from; Jewell, 2003).
Animals were kept in pastures and supplemented with fresh hay and commercial
concentrate pellets (14% CP; 2.3 kg per cow) during the lactation induction protocol.
Three weeks from the expected initiation of milking, concentrate supplementation was
increased to 4.54 kg per animal (18 % CP). At the initiation of milking, normal milk
secretion was only observed in one cow. Cow # 138 (Jersey; Age 3.25 yrs; 325 DIM
previous lactation <15.9 kg; culled reason: open) was then selected for the mastitis
challenge and brought into a pen (dimensions 2.4 by 3.4 m) inside a BSL-2 approved
animal isolation room, for an acclimation period of 5 days. The flooring was settled up
with rubber panels covered with saw dust. Individual quarter milk samples as well as saw
dust samples were sent to the diagnostic laboratory for bacterial identification.
Microorganims identified in saw dust samples by aerobic culture were: light growth of
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Micrococcus sp., Bacillus sp., and Staphylococcus warneri. During the acclimation
period, milking was performed twice a day (12 h apart) with an electronic portable
milking machine (Porta-Milker, Fairgrove, MI). The quarter to be challenged (rear left)
was milked and weighed individually using a quarter milker (Coburn Company Inc.,
Whitewater, WI).
Experimental Case Study 2 (Trial 2)
Induction of lactation was not performed in the subsequent Trials. A multiparous
lactating Holstein cow (Cow ID 609; Age 4.7 yrs; 412 DIM; < 20.5 kg/day milk yield;
culled reason: open) obtained from the MSU Bearden Research Dairy herd population
was used for this Trial. Cows were confirmed as S. aureus-free by serum antibody
crossreactivity to S. aureus exoproteins performed by Western blot analysis. Fresh hay
and commercial concentrate pellets (18% CP; ~9.1kg per cow) were provided during the
acclimation period (5 days). Milking was performed every 12 h and milk weighted using
the same procedure as in Trial 1.
Experimental Case Study 3 (Trial 3)
A multiparous lactating Holstein cow (Cow ID 712; Age 2.89; DIM 333 < 20.5
kg milk yield) was obtained from MSU Bearden Research Dairy herd population. Due to
complications in feed consumption adaptation observed in Trial 2, cow in Trial 3 was fed
with total mix ratio (TMR) obtained from the MSU Dairy. Bags (~15.9 kg each) were
collected every 5 days and stored in a freezer to keep these from fermenting and for
storage purposes. One bag per milking as well as fresh hay and commercial concentrate
pellets (18% CP; ~2.27 kg per milking) was provided. Milking was performed every 12 h
and milk weighed using the same procedure as in Trials 1 and 2.
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Staphylococcus aureus RF122 inoculum preparation and intramammary challenge
Experimental Case Study 1 (Trial 1)
Bacterial handling and inoculations were conducted in accordance with the
guidelines and recommendations stipulated by the MSU Institutional Biosafety
Committee (IBC approval # 013-10). Staphylococcus aureus RF122 wild type was
conferred with bioluminescent properties (S.aureus RF122-lux) by incorporation of
plasmid pkA4 (Dr. Seo; Department of Basic Sciences, School of Veterinary Medicine,
MSU). Bacterial inoculum used for the intramammary challenge was prepared by the
following method. One isolated colony from a S.aureus RF122-lux streaked in a brain
heart infusion agar plate plus chloramphenicol (5µg/ml; BHI + Cam) was used to
inoculate 3ml of BHI + Cam broth and incubated for 18 h in an orbital incubator at 37 ˚C
at 180 rpm. Then, 100µl from the overnight culture was diluted to 10 -3 dilution in sterile
phosphate buffered saline (PBS) and an aliquot (100 µl) from this dilution was used to
inoculate fresh/sterile 10 ml BHI + Cam broth and growth for 18 h, under the conditions
mentioned above. Aliquots (100 µl) from dilutions 10 -6, 10-7, and 10-8 were plated daily
in duplicates to track bacterial numbers. This same procedure was conducted for three
consecutive days and coordinated with the day of intramammary inoculation to ensure
fresh and actively growing bacteria. At the third day, 100µ aliquot from fresh S.aureus
RF122-lux culture was targeted for 20 to 30 colony forming units (CFU) by ten-fold
dilutions to10-7, and the content (1 ml) transferred to a 50 ml Falcon tube containing 9 ml
of sterile PBS, which was used as the inoculum to challenge the cow.
Approximately 30 min after the morning milking, the rear left quarter teat end
was scrubbed thoroughly with a gauze pad embedded with 70% ethanol and dried with a
disposable paper towel. Then, the mammary gland quarter was challenged through the
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streak canal using a 20 ml disposable syringe fitted with a 1 1/3 sterile teat infusion
cannula (Jorgensen Laboratories Inc., Loveland, CO). After inoculation, the mammary
gland cistern was gently massaged and the teat end dipped with an iodine based post teat
dip. No quarter was used as a control (uninfected) due to previous bacterial challenges
performed in the front homolateral and contralateral quarters with other S. aureus lux
strains (S. aureus Newbould 305 and S. aureus Xen8.1, respectively) and a naturally
occurring infection found in the homolateral rear quarter with S. aureus. However, milk
samples were collected from the homolateral rear quarter during every photonic imaging
to collect background PE.
Experimental Case Study 2 (Trial 2)
In Trial 2, bacterial inoculums were prepared using the same methodology and
conditions as in Trail 1 to target a challenge inoculum for 10 to 20 CFU. Bacteria
challenge was conducted in the rear right quarter and the homolateral quarter (i.e., rear
left quarter) was used as control.
Experimental Case Study 3 (Trial 3)
Due to the severe mastitis symptoms observed in Trial 2 (gangrenous quarter,
bloody secretions from the challenged quarter, etc.), when 10 CFU of S.aureus RF122lux (wild type) were used as the bacterial challenge concentration, a mutant deletion was
developed by Dr. Seo (hemolysin-β gene deletion; denoted as S.aureus RF122-8-lux).
The bacterial inoculum was prepared under the same methods and conditions to target a
challenge inoculum of 5 CFU. After plating a portion of the suspension used to inoculate
the mammary gland quarter, 2 CFU were found. The cow’s health status was monitored
after the inoculation (rectal temperature and on site SCC determination; see below) as
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well as plating of milk samples. After obtaining negative cultures for S.aureus RF122-8lux for three consecutive days, the cow was re-challenged in the same quarter targeting 5
to 10 CFU. Bacteria inoculation was performed in the rear right quarter and the
homolateral quarter (i.e., rear left) was used as control.
Thermal imaging, milk and blood sampling, and monitoring of animal health status
post bacterial challenge
Experimental Case Study 1 (Trial 1)
The use of thermal imaging was evaluated as a non invasive approach for early
detection of mastitis. Imaging of the hind quarters was performed prior to the AM
milking once a day, during the acclimation period, to determine basal udder surface
temperature, and twice a day prior to each milking, post bacterial challenge using the
FLIR SC660 thermography unit (FLIR Systems AB, Sweden). Thermal patterns were
quantified using vertical rectangular transects drawn on thermal images of infected and
control mid hinder quarters as well as in teat ends of each quarter (See Fig. 4.18-A) using
the ThermalCamTM Researcher Pro 2.7 software (FLIR Systems AB, Sweden). The max
temperature (˚C) within the transect areas is reported in the current study. Rectal and
room temperatures where determined with the use of an electronic digital thermometer
GLA 525-550 (GLA Agricultural Electronics, San Luis Obispo, CA). Rectal
temperatures were collected by full insertion of the thermometer probe into the rectal
cavity and registered once the lecture was stable for 10s. To collect room temperatures,
the thermometer was placed inside the animal cage at a height similar to the cow and
lecture registered using the same approach mentioned previously.
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Milk samples (10 ml) from the challenged and homolateral quarter were
aseptically collected before each milking for in site determination of somatic cell counts
(SCC) using a De Laval cell counter (DCC; De Laval International AB, Tumba, Sweden).
In addition, aliquots from the challenged and control quarter milk sample tubes were used
for photonic imaging (see below). Milk sample tubes were then stored at -20 ˚C for
further analysis of acute phase proteins and mammary gland tissue damage biomarkers
(e.g., haptoglobin, serum amyloid A, lactoferrin, lactate dehydrogenase). Blood collection
was performed through indwelling catheters once a day during the acclimation period and
twice a day (at each milking) post bacterial challenge. Blood samples were collected in
10 ml Plasma BD Vacutainer® Lithium Heparin and in 8.5 ml Serum BD Vacutainer®
STTTM tubes (BD Franklin Lakes, NJ). Plasma was isolated after centrifugation at 3,000
RPM for 15 min at 4˚C and stored at -80˚C for further analysis.
Cow’s health status was closely monitored once symptoms associated with the
infection were observed (elevated rectal temperature (≥ 39.5 ˚C; lethargy, anorexia). The
combination of SCC > 200,000 cells/ml, rectal temperature of 40.5 ˚C and PE ≥ 50
RLU/s (~105 CFU/ml) in milk samples collected from the challenged quarter were used
as criteria to treat animals with intramammary antibiotic. A mastitis extended antibiotic
therapy using a commercial intramammary antibiotic preparation (200 mg/10ml;
Cephapirin sodium; Fort Dodge, IA) labeled for treating major mastitis pathogens such as
S. aureus was used (one intramammary infusion every 12 h within the first 24 h and one
intramammary infusion per day for the following 4 days). After the first intramammary
infusion, milk samples were imaged until PE were comparable to background noise and
confirmed by plating the samples to determine S. aureus CFU. Once isolation for S.
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aureus was negative for three consecutive days, the cow was humanly euthanized as per
our IACUC protocols.
Experimental Case Study 2 (Trial 2)
All sampling procedures (e.g., milk samples, thermography and photonic
imaging) were performed using the same methodology as in Trial 1. Due to previous
complications with indwelling catheters as in the first Trial (displaced by the cow),
sampling of blood was performed via vena cava venipuncture at -48, -24, and each 12 h
post bacterial challenge. After intramammary bacterial infusion, milk samples were
imaged and plated every 12 h.
Experimental Case Study 3 (Trial 3)
All sampling procedures (e.g., milk samples, thermography and photonic
imaging) were performed using the same methodology as in Trials 1 and 2. In this Trial,
intravaginal temperatures were collected each 15 min using a data logger HOBO U22
Water Temp Pro v2 (Onset Computer Corporation, Cape Cod, MA), inserted into the
vagina at day -3, to record real time body temperatures through the Trial (Hillman et al.,
2009). Due to temperamental reasons with cow in Trial 3, blood samples were collected
at -48, -24, and each 12 h post bacterial challenge via coccygeal venipuncture and
samples managed and stored under the conditions described in Trials 1 and 2. After
intramammary infusion, milk samples were imaged and plated every 12 h post antibiotic
infusion.
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In vivo imaging of bioluminescence Staphylococcus aureus RF122 in milk samples
and ex vivo imaging of whole mammary gland tissues
Immediately after collection of milk samples from the challenged and control
quarters (used for PE background subtraction), aliquots (n = 5/trt; 100 µl) were
transferred to pre-warmed (37˚C) black 96 well plate and imaged for 10 min acquisition
time to collect PE using the XR/MEGA-10ZeroTM imaging system (Stanford Photonics,
Inc., Palo Alto, CA, USA). During the imaging period, samples were maintained warm
(~37 ˚C) by a built in hot plate inside the imaging system chamber to prevent variations
in PE activity due to temperature changes. Photonic emissions collected were analyzed
using Image J software (National Institutes of Health, Bethesda, MD, USA) in which
pixel intensities associated with PE were quantified within regions of interest (e.g.,
individual wells of a 96-well plate) and standardized to relative lights units per second
(RLU/s). Furthermore, PE collected from control quarter milk samples were used for
background subtraction of PE collected from S.aureus RF122-lux in the challenged
quarter milk samples. An in vitro regression line (PE vs CFU; data not shown) was used
to estimate S.aureus RF122-lux CFU in milk samples imaged and used to determine how
far samples had to be diluted in order to obtain from 25 to 250 CFU in plates. The content
of individual wells (100 µl; n = 3 wells) was then diluted in sterile PBS tubes (900 µl)
and plated in BHI + Cam followed by a 24-h incubation at 37 ˚C. Plates were examined
for bacterial growth and colonies enumerated to allow CFU to be compared to levels of
PE activity. Imaging of milk samples with further CFU determination in Trial 1 was
performed every 12 h from time 12 to 84, and approximately every 6 h from time 84 to
177 post bacterial challenge. In Trials 2 and 3, imaging of milk samples with further
bacterial numbers determination was performed every 12 h. In addition, in Trial 3, within
30 min post euthanasia, the mammary gland was excised and tissues dissected from the
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challenged, control and front right quarter (suspected of cross contaminated quarter) for
ex vivo imaging of bioluminescence S. aureus RF122 as a means to evaluate in real time
detection of bacterial spatial distribution in mastitic mammary gland tissues (See Fig.
4.16). Additional mammary gland tissues were collected and placed in 10 %
formaldehyde solution for histological evaluation.
Statistical analysis
Descriptive statistics were performed using SAS version 9.2 for Windows (SAS,
Cary, NC, USA) to obtain the average ± SE of milk yield, CFU/ml, and PE of S. aureus
RF122-lux collected during the experimental Trials. The coefficient of correlation
between mean CFU and PE in each sampling point was calculated using Pearson
Correlations in SAS.
RESULTS
Experimental Case Study 1 (Trial 1)
Mean ± SEM milk yield from the challenged quarter (rear left) from day -2 to day
0 was 2.51 ± 0.07 kg (Fig. 4.1). Mean ± SEM SCC during the same period was 7.5 x 10 3
± 2.1 x 103 cells/ml (Fig. 4.4). During the same period, mean rectal temperature ranged
within the normal physiological values during the acclimation period (37.9 ± 0.02 ˚C;
Fig. 4.2) and max quarter skin surface temperature, as determined by thermography
imaging, was 35.9 and 35.2 ˚C for the challenged and control quarter, respectively (Fig.
4.3-A). All quarters were negative for bacterial presence with the exception of the rear
right quarter, were the presence of S. aureus was observed (> 1.0 x 104 CFU/ml). When a
portion of the bacterial suspension used for the intramammary challenge (inoculation
performed post AM milking; 0930 h at Day 0) was plated and incubated for 24 h, 25 CFU
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were found. Twelve hours post inoculation (PM milking), milk samples collected from
the challenged quarter were imaged. Photonic emissions detected at this point were
comparable to background photonic noise (0.15 ± 0.01 vs 0.16 ± 0.01 RLU/s,
respectively; Fig. 4.5). Milk samples were then plated to determine the number of S.
aureus RF122-lux cells in the imaged samples. At this time, 5 cells of S. aureus RF122
were recovered from the challenged quarter (Fig. 4.5). Rectal temperature as well as max
udder skin temperature 24 h post challenge did not numerically change from that
observed during the acclimation period (see Fig. 4.2 and Fig. 4.3-A, respectively).
Interestingly, a 0.9 ˚C difference in max teat end skin surface temperature was observed
between the challenged and control quarters (35. 3 ± 0.03 vs 34.4 ± 0.2 ˚C, respectively;
Fig. 4.3-B).
At 24 h post bacterial challenge, a 6.2 fold numerical increase in PE, relative to
background PE collected from the control quarter, was detected from milk samples
collected from the challenged quarter (1.33 ± 0.05 vs 0.21 ± 0.04 RLU/s; Fig. 4.5). This
numerical increase in PE corresponded to a raise in CFU numbers found 24 h post
inoculation (4.3 x103; Fig.4.5). During the mentioned period, a numerical increase in
SCC was observed (2.6 x 105 cells/ml; Fig.4.4) as well as a drop in milk yield of 5.0 %
(Fig. 4.1). Nevertheless, rectal temperature 24 h post inoculation was not numerically
different from that found during the pre challenge period (37.83 vs 37.9 ˚C, respectively).
Challenged quarter skin surface temperature 24 h post challenge, however, was
numerically greater than the average skin temperature of the same quarter during the pre
challenge period (36. 4 ± 0.3 vs 35.9 ± 0.4 ˚C, respectively), but not numerically different
from the control quarter during the same sampling point (24 h; 36.2 ± 0.3 ˚C). When
thermography imaging of the teat end skin surface of the challenged quarter was
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measured, more evident differences were observed when compared to the untreated
quarter (35. 4 ± 0.3 vs 34.5 ± 0.1 ˚C, respectively; Fig. 4.3-B).
At 36 h post inoculation, a numerical increase in rectal (40.3 ˚C) as well as
surface skin temperature of the challenged quarter (37.1 ± 0.3 ˚C) was detected relative to
that observed 24 h post bacterial inoculation. In addition, a 1.5 ˚C difference in udder
skin max surface temperature was observed between the challenged and control quarter
during the same sampling point (37.1 ± 0.3 ˚C vs 35.7± 0.2 ˚C, respectively). Somatic
cells counts at this time had also increased (5.3 x 107 cells/ml), relative to the previous
sampling point. Unexpectedly, PE as well as bacterial cell numbers decreased during the
same sampling point (0.19 ± 0.06 RLU/s and 8.2 x 102 CFU/ml, respectively). Since
symptoms established as criteria to intervene with intramammary antibiotic were
observed at this time (elevated rectal temperature and SCC), but PE detected were below
the levels stipulated (i.e., 50 RLU/s), the cow was treated only with the anti-inflammatory
Flunixin meglumine (50mg/45.5 kg body weight; Schering-Plough Animal Health,
Union, NJ). Rectal temperatures, as shown in Fig. 4.2, dropped during the 3 interventions
with Flunixin meglumine made (~36, 48 and 84 h post challenged). However, udder skin
surface did not numerically decline until 96 h post bacterial challenge (Fig. 4.3-A).
During 24 to 84 h post bacterial challenge S. aureus RF122-lux PE as well as CFU
remained stationary (Fig. 4.5). Photonic emissions during this period ranged from 0.18 to
1.24 RLU/s with CFU ranging from 8.2 x 102 to 1.6 x 104 CFU/ml. Somatic cell counts
during the same period ranged between 107 and 108 cells/ml. In addition, at 48 h post
bacteria challenge milk yield had dropped about 90 %, relative to the averaged milk yield
calculated during the pre challenge period (i.e., 2.51 vs 0.29 kg/day; Fig. 4.1).
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Ninety six hours post bacterial challenge, a 3.6 fold numerical increase in PE
relative to the average PE detected from time 24 to 84 h post challenge was observed
(2.44 ± 0.43 vs 0.59 ± 0.24 RLU/s, respectively). This numerical increase in PE
corresponded to a 3.4 fold increase in CFU when compared to the average CFU from
time 24 to 84 h post challenge (3.6 x 104 vs. 1.0 x 104 CFU/ml). During 84 to 108 h post
bacterial challenge, both quarters max skin surface temperature decreased with respect to
time 72, with the challenged quarter having a higher skin temperature relative to the
control quarter during the mentioned period (Fig. 4.3-A). The same response was
observed in teat end max skin temperature (Fig. 4.3-B).
An evident increment in PE from time 96 to 120 h post bacterial challenge was
observed (2.44 ± 0.43 to 153.88 ± 6.53 RLU/s, respectively). Bacterial cell numbers
associated during the mentioned period also increased from 3.6 x 104 to 8.9 x 105 ± 9.3 x
104 CFU/ml. The peak in PE detected was in parallel with the peak in rectal temperature
(i.e., 41.1˚C) observed at120 h post challenge. Max skin surface temperature of the
challenged quarter began to increase back from this point peaking at time 144 post
bacterial inoculation (i.e., 39.6 ± 0.6 ˚C). At 120 h post bacterial challenge, the first
intramammary infusion (200 mg/10ml; Cephapirin sodium), as part of the extended
mastitis antibiotic therapy was delivered to the infected quarter.
Photonic emissions numerically dropped to 60.0 ± 1.09 RLU/s at Time 126 h post
challenge, which corresponded to the decrease in S. aureus RF122 cell numbers found
when milk samples were plated (2.4 x 105 CFU/ml). As shown in Fig. 4.2, rectal
temperature also dropped one degree 6 h post intramammary antibiotic infusion (41.1 vs
40.1 ˚C). However skin surface temperature of the challenged as well as the control
quarter increased from time 120 to 144 post bacterial challenge. Furthermore, PE dropped
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in a stepwise fashion, until reaching background levels 44 h post antibiotic infusion (0.12
± 0.06 RLU/s; Time 164, Fig. 4.5). This coincided with the absence of bacterial presence
observed when samples were plated in BHI agar plates and allowed growing for 24 h.
Surface skin temperature of the challenged quarter dropped at 144 post bacterial
challenge (Fig. 4.3-A). A highly significant (P < 0.0001) and positive coefficient of
correlation (r2 = 0.97) between the mean PE and mean CFU/ml at each sampling point
during the in vivo Trial was found.
Experimental Case Study 2 (Trial 2)
Milk yield from day -2 to day 0 ranged from 3.86 to 3.65 kg in the rear right and
from 1.23 to 2.08 kg in the rear left quarter (Fig. 4.6). Rectal temperature during the same
period averaged 37.0 ± 0.05 ˚C (Fig. 4.7) and max quarter skin surface temperature, as
determined by thermography imaging, was 35.5 and 35.6 ˚C for the challenged (rear
right) and control (rear left) quarter (Fig. 4.8-A). Milk SCC from the pre-challenged
quarter (Time 0; AM milking) was 8.5 x 104 cells/m (Fig. 4.9), and rectal temperature
associated with this was 37.8 ˚C. Bacterial inoculation was performed within 30 min after
the AM milking using 10 CFU.
Twelve hours post bacterial challenge, PE collected from the challenged quarter
were comparable to those collected from the control quarter (0.12 ± 0.01 vs 0.11 ±
0.01RLU/s, respectively; Fig. 4.10). When imaged milk samples were plated, no CFU
were found in any of the plates (n = 3; Fig. 4.10). However, at this point, a slight
increment in rectal temperature (Fig. 4.7) and SCC (Fig. 4.9) relative to the previous
sampling points was observed (38.1˚C and 1.5 x 105 cells/ml, respectively). No numerical
differences in surface skin temperature were observed in the challenged and control
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quarter at this point (33.8 vs 33.6 ˚C, respectively); however, a ~2.0 ˚C increment in max
teat end temperature was observed in both teats with respect to the previous sampling
point (Fig. 4.8-B).
At 24 h post inoculation, the quarter when palpated felt hot with max surface skin
temperature 0.7 ˚C above that measured in time 12 post bacterial challenge (36. 0 ± vs
36.7 ˚C, respectively). At this point, marked differences were observed in teat skin
temperature (34. 1 vs 36.2 ˚C, respectively); however, teat end skin temperature of the
control quarter remained higher than the challenged quarter during the whole Trial (Fig.
4.8-B). Milk production in the challenged quarter remained relatively unchanged to the
average milk yield in day 0 (3.15 vs 3.13 kg, respectively; Fig. 4.6). Photonic emissions
collected 24 h post challenge increased 1.3 fold, relative to time 12 (0.16 ± 0.02 vs 0.12 ±
0.01 RLU/s), corresponding to 3.0 x 102 CFU/ml. At 30 h post challenge, the cow was
showing early signs of systemic illness, as moderate anorexia, lethargy and elevated body
temperature (rectal temperature 39.8 ˚C).
At Time 36, the cow was completely anorexic, and recumbent. The challenged
quarter was showing aggravated symptoms of mastitis such as profound inflammation
and redness. When the quarter was palpated, it was extremely firm and the cow showed
symptoms of discomfort and local pain. Milk production at this point (PM milking; Day
1) had dropped 22.4%, relative to the average milk yield calculated in day 0 (2.43 vs 3.13
kg, respectively; Fig. 4.6). When milk samples from the infected and control quarter were
analyzed for in situ determination of SCC, cell counts had reached several log scales
higher than the control quarter (2.5 x 107 vs 6.4 x 105 cells/ml, respectively; Fig. 4.9),
however, skin surface temperature between the challenged and control quarter were not
different (Fig. 4.8-A). Photonic emissions at this point had increased about ten-fold
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relative to time 24 (0.16 ± 0.02 vs 1.35 ± 0.16 RLU/s) with bacterial numbers
corresponding to 1.4 x 103 ± 4.1 x 102 CFU/ml. Three hours later, the cow was intervened
with Flunixin meglumine (50mg/45.5 kg body weight) due to elevated rectal temperature
(40.7 ˚C; data not shown); however, was not treated with intramammary antibiotics due
to the low levels of PE collected at this point.
At 48 h post challenge, the cow was showing severe distress and lethargy, it was
recumbent and fully anorexic. Due to these symptoms, the cow was not able to be milked.
In addition, the teat end of the challenged quarter was becoming gangrenous, featured by
a purple skin discolouration. Somatic cell counts in milk samples collected from both
quarters decreased at this time period relative to the previous 12 h (3.0 x 10 6 vs 4.0 x 105
cells/ml, respectively). Additionally, rectal temperature dropped 1 ˚C, when compared
with the previous sampling point (36 h post bacterial challenge; 40.2 to 39.2 ˚C,
respectively). When a milk sample from the rear right quarter was transferred to black
96-well plates for collection of photonic activity, an increment of 5.3 fold in PE relative
to time 36 was observed (4.84 ± 0.50 vs. 0.93 ± 0.13 RLU/s, respectively). This increase
in PE corresponded to a bacterial cell number increment of 2.2 fold (3.1 x 10 3 vs 1.4 x 103
CFU/ml). Although PE did not reach the criteria stipulated to intervene with the
intramammary infusion of Cephapirin sodium, due to the severe systemic distress
observed and the degree of gangrene at the udder level, it was decided to treat the
mastitic quarter with the intramammary antibiotic infusion. From this point to the
following 14 hours the cow’s health status was closely monitored. During this period the
cow was clinically intervened several times by the veterinarians associated to the study
(e.g., i.v. double dose of Flunixin meglumine; 100 mg/45.5 kg body weight) and oral
administration of electrolytes (700 ml of calcium drench, 700 ml propylene glycol and 1
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pack of electrolyte (made by MSU Veterinary Clinic)). The cow was fully recumbent and
had elevated heart rate (85 beats/min). At 56 h post challenge, 500 µl of purulent
secretion from the challenged quarter were taken and SCC as well as PE and bacterial
density were analyzed. Somatic cell counts, relative to the previous sampling time,
decreased to 2.0 x 107 cells/ml, however it was apparent that bacterial numbers had
dramatically increased when a 16.1 fold increase in PE (Fig. 4.10) was detected from the
purulent secretion when imaged. When samples were plated, CFU numbers had, in fact,
increased several logs (3.0 x 103 to 2.4 x 105 CFU/ml). At the PM milking (time 60), the
second intramammary infusion was not able to be infused due to the severe teat tissue
degradation (teat canal was protuberated). The cow at this time was panting, with severe
distress, with the extremities cold (tail and nose) and the quarter skin surface was more
than 50 % gangrenous (Make reference to Fig. 4.18-B for thermography representation of
gangrene distribution in the challenged quarter). Mortality occurred at ~ 63 h post
bacterial challenge, regardless of the clinical interventions conducted to mitigate the
symptoms of the mastitis infection.
Experimental Case Study 3 (Trial 3)
Milk yield at the quarter level at day -2 was 5.71 and 7.34 kg/day in the quarter to
be challenge (rear right) and control quarter (rear left), respectively (Fig. 4.11). During
the pre-challenge period (Times -2, -1 and AM milking of Day 0) health parameters, such
as SCC and rectal temperature, where within normal physiological range. Average SCC
pre challenge (times -2, -1 and in the rear right and rear left quarters were 4.7 x 104 and
8.8 x 104 cells/ml (Fig. 4.14).The average intravaginal temperature during the same
period was 38.3 ± 0.02 ˚C (Fig. 4.12) and max skin surface of the challenged and control
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quarters were 36.5 and 36.7 ˚C, respectively (Fig. 4.13-A). When a portion of the
bacterial suspension used for the intramammary challenge was plated, 7 CFU/ml were
found.
Twelve hours post bacterial inoculation, milk yield in the challenged quarter was
lower than the average PM milkings in days -2 and -1 (3.05 vs 3.85 ± 0.18 kg,
respectively). Somatic cell counts, however, remained unchanged relative to the average
SCC determined between the same sampling points described (2.2 x 10 4 vs 2.4 x 104 ±
3.0 x 103 cells/ml). Photonic emissions collected from the rear right quarter milk were
comparable to background PE (0.135 ± 0.01 vs 0.146 ± 0.01 RLU/s, respectively; Fig.
4.15). When milk samples where plated and incubated, 1 CFU/ml in each of the n = 3
replicates was found (Fig. 4.15). Intravaginal temperature at this sampling point (PM
milking; Time 12) was 0.5 ˚C higher with respective to that measured during the AM
milking (Time 0; 38.7 vs 38.1˚C, respectively), and udder skin surfaces between the two
quarters evaluated were relatively the same (Fig. 4.13-A). Interestingly, a markedly
increase in max skin teat end temperature was observed in both teats relative to the
previous sampling (Time 0; Fig. 4.13-B).
The next morning (24 hours post bacterial challenge), early signs of anorexia
were observed, but no clinical mastitis symptoms in the challenged mammary gland
quarter were observed. However, an increment of ~3.0 ˚C in udder skin surface
temperature in both quarters was detected; with respect to the previous sampling point
(Fig. 4.13-A).Teat end skin temperature however, dropped with respect to Time 12, but
remained elevated relative to basal teat end skin temperatures collected prior to bacterial
challenge (Fig. 4.13-B). Intravaginal temperature at this point was 38.5 ˚C. When milk
from the challenged quarter was analyzed for SCC, a 3.2 fold numerical increase, relative
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to the previous sampling was found (7.0 x 104 vs 2.2 x 104 cells/ml, respectively). In
accordance with this, PE collected from the challenged quarter had increased 8.1 fold
with respect to background PE (1.16 ± 0.04 vs 0.14 ± 0.01 RLU/s, respectively).
Bacterial numbers associated to the milk sample imaged were 3.0 x 10 3 ± 1.2 103
CFU/ml.
At the next milking, 36 hours post bacterial challenge; evident signs of mastitis
were observed. The challenged quarter was showing early signs of swelling, redness, and
felt firm to the touch with elevated temperature. At this time, surface skin temperature of
the challenged and control quarters increased relative to the previous 12 h sampling, with
no apparent differences in skin temperature between these (Fig. 4.13-A). However,
evident differences in teat end skin temperatures were found at this point (Fig.4.13-B).
Intravaginal temperature as well as SCC had also changed to abnormal levels (41.1˚C and
1.9 x 107 cells/ml, respectively). Photonic emissions collected from the challenged
quarter had also noticeable increased when compared to the previous sampling point
(14.9 ± 0.37 RLU/s), with bacterial cell numbers associated to this of 1.2 9 x 105 ± 5.3 x
103 CFU/ml.
Forty eight hours post challenge, degree of swelling had notably increased and
early signs of gangrene in the teat end were observed. Intravaginal temperature remained
elevated with 39.3 ˚C and SCC remained above normal levels (1.6 x 107 cells/ml). Milk
production had markedly decreased relative to the average milk yield in the previous 3
AM milkings (0.38 vs 3.87 kg, respectively; Fig. 4.11). When milk samples from the
challenged quarter were imaged, photonic emissions had increased to 105.6 ± 1.4 RLU/s
with bacterial numbers corresponding to this of 1.7 x 10 6 ± 2.4 x 105 CFU/ml. At this
point the infected quarter was treated with intramammary antibiotic (200 mg/10ml;
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Cephapirin sodium), i.v. double dose of Flunixin meglumine (100 mg/45.5 kg of body
weight) and a subcutaneous injection of Procaine Penicillin G (300,000 U/45.5 kg of
body weight; Butler Schein Animal Health, Dublin, OH). A milk sample was collected 6
h post intramammary antibiotic infusion. Photonic emissions detected at this point had
numerically dropped to 12.9 ± 1.3 RLU/s with bacterial cell numbers associated to this of
4.2 x 104 ± 3.7 x 103 CFU/ml. Twelve hours later (Time 48), the cows was intervene
again with 50 mg/45.5 kg of body weight of Flunixin meglumine, 300,000 U/45.5 kg of
body weight of Procaine Penicillin G and 8 L of oral fluid solution (700 ml of calcium
drench, 700 ml propylene glycol and 1 pack of electrolyte (made by MSU Veterinary
Clinic)).
At time 60, SCC had dropped a log scale (2.0 x 105 cells/ml), intravaginal
temperature decreased to 38.5 ˚C. Photonic emissions detected at this point had decreased
to 0.48 ± 0.07 RLU/s with bacterial cell numbers associated to this of 5.5 x10 2 ± 7.8 x 101
CFU/ml. However, the cow remained clinically ill and the infected quarter was showing a
higher degree of gangrene, characteristic of purple skin discoloration and lower skin
temperature, relative to the control quarter, as shown in Fig. 4.13-A and B. In addition,
the front homolateral quarter was showing early signs of swelling and redness, therefore a
milk sample was collected for imaging as a means for in real time detection of the
presence of bioluminescent S. aureus RF122. Photonic emissions collected from the front
right quarter in effect were 1.9-fold greater than background noise collected from the
control quarter (0.32 ± 0.01 vs 0.18 ± 0.02 RLU/s, respectively), with bacterial numbers
associated to this of 1.8 x 103 CFU/ml. Somatic cell counts corresponding to the imaged
milk sample were in the millions of cells (2.3 x 106 cells/ml). The cow was given a
second intramammary infusion of Cephapirin sodium, in each quarter regardless of the
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symptoms (the two left quarter were not showing any sign of infection), as well as double
doses of Procaine Penicillin G and Flunixin meglumine (600,000 U/45.5 kg and
100mg/45.5 kg of body weight, respectively).
At time 72, SCC in the challenged quarter remained in the same log scale as in the
previous sapling point (3.9 x 105 cells/ml) and intravaginal temperature had decreased to
38.6 ˚C. However, the challenged quarter had progressively deteriorated with the whole
lower quarter becoming purple and colder. Interestingly, when milk samples were
analyzed, PE showed an 8.23 fold increment in RLU/s relative to the previous imaging
time point (3.9 ± 0.10 vs 0.48 ± 0.07, respectively; Fig. 4.15). Bacterial cell numbers
corresponding to this also increased to 1.2 x 104 ± 3.3 x 102 CFU/ml. In addition, the front
right quarter showed a higher degree of swelling and hardiness, protuberating toward the
abdominal area with milk SCC reaching tens of millions of cells (i.e., 1.2 x 107 cells/ml).
Photonic emissions in milk samples collected from the front right quarter had dropped to
0.15 ± 0.02 RLU/s, however remained above background photonic noise. At this point,
the cow was not milked due to the level of distress and all quarters were treated with
intramammary antibiotic. Six hours later, a subcutaneous injection with oxytetracycline
(Liquamycin LA-200; Pfizer Animal Health; 19.8 mg/kg body weight) was administered
to the cow. Systemic symptoms at this time period had slightly improved (consumption
of feed/water and more awareness).
At time 84, although systemic symptoms had noticeable improved; at the quarter
level (rear right) purple skin discolouration was progressively spreading with purulent
secretions leaking out from the challenged quarter teat end orifice. Purulent secretions
were collected, imaged (2.23 ± 0.08 RLU/s) and plated (1.3 x 104 ± 2.8 x 102 CFU/ml).
The front right quarter remained hard, hot and swollen with SCC increasing within the
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hundreds of millions (1.8 x 108 cells/ml). The cow was intervened once again with a
double dose of anti-inflammatory as well as an intramammary antibiotic instillation with
Cephapirin sodium into the two right quarters (same doses as described above). The next
day (Time 96), SCC in the challenged quarter had dropped to 8.2 x 10 3 cells/ml and
systemic symptoms had also noticeable improved. However, the quarter remained
deteriorating with deeper purple skin discolouration covering more than 50% of the
dorsal portion of the challenged quarter (make reference to Fig. 4.18-C for thermography
representation of gangrene distribution in the rear right quarter). As a means to prevent
further necrotizing mastitis, it was decided to euthanize the animal. Within 30 min post
euthanasia, the mammary gland was excised and tissue sections from the challenged,
front right and rear left quarter (control) were obtained for histological analysis and for
whole tissue imaging. Whole tissue imaging was performed within 30 min of mammary
gland dissection. Photonic emissions collected from these tissues as well as bacterial
density corresponding to the areas of interest are shown in Fig. 4.16.
DISCUSSION
In this study we investigated the use biophotonic imaging techniques to monitor
bacterial progress, and clearance post antibiotic treatment, in real time as during
experimentally induced bovine mastitis. To our knowledge, this is the first study
conducted using a bioluminescent transformant pathogen to monitor bacterial presence in
real time in an in vivo bovine mastitis model. Conferring bioluminescent properties to S.
aureus RF122 by incorporation of the lux operon seems to cause no physiological
alterations to the pathological characteristics of the pathogen. This is supported by the
similarities in bacterial concentration used in the current study to induce mastitis and the
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clinical mastitis outcomes (i.e., temporal changes in SCC, rectal temperature and
bacterial numbers) observed between the present report and a previous study where a non
bioluminescent S. aureus RF122 wild type was used in vivo bovine mastitis models (5
CFU; Seo et al. personal communication). In addition, these findings are in agreement
with a study where a similar luciferase-based reporter system was used to monitor the
association between S. aureus cell density and the expression of toxic shock syndrome
toxin-1 gene in real time (tst; Timmins and Holland, 1999). These researchers reported
that incorporation of the lux AB in S. aureus did not affect the general physiology of the
bacterium and that this system resulted in a sensitive reporter of the tst expression.
Therefore, the use of lux reporters incorporated into bacteria represents an efficient
model to monitor bacterial progression in vivo infectious models.
Imaging of bioluminescent bacteria through the bovine mammary gland tissue
would represent a more practical and rapid approach to monitor bacterial progress in vivo,
however due to previous findings obtained in vitro studies conducted in our laboratory
(Curbelo et al. in prep), monitoring of bacterial progress was conducted in milk collected
from inoculated quarters. In the mentioned study, while detection of S. aureus Xen8.1
through mammary gland teats was very low (< 4 RLU/s), it required a superphysiological
bacterial concentration (3.5 x 1014 CFU). In addition, in the mentioned study, PE
collected from inoculated bovine milk with S. aureus Xen8.1 where 1.67 times greater
than PE collected when the same pathogen with similar bacterial concentration (2.6 x
107± 7.5 x 106 vs 3.7 x 107± 1.7 x 106; P > 0.05) was imaged in a traditional bacterial
growth media (LB broth; 245.3 ± 13.5 vs 75.2 ± 3.7 RLU/s, respectively). Therefore, due
to these findings it was suggested that imaging through the bovine mammary gland tissue
may be restricted due to tissue thickness and superphysiological concentrations of
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bacteria needed to detect photonic activity indicative of S. aureus-Xen8.1 presence and
consequently imaging of bioluminescent bacteria in milk samples would be the adequate
approach to monitor bacterial presence in vivo bovine mastitis models.
Although in the present study a small number of animals (n = 3) were employed
to test this novel approach, consistent observations regarding to the onset of clinical
outputs were found between the subjects tested. While differences in the bacterial
inoculum concentration between the present study (ranging from 25 to 7 CFU) and other
studies conducted using S. aureus for bovine mastitis models (Hensen et al., 2000;
Shoshani et al., 2000; 200 and 2,000 CFU, respectively), clinical mastitis output
similarities were observed. For instance an initial increment in SCC was first observed 24
h post bacterial challenged in the current and mentioned studies (Hensen et al., 2000;
Shoshani et al., 2000). In addition, S. aureus RF122 was first recovered from milk
samples 24 h post bacterial challenge, as well as in Shoshani et al. (2000), which in the
present study corresponded to the first numerical increase in PE found in the three Trials.
Although in the present study S. aureus cells were found in cultured plates with milk
samples collected 12 h post inoculation (ranging from 1 to 5 CFU; Trials 1 and 2,
respectively), these were not associated to an immune response, as determined by the
similar concentrations of SCC between the pre-challenge period and 12 h post bacterial
inoculation. The similarities observed in bacterial shedding pattern and SCC changes
between the current and mentioned studies, even when bacterial inoculum concentrations
deffered, could be attributed to the highly adaptive and virulent S. aureus strain used in
the current study relative to the previously mentioned studies (Hensen et al., 2000;
Shoshani et al., 2000), were S. aureus strains associated to subclinical mastitis infections
were used. This is supported by the dramatic drop in milk yield observed in the current
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study relative to that observed in Shoshani et al. (2000), where no significant differences
were found in milk yield between inoculated and control quarters. Although the initial
drop in milk yield observed in the current study is mostly associated to anorexia,
(decreased in milk yield in all quarters regardless of the infection status), milk yield loss
in infected quarters late during the infection could be attributed to damage of mammary
gland parenchymal tissue. The advanced necrosis stage found in Trials 2 and 3 are
evidence of the substantial tissue degradation; that although not histologically confirmed
in Trials 1 and 2, it was evident in Trial 3. For instance, morphological examination of
dissected mammary gland tissue samples collected from Cow # 712 illustrate a sharply
demarcated area of grey green discoloration (necrotizing mastitis) as well as expansion of
interlobular septae by edema fluid, characteristics of necrotizing mastitis (Fig. 4.16; front
right quarter). In addition, histological analysis of mammary gland cross sections
collected from the same quarter show evident coagulative necrosis (Fig. 4.17; Panel A),
degradation of vascular tissues (vasculitis; Panel B), and karyolysis of mammary gland
skin (Panel D). In agreement with these findings, S.aureus mastitis has been associated
with mammary parenchymal tissue necrosis, either indirectly by eliciting a massive
infiltration of neutrophil cells as reported by Heald (1979), and/or directly by production
of proteases that digest cell membranes, directly damaging parenchymal tissue (Heald,
1979; Nickerson and Heald, 1981).
The rapid development of clinical mastitis symptoms and the acute response
observed in the cases reported here could be explained by the wide repertory of
exotoxins, catabolic enzymes, and cytotoxic proteins expressed by S. aureus (Garzoni et
al., 2007). For instance, S. aureus RF122 produces several extracellular protein such as αtoxin, β-toxin (deleted in Trial 3), and phospholipase C which, in conjunction, are
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responsible for the cytotoxic effects on erythrocyte and immune cells as well as
hydrolysis of membrane lipid and protein-containing phospholipase-C in mammalian
cells (Bhakdi and Tranum-Jensen, 1991; Daugherty and Low, 1993; Marshall et al.,
2000). The persistence S. aureus RF122 post antibiotic treatment observed in Trials 2 and
3 could be attributed to severe tissue degradation, featured by the acute gangrene,
therefore making antibiotic treatments ineffective due to the poor diffusion of antibiotics
into an avascular region (Refaely and Weissberg, 1997). Another putative explanation for
the persistence of S. aureus RF122 in challenged mammary gland quarters found in Trials
1 and 2 is the ability of this pathogenic bacterium to internalize in mammalian cells
(Garzoni and Kelley, 2009; Herron-Olson et al., 2007). Herron and collaborators (2007),
suggested that S. aureus RF122 could be altering biosynthetic components toward the
adaptation of intracellular survival. This scenario is supported by the fact that genes
required for extracellular survival, such as those that code for the expression of antibiotic
resistance, iron metabolism, adhesion and host protein-binding proteins, have decayed in
S. aureus RF122 (Herron-Olson et al., 2007).
In general, the onset of clinical mastitis symptoms (temporal response of SCC,
body temperature, clinical symptoms at the quarter level) was similar in the three Trials,
with the exception of the temporal bacterial proliferation observed in Trial 1. The delay
in the temporal bacterial proliferation observed in Trial 1, relative to Trial 2 and Trial 3,
could be attributable to differences in immune response between breeds. It has been
reported that differences exist in the innate immune response associated to the differences
observed in the prevalence of mastitis in Holstein and Jerseys. For example, in an
experimental mastitis E. coli challenge, temporal onset, cessation and duration of several
immune parameters in Holsteins and Jersey was found (Bannerman et al., 2008).
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However, these authors reported that overall innate immune responses were similar
between these two breeds (Bannerman et al., 2008). An alternative explanation for the
differences in mastitis outputs observed in Trial 1 vs Trials 2 and 3 could be then
attributed to the development of an adaptive immune response during previous exposure
to S. aureus mastitis.
In cow # 138 (Trial 1), at the initiation of lactation (induced), S. aureus was
isolated from the rear right quarter (> 1.0 x 104 CFU/ml; natural infection). Furthermore,
prior to the intramammary challenge with S. aureus RF122, two different intramammary
inoculations with 2 different S. aureus strains were performed, during previous Trials
(data not shown). The first experimental inoculation (Front Left quarter) was performed
with 7.0 x 102 CFU of a commercially available human isolate bioluminescent S. aureus
(Xen8.1; Caliper Life Sciences). In this Trial, an increase in SCC relative to baseline
levels was observed 24 h post inoculation (1. 8 x 103 vs 4.9 x 106 cells/ml) with low
numbers of viable cells recovered in milk 48 h post bacterial challenge (i.e., < 10
CFU/ml). Somatic cell counts returned to baseline levels after 72 h of inoculation and S.
aureus Xen8.1 cells at this point were not detected in cultured milk samples. A second
inoculation (front right quarter) was performed with 1.2 x 10 3 CFU of a bioluminescent
transformant bovine isolate (S. aureus Newbould 305 pkA4-lux). In this Trial, SCC
increased over baseline levels at 24 h post bacterial challenge. Viable S. aureus
Newbould 305 cells were observed in cultures in the range of 1.0 x 10 3 CFU during the
first 36 h post challenge. However, 72 h later no viable cells were recovered in cultured
milk samples. Therefore, it is evident that an immune response was elicited, as seen by
the increment in SCC above baseline levels. This could result in activation of the
adaptive immune response and production of antibodies against S. aureus antigens.
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However, the period from the first S. aureus challenge (S. aureus Xen8.1) and the
intramammary inoculation with RF122 occurred in less than 2 weeks. It has been
suggested that the time required for antigen processing and production of antibodies
against S. aureus components, such as Enterotoxin D, requires at least 6 weeks
(Tollersrud et al., 2006). However, as mentioned earlier, a naturally occurring S.aureus
mastitis was detected during the onset of lactation. Nevertheless, it is unknown how long
this pathogen was present in the quarter; however, according to the subclinical
appearance (normal milk accompanied by no clinical signs of inflammation) it suggests
that it developed during the dry period and remain chronic, as a characteristic of S.
aureus mastitis. Further analysis of specific antibodies in blood samples collected during
the mentioned Trial will be required to determine if antibodies against this pathogen were
produced (Cow # 138 was not prescreened for determination of previous expose with S.
aureus).
Previous exposure to S. aureus strains (other than strain RF122) seems to provide
no benefit regarding to a faster immune response, as seen in Fig. 4.4, 4.8, and 4.12,
therefore an effective action toward elimination of the invading pathogen. This statement
is supported by the fact that the first increment in SCC was found 24 h post bacterial
challenge in all three cows regardless of previous exposure to S. aureus. Moreover, in all
three cows, SCC increased to 107 SCC/ml 36 h post bacterial challenge. These findings
suggest that S. aureus RF122 possess many specialized virulence factors, such as those
required for evasion of the immune response (i.e., Superantigens) that are not found in
the previous S. aureus strains used in Trial 1 (Xen8.1 and Newbould 305). Further
analysis of the expression of specific virulence factors could provide relevant information
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about determinants required for evasion of the immune system and eventual colonization
of the mammary gland.
Furthermore, the low PE detection observed relative to the number of
bioluminescent S. aureus cells recovered in milk samples during sampling points 24 to 84
in Trial 1could be attributable to alterations in the metabolic status of S. aureus RF122
during early development of mastitis. For instance, S.aureus can regulate several genes
during the different stages of infection through a complex regulatory network set of
transcription factors, such as the accessory gene regulator (Frees et al., 2005; Novick,
2003). These global regulatory genes has been described to act in a time and density
dependent fashion to integrate signals received from the environment and the internal
metabolic system of the bacterium to achieve the production of particular virulence
factors appropriate to the needs of the organism during the infection progress (Novick,
2003). In addition, extensive alterations in bacterial gene expression have been reported
upon S. aureus internalization in human epithelial cells (Garzoni et al., 2007). These
researchers found significant down regulation of metabolic pathways such as cell
division, nutrient transport and regulatory processes, whereas up regulation of genes
associated with iron transport and virulence factors was observed (Garzoni et al., 2007).
Consequently, since the bioluminescent reaction of bacterial lux system requires
metabolization of molecules such as FMNH2 and aldehyde generated by the bacterial
host, PE generated by the lux genes incorporated into bacterial transformants are directly
related to the metabolic status of the host (Unge et al., 1999). Therefore, the use of
bioluminescence as a biomarker for in real time and in vivo monitoring of mastitis
progression could also provide information regarding the metabolic status of pathogens
during the different stages of mastitis. Biophotonic imaging coupled with molecular
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biology techniques (PCR, Western Blot) as a means to determine type and concentration
of a particular immunological component (IG, antimicrobial peptides, neutrophils and/or
antibodies, etc.) present during changes observed in light activity could provide insight
regarding pathogenesis of mastitic pathogens.
Monitoring bacterial proliferation during mastitis development by imaging
bioluminescent bacteria from milk samples collected from infected quarters resulted to be
an excellent predictor of bacterial numbers in real time in vivo. This is supported by the
highly and significant correlation found in the present study; r2 = 0.97 in Trials 1, and r2
= 0.99 in Trials 2 and 3; P < 0.0001). However, it was evident that once mastitis
symptoms associated to the bacterium employed in this study are developed, such as
complete loss in milk yield; monitoring of bioluminescent bacteria in milk was not longer
possible. Therefore, even when large numbers of S. aureus RF122 remained in the
infected quarter (as observed in post mortem whole imaging of mammary gland tissues;
Fig. 4.16), assessment of the efficacy of mastitis antibiotics using milk samples may not
represent an appropriate approach. This is supported by the fact that high numbers of S.
aureus RF122 were recovered from mammary gland tissues collected post mortem than
those collected from mammary gland secretions, post cessation of milk synthesis.
Nevertheless, the high levels of PE collected from mammary gland tissues post mortem,
suggests that imaging of bacterial presence through the udder tissue might be feasible, if
optimized optical instrumentation coupled with better bioluminescent probes and agents
that increase transference of PE are used. This could represent an efficient model for in
real time detection, providing immediate information about bacteria presence and
distribution. Further investigation of the use of optical instrumentation for in vivo
imaging is required to validate more efficient models.
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Figure 4.1

Experimental Case Study 1. Challenged quarter (rear left) milk yield pre
and post experimental mastitis induction with bioluminescent
Staphylococcus aureus RF122 in Cow # 138.

Milking was performed twice a day, 12 hours apart, using an electric portable milking
machine. Milk from the challenged quarter (rear left) was collected and weighed
individually using quarter milker. Milk yield pre (Time -48, -24 and 0) and post bacterial
challenge (Time 12 to 168) is expressed in kg/day. As shown in this Figure, milk yield
decreased 76.7 % 24 h post bacterial challenge and remained low throughout the Trial
(i.e., <1.0 kg/day).
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Figure 4.2

Experimental Case Study 1. Rectal and room temperature pre and post
experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 138.

Rectal and room temperatures where determined with the use of an electronic digital
thermometer (GLA M500). Rectal temperatures were collected by full insertion of the
thermometer probe into the rectal cavity and registered once the lecture was stable for
10s. During room temperature determination, the thermometer was placed inside the
animal cage and lecture registered using the same approach mentioned previously.
Temperatures were collected once a day from times -48 and -24, every 12 h from time 12
to 84, and approximately every 6 h from time 84 to 177 post challenge
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A

Figure 4.3

Experimental Case Study 1. Udder skin surface temperatures (Panel A) and
teat-end skin surface temperatures (Panel B) of challenged and control
quarters determined by thermography imaging pre and post experimental
mastitis induction with bioluminescent Staphylococcus aureus RF122 in
Cow # 138.

Imaging of the hind quarters was performed prior to milking once a day, during the
acclimation period, to determine basal udder surface temperature, and twice a day prior to
each milking, post bacterial challenge using the FLIR SC660 thermography unit and
thermal patterns quantified using ThermalCamTM Researcher Pro 2.7. Quantification of
thermal images was performed using rectangular transects drawn over the infected and
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control rear quarters (Panel A) as well as in the rear teat ends (Panel B) of each quarter.
Skin surface max temperature (˚C) at each imaging point is shown in this figure.
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Figure 4.4

Experimental Case Study 1. Milk somatic cell counts (SCC) pre and post
experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 138.

A milk sample (10 ml) was aseptically collected, prior to each corresponding milking,
and analyzed within 30 min for in site determination of milk SCC using a De Laval cell
counter. Milk samples were analyzed for SCC once a day from times -48 and -24, every
12 h from time 12 to 84, and approximately every 6 h from time 84 to 177 post challenge.
Milk SCC where within physiological concentration (< 2.0 x 10 5 cells/ml) from time -48
to 12. At time 24 h post bacterial challenge, SCC had increased to (2.6 x 10 5 cells/ml).
However, as early as 30 h post bacterial challenge SCC had increased 2 log scales
relative to time 24 (2.4 x 107 cells/ml). Milk SCC in the challenged quarter remained
within the levels observed in infected bovine mammary glands; even 4 days post the
initial intramammary antibiotic infusion (administered at time 120 post bacterial
challenge).
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Figure 4.5

Experimental Case Study 1. Bacterial Density and Photonic Emissions (PE)
post experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 138.

Milk samples from the challenged quarter and control quarter (100 µl; n = 5/trt;) were
transferred to a black 96 well plate and imaged for 10 min acquisition time using the
XR/MEGA-10ZeroTM imaging system. Sampling points represent the mean PE from the
challenged quarter subtracted to PE collected from the rear right quarter milk
(background PE) and standardized to relative light units per s (RLU/s). Data are shown as
mean log10 RLU/s ± SEM. Immediately after imaging, the content of n = 3 wells was
plated to determine bacterial cell numbers (expressed in CFU/ml) in the imaged milk
samples. Data are shown as mean log10 CFU/mL ± SEM. A highly significant (P <
0.0001) and positive coefficient of correlation (r2 = 0.97) between the mean PE and mean
CFU/ml at each sampling point during the in vivo Trial was found.
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Figure 4.6

Experimental Case Study 2. Control quarter (rear left) and challenged
quarter (rear right) milk yield pre and post experimental mastitis induction
with bioluminescent Staphylococcus aureus RF122 in Cow # 609.

Milking was performed twice a day, 12 hours apart, using an electric portable milking
machine (Porta-Milker). Milk from the challenged and control quarters were collected
and weighed individually using quarter milkers. Milk yield pre (Time -48, -24 and 0) and
post bacterial challenge (Time 12 to 168) is expressed in kg/day. As shown above, a
progressive milk yield decrease was observed 24 h post challenged in both the control
and challenged quarter.
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Figure 4.7

Experimental Case Study 2. Rectal and room temperature pre and post
experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 609.

Rectal and room temperatures where determined with the use of an electronic digital
thermometer (GLA M500). Rectal temperatures were collected by full insertion of the
thermometer probe into the rectal cavity and registered once the lecture was stable for
10s. During room temperature determination, the thermometer was placed inside the
animal cage and lecture registered using the same approach mentioned previously.
Temperatures were collected once a day from times -48 and -24 and every 12 h from time
0 to 60. As observed in this graph, rectal temperatures where within physiological range
during the period pre bacterial challenge (ranging from 37.3 to 37.8 ˚C) and progressively
increased 12 h post bacterial challenged to reach 40.2 ˚C at time 36 post challenge. The
drop in temperature observed from time 39 to 60 post bacterial challenge can be
attributable to the interventions made where the cow was treated with anti-inflammatory.
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Figure 4.8

Experimental Case Study 2. Udder skin surface temperatures (Panel A) and
teat-end skin surface temperatures (Panel B) of challenged and control
quarters determined by thermography imaging pre and post experimental
mastitis induction with bioluminescent Staphylococcus aureus RF122 in
Cow # 609.

Imaging of the hind quarters were performed prior to milking once a day, during the
acclimation period, to determine basal udder surface temperature, and twice a day prior to
each milking, post bacterial challenge using the FLIR SC660 thermography unit and
thermal patterns quantified using ThermalCamTM Researcher Pro 2.7. Quantification of
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thermal images was performed using rectangular transects drawn over the infected and
control rear quarters (Panel A) as well as in the rear teat ends (Panel B) of each quarter.
Skin surface max temperature (˚C) at each imaging point is shown in this figure.
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Figure 4.9

Experimental Case Study 2. Control quarter (rear left) and challenged
quarter (rear right) milk somatic cell counts (SCC) pre and post
experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 609.

A milk sample (10 ml) was aseptically collected and analyzed within 30 min for in site
determination of milk somatic cell count (SCC) using a De Laval cell counter. Milk
samples were analyzed for SCC once a day from times -48 and -24 and every 12 h from
time 0 to 56. Milk SCC where within physiological concentration (< 2.0 x 10 5 cells/ml)
from time -48 to 12. However, at 36 h post bacterial challenge, SCC had reached several
log scales higher than the control quarter (2.5 x 10 7 vs 6.4 x 105 cells/ml, respectively).
Milk SCC in the challenged quarter slightly decreased at time 48, with respect to the
previous 12 h but remained elevated relative to the untreated quarter from this time
throughout the end of the Trial.
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Figure 4.10

Experimental Case Study 2. Bacterial Density and Photonic Emissions (PE)
post experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122.

Milk samples from the challenged and control quarter (100 µl; n = 5/trt;) were transferred
to a black 96 well plate and imaged using the XR/MEGA-10ZeroTM imaging system.
Sampling points represent the mean PE from the challenged quarter subtracted to PE
collected from the control quarter milk (background PE) and standardized to relative light
units per s (RLU/s). Data are shown as mean log10 RLU/s ± SEM. Immediately after
imaging, the content of n = 3 wells were plated to determine bacterial cell numbers
(expressed in CFU/ml) in the imaged milk samples. Data are shown as mean log10
CFU/mL ± SEM. A highly significant (P < 0.0001) and positive coefficient of correlation
(r2 = 0.99) between the mean PE and mean CFU/ml at each sampling point during the
Trial was found.
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Figure 4.11

Experimental Case Study 3. Control quarter (rear left) and challenged
quarter (rear right) milk yield pre and post experimental mastitis induction
with bioluminescent Staphylococcus aureus RF122 in Cow # 712.

Milking was performed twice a day, 12 hours apart, using an electric portable milking
machine. Milk from the challenged and control quarters were collected and weight
individually using quarter milkers. Milk yield pre (Time -48, -24 and 0) and post bacterial
challenge (Time 12 to 96) is expressed in kg/day. As shown above, a progressive
decrease in milk yield occurred 24 h post challenged in both the control and challenged
quarter.
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Figure 4.12

Experimental Case Study 3. Intravaginal and room temperature pre and
post experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 712.

Intravaginal and room temperatures were collected automatically with the use of HOBO
Water Temp Pro thermometers. Intravaginal and room temperatures are represented as
the average of 4 lectures (temperatures collected every 15 min) taken each hour during
the period pre and post bacterial challenge. As shown in this graph, rectal temperatures
where within physiological ranges during the period pre bacterial challenge (ranging
from 37.8 to 38.8 ˚C) and progressively increased 24 h post bacterial challenged reaching
40.1 ˚C at time 28. Maximum intravaginal temperature was collected at 39 h post
challenge (41.2 ˚C). The initial drop in intravaginal temperature was independently from
any treatment (cow was not intervened with antimicrobials and/or anti-inflammatory until
Time 48). The drop in temperature observed at 48 h post bacterial challenge corresponds
to the first clinical intervention. A progressive decrease in temperature can be seen from
time 60 to 96, which corresponded to the beginning of the intramammary antibiotic
therapy and anti-inflammatory interventions.
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Figure 4.13

Experimental Case Study 3. Udder skin surface temperatures (Panel A) and
teat-end skin surface temperatures (Panel B) of challenged and control
quarters determined by thermography imaging pre and post experimental
mastitis induction with bioluminescent Staphylococcus aureus RF122 in
Cow # 712.

Imaging of the hind quarters were performed prior to milking once a day, during the
acclimation period, to determine basal udder surface temperature, and twice a day prior to
each milking, post bacterial challenge using the FLIR SC660 thermography unit and
thermal patterns quantified using ThermalCamTM Researcher Pro 2.7. Quantification of
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thermal images was performed using rectangular transects drawn over the infected and
control rear quarters (Panel A) as well as in the rear teat ends (Panel B) of each quarter.
Skin surface max temperature (˚C) at each imaging point is shown in this figure.
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Figure 4.14

Experimental Case Study 3. Control quarter (rear left) and challenged
quarter (rear right) milk somatic cell counts (SCC) pre and post
experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 712

A milk sample (10 ml) was aseptically collected, and analyzed within 30 min for in situ
determination of milk SCC using a De Laval cell counter. Milk samples were analyzed
for SCC once a day from times -48 and -24 and every 12 h from time 0 to 96. Milk SCC
where within physiological concentration (< 2.0 x 10 5 cells/ml) from time -48 to 12. At
36 h post bacterial challenge, SCC had reached several log scales higher than the control
quarter (1.9 x 107 vs 7.0 x 105 cells/ml, respectively). Milk SCC collected from the
challenged quarter noticeable decreased from time 48 to 60, but remained elevated
relative to the previous sampling points. At 36 h post challenge; however, SCC in the
control quarter progressively increased throughout the end of the Trial.
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Figure 4.15

Experimental Case Study 3. Bacterial Density and Photonic Emissions (PE)
post experimental mastitis induction with bioluminescent Staphylococcus
aureus RF122 in Cow # 712.

Milk samples from the challenged and control quarter (100 µl; n = 5/trt) were transferred
to a black 96 well plate and imaged using the XR/MEGA-10ZeroTM imaging system.
Sampling points represent the mean PE from the challenged quarter subtracted to PE
collected from the control quarter milk (background PE) and standardized to relative light
units per s (RLU/s). Data are shown as mean log10 RLU/s ± SEM. Immediately after
imaging, the content of n = 3 wells were plated to determine bacterial cell numbers
(expressed in CFU/ml) in the imaged milk samples. Data are shown as mean log10
CFU/mL ± SEM. Imaging of milks samples with further bacterial numbers determination
was performed every 12 h. A highly significant (P < 0.0001) and positive coefficient of
correlation (r2 = 0.99) between the mean PE and mean CFU/ml at each sampling point
during the in vivo Trial was found.
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Figure 4.16

Ex vivo imaging of bioluminescent S. aureus RF122 in challenged (rear
right), naturally infected (front right) and uninfected (rear left) mammary
gland quarters.

Cow in Trial 3 was euthanized and the udder excised within 30 min. Tissue samples from
the challenged, front right and rear left quarter were dissected and collected into
containers for imaging and histological analysis (Fig. 6). Within 30 min, tissues were
imaged with the XR/MEGA-10ZeroTM imaging system and photonic emissions collected
(2 min acquisition time). During imaging of tissues, fluid (i.e., blood; 1 ml) from each
container was collected into centrifuge tubes and imaged (letters C, D and A in the
challenged, front right and rear left quarter, respectively) and aliquots plated to determine
if bacterial presence in the tissues corresponded to bacterial contamination from fluids.
After imaging, areas of interest (labeled with yellow letters as corresponding in each
imaged quarter) were swabbed, swabs placed in1 ml sterile PBS and the content plated to
allow comparison of PE activity with number of S. aureus RF122 cell.
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Figure 4.17

Histological evaluation of cross section mammary gland tissues (front right
quarter) infected with S. aureus RF122 in cow # 712.

In panel A, the area under the arrows shows an example of coagulative necrosis featured
by loss of cellular integrity (pyknosis, karyorrhexis, and karyolysis). The area pointed by
the arrows illustrates a sharp line of demarcation featured by a high density of
inflammatory cells between full necrotic tissue (lower area) and acute inflamated tissue
(upper area). The upper area (above the arrows) shows acute inflammation; however,
cellular integrity still visible (see Fig. 5 Front Right quarter picture for morphology
illustration of the tissue where samples were collected). Panel B illustrates evident
vasculitis featured by karyorrhexis (upper arrow) and karyolysis (bottom arrow) of the
vascular wall cells. Panel C represent a cross section of a bovine mammary gland tissue
sample collected from intact skin whereas Panel D illustrates tissue samples collected
from necrotic skin.
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Figure 4.18

Quantification of thermal images and thermography imaging of infected
(rear right) and control (rear left) mammary glands with Staphylococcus
aureus RF122 in cows 609 and 712.
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Representation of thermal images quantified to determine skin surface temperature of the
infected and control hinder quarters and their corresponding teat ends (Panel A). Thermal
patterns were quantified using the ThermalCamTM Researcher Pro 2.7 software, were
vertical rectangular transects were drawn on thermal images of infected and control
hinder quarters as well as in teat ends of each quarter to calculate the average and SD
skin surface temperature (˚C). Thermography imaging of the challenged quarter in Cow #
609 (Panel B) and in Cow # 712 (Panel C) with S. aureus RF122-lux. Purple regions of
the challenged quarter’s thermal images (right quarter) represent gangrenous areas, as
they become colder.
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